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Preface
The employment of computers, software tools, and internet services in basic sciences 
and medicine has led to changes in investigation methodologies. This occurrence 
resulted in the establishment of multidisciplinary sciences involving bioinformatics 
and systems biology. The computational multidisciplinary sciences represented new 
types of studies and laboratories. In silico investigations and dry laboratories have been 
the invaluable products of these sciences. The serious and continuous activities in this 
regard led to the accumulation of a huge amount of digital data (bioinformatic data) in 
the form of databases. These progressions and facilities resulted in invaluable outcomes 
such as computational biology and chemistry. I call them soft biology and chemistry.
The reason for the success and progression in soft biology and chemistry is the 
appearance of effective and precise bioinformatic software tools and databases such as 
the National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.
nih.gov/), Kyoto Encyclopedia of Genes and Genomes (KEGG) (https://www.genome.
jp/kegg/), and Research Collaboratory for Structural Bioinformatics PDB (RCSBPDB) 
(https://www.rcsb.org/).
Visualization and 3-dimentionization of different biomolecules, structures, and 
complexes are the most fantastic facilities that are provided and represented by 
bioinformatics, systems biology, computational biology, and chemistry.
The results of traditional investigations within wet labs by molecular biologists, 
biologists, biochemists, and chemists produced only raw data including nucleotides 
and amino acid sequences.
With the appearance of bioinformatics and the use of computational technologies, 
we are able to visualize these data to have their putative spatial configurations and 
conformations. Today, we are able to 3-dimensionalize the discovered raw data to 
have a limited imaging capability of their natural structure to understand the related 
characteristics, practicalities, and functionalities.
Moreover, the use of computational biology and chemistry has had effective conse-
quences in pharmaceutics. As we know, the traditional procedure of preparation and 
provision of a drug or antibiotic includes several control and check processes in differ-
ent levels of assays. These procedures and processes cost a lot of money and takes a long 
duration of time.
Recruitment of computational biology and chemistry represents a great opportunity for 
pharmaceutics. Drug designing is a brilliant bonus to pharmaceutics to shorten technical 
procedures and duration of time to reduce the costs of drugs and antibiotics. 
All in all, we are at the beginning point of the soft biology and chemistry pathway. 
The progressions of these scientific disciplines support us to have incredible imaging, 
illustration, and interpretation of the obtained raw data in traditional wet labs. In the 
future we can have a precise image of the reason of spatial architecture of different 
biomolecules and their interactions with other structures and complexes. The dry labs 
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pharmaceutics. Drug designing is a brilliant bonus to pharmaceutics to shorten technical 
procedures and duration of time to reduce the costs of drugs and antibiotics. 
All in all, we are at the beginning point of the soft biology and chemistry pathway. 
The progressions of these scientific disciplines support us to have incredible imaging, 
illustration, and interpretation of the obtained raw data in traditional wet labs. In the 
future we can have a precise image of the reason of spatial architecture of different 
biomolecules and their interactions with other structures and complexes. The dry labs 
determine the future of biology and chemistry!
IV
The book “Computational Biology and Chemistry” is a collection of invaluable results 
and outcomes obtained by global and international scientists. This book involves seven 
chapters in five sections.
The first chapter is written by the editor and it completes the first section of the book. 
This chapter has a deep look at the background and historical features regarding the 
establishment of bioinformatics and computational biology and chemistry.
Section two comprises the single chapter (Chapter two) entitled: “Search Proteins Based 
on Human-Specific Availability Scores of Short Constituent Sequences: Identification of 
a WRWSH Protein in Human Testis”. This chapter presents great information regarding 
in vitro-in silico studies.
Section three includes two chapters entitled: “Bioinformatics as a Tool for the Structural 
and Evolutionary Analysis of Proteins” and “Scaffolding Contigs Using Multiple 
Reference Genomes”. These chapters offer brilliant information in association with the 
importance of bioinformatics and the related software tools and databases for analyzing 
proteins and genomes.
Section four contains two chapters, entitled: “Biological Evaluation and Molecular 
Docking Studies of a Double Active Pharmaceutical Ingredient, Benzalkonium 
Ibuprofenate” and “Hydrazones: An Important Scaffold to Construct Fluorescent 
Chemosensor for Biological purposes”. These chapters provide fabulous information 
in the fields of computational biology and chemical monitoring.
Section five as the final section involves Chapter seven entitled: “Systems Glycobiology: 
Past, Present, Future”. This chapter reveals the linkage between bioinformatics, 
databases, systems biology, and computational biology. An informative chapter with 
fantastic outcomes!
I, as the Editor of the book “Computational Biology and Chemistry”, am honored and 
thankful to have marvelous cooperation and collaboration with valuable scientists from 
different countries and continents. They contributed as informative authors in this 
brilliant book. This book offers up-to-date information in the field to readers worldwide. 
And finally, I have special thanks to my Italian colleague Dr. Nicola Bernabò from 
Università Degli Studi di Teramo, who collaborated with me as an invaluable Co-editor, 
Dolores Kuzelj the Author Service Manager, Lucija Tomicic-Dromgool and Martina 
Usljebrka Kauric the Commissioning Editors of IntechOpen for their excellent 
collaboration, management, and arrangement for preparing this valuable book.
Dr. Payam Behzadi
Department of Microbiology,

















Introductory Chapter: From Hard 
to Soft Biology
Payam Behzadi
1. Experimentation and computation
On the evening of Monday, April 13, 2020, during “the Wuhan-China virus 
(COVID-19) Home-Self Quarantine Era,” I was drinking coffee and simultaneously 
searching on Google Scholar to find some valuable papers regarding “computational 
biology.”
Among a mass of article links, an article entitled “laptop biology” [1] attracted 
me. I began to read this paper carefully and found some valuable terms including 
“hard science” and “soft science.” Indeed, the term “soft science” was used for 
“experimentation, classification, observation and intuition,” while the “hard sci-
ence” term depicted “mathematics and algorithms” [1].
Then I checked https://www.thefreedictionary.com/ and searched for the terms 
“hard science” and “soft science.” The results were as follows:
• “Hard Science: one of the natural or physical sciences, such as physics, 
chemistry, biology, geology, or astronomy, any of the natural or physical 
sciences, in which hypotheses are rigorously tested through observation and 
experimentation” (https://www.thefreedictionary.com/hard+science).
• “Soft Science: a science, such as sociology or anthropology, that deals with 
humans as its principle subject matter, and is therefore not generally consid-
ered to be based on rigorous experimentation, any of the scientific disciplines, 
as those which study human behavior or institutions, in which strictly mea-
surable criteria are difficult to obtain” (https://www.thefreedictionary.com/
Soft+science).
Although the meanings of these terms were very different from what I thought, 
I liked them. Due to this fact I found that it is better to use my terminology talent to 
represent new terms “hard biology” and “soft biology.”
I used the term “hard biology” for experimental (in vitro, in vivo, and in situ 
investigations) biology. This term has a direct deal with experimentation and work 
bench within the wet labs [2].
In contrast to “hard biology,” I used the term “soft biology” based on in silico or 
desktop work [2] and laptop biology [1].
I hope that these terms are useful for the readers of this book and other scientists 
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2. Biology and computer
Undoubtedly the famous physical chemist from the USA, Margaret Dayhoff 
(1925–1983), the mother and father of bioinformatics, was the key scientist who 
employed computers and the related software tools in biochemistry [3, 4].
Indeed, it was Dayhoff who understood the importance of computers and 
computational methods not only in biology but also in medicine [4].
In 1960, Dayhoff as the Associate Director of the National Biomedical Research 
Foundation began her collaboration with her physicist colleague, Robert S. Ledley, 
who, like Dayhoff, was interested in employing computers in biomedical sciences 
[3, 5, 6].
The outcome of their scientific collaboration (Dayhoff-Ledley) in the period of 
1958–1962 led to a computer program COMPROTEIN (coded FORTRAN) which 
was designed for IBM 7090. The software COMPROTEIN (a de novo sequence 
assembler) was able to determine the primary structure of protein throughout the 
Edman peptide sequencing data [3, 7].
The amino acid one-letter coding system was founded by Dayhoff [3, 8]. 
Dayhoff and Eck continued their scientific activities by publishing the first  edition 
of the invaluable book entitled Atlas of Protein Sequence and Structure in 1965 
which involved 65 protein sequences [3, 4, 9]. The fourth edition of Atlas of Protein 
Sequence and Structure which was published in 1969 included more than 300 protein 
sequences. So, this atlas established the first database of biological sequence [3, 4]. 
Interestingly, the sequence alignment of biopolymers was started by proteins 
not DNA molecules. This claim is proven by representing a 12-sequenced DNA 
 fragment in 1971 [4].
3. Molecular biology and computer
During the golden decade between the years 1970 and 1980, the DNA language 
was decoded. However, the genetic codes of 64 codons were decoded in 1968 
[3, 10]. Sanger’s sequencing method of DNA based on “plus and minus” strands was 
performed 25 years after the recognition of the first protein sequence [3, 11, 12]. 
1979 is the historical year for using the first software for Sanger’s DNA sequencing 
method. In the paper published by Rodger Staden in 1979 via the journal of Nucleic 
Acids Research, the applied programs including OVRLAP, XMATCH, and FILINS 
(coded FORTAN) were described [3, 13].
During the years of 1980–1990, the application of computational sciences 
significantly increased. In 1983, the polymerase chain reaction (PCR) was invented 
by Kary B. Mullis (1944–2019 (https://www.nytimes.com/2019/08/15/science/kary-
b-mullis-dead.html)). Kary Banks Mullis as an American biochemist invented a 
valuable molecular method which was based on in vitro synthesis of DNA [14–16]. 
So, by the discovery of DNA molecules in the 1950s, and in consequence the early 
application of pro-computers, invention of molecular and sequencing methods, and 
utilizing Internet services within a short duration, it seems that several revolution-
ized features have happened in molecular biology [17].
Although computers and the related software tools were employed since the 1960s 
in biology, it was in the limited scales. I believe that by the invention of PCR as an in 
silico-in vitro (dry lab-wet lab) technology and its flying speed as a general molecular 
biology approach changed the traditional methodologies. By global generalization 
of PCR, the use of Internet services, computers, and software tools got significant 
acceleration. In this regard, designing different primers in large and global scales led 
to progression of in silico studies and appearance of dry labs within the wet labs.
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Due to this fact, during a very short time, a mass of raw data was obtained by 
scientists around the world, and these data got stored within different biological 
databases like the National Center for Biotechnology Information (NCBI) (https://
www.ncbi.nlm.nih.gov/), European Molecular Biology Laboratory (EMBL) 
(https://www.embl.org/), Kyoto Encyclopedia of Genes and Genomes (KEGG) 
(https://www.genome.jp/kegg/), and DNA Data Bank of Japan (DDBJ) (https://
www.ddbj.nig.ac.jp/index-e.html) [18].
At the same time, these giant databases began to give more free software tools, 
information, and other services. These features have led to establishing 1637 free 
online databases (http://www.oxfordjournals.org/nar/database/c/) up to now [19].
Today, some databases including The Research Collaboratory for Structural 
Bioinformatics Protein Data Bank (RCSB PDB) (https://www.rcsb.org/) serve its 
global users for free. 3D macromolecular structure data is one of the most popular 
products which scientists and researchers use for free around the world [20].
Since 1971 when the US data center of RCSB PDB was founded, it provided 
digital data in biology for its users with open-access policy [20], an opportunity 
which all the consumers should be grateful for.
All in all, soft biology was founded in the 1960s with a low speed, but it acceler-
ated by the invention of PCR in the 1980s. The PCR invention softened the science 
of biology throughout Internet services, an occurrence which resulted in progres-
sive in silico studies, dry labs, and software tools.
Today, a biologist is recognized by her/his laptop, Internet connection, and filled 
USB flash drives with different bioinformatics software tools!
Hence, hard biology got softened by establishing the science of bioinformatics 
and is continued to be more softened by computational biology!
But the important question is:
“How does biology get more softened in the future?”
Conflict of interest
The authors declare no conflicts of interest.
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Abstract
Little is known about protein sequences unique in humans. Here, we performed
alignment-free sequence comparisons based on the availability (frequency bias) of
short constituent amino acid (aa) sequences (SCSs) in proteins to search for
human-specific proteins. Focusing on 5-aa SCSs (pentats), exhaustive comparisons
of availability scores among the human proteome and other nine mammalian
proteomes in the nonredundant (nr) database identified a candidate protein
containing WRWSH, here called FAM75, as human-specific. Examination of vari-
ous human genome sequences revealed that FAM75 had genomic DNA sequences
for either WRWSH or WRWSR due to a single nucleotide polymorphism (SNP).
FAM75 and its related protein FAM205A were found to be produced through
alternative splicing. The FAM75 transcript was found only in humans, but the
FAM205A transcript was also present in other mammals. In humans, both FAM75
and FAM205A were expressed specifically in testis at the mRNA level, and they
were immunohistochemically located in cells in seminiferous ducts and in acro-
somes in spermatids at the protein level, suggesting their possible function in sperm
development and fertilization. This study highlights a practical application of SCS-
based methods for protein searches and suggests possible contributions of SNP
variants and alternative splicing of FAM75 to human evolution.
Keywords: availability score, short constituent sequence (SCS), alternative
splicing, single nucleotide polymorphism (SNP), testis, FAM75, FAM205A, human
genome, human proteome
1. Introduction
The human species has unique traits among animals. It is well known that
morphological and physiological traits such as erect bipedalism, speech and lan-
guage, and long reproductive period are very different from those of other primate
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1. Introduction
The human species has unique traits among animals. It is well known that
morphological and physiological traits such as erect bipedalism, speech and lan-
guage, and long reproductive period are very different from those of other primate
species. Only humans have high intelligence that fosters sophisticated
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communications and complex societies. This intelligence is related to continuous
brain development after birth in humans, which is not observed in other great apes,
including chimpanzees [1]. The evolutionary emergence of these unique traits in
humans likely contributes to human speciation. The simplest hypothesis to explain
human uniqueness is that it originates from the uniqueness of constituent molecules
(i.e., genes and proteins) themselves. In this “constituent hypothesis,” humans have
unique genes and proteins that do not exist in chimpanzees. A contrasting hypoth-
esis is that constituent molecules are similar between humans and chimpanzees, but
they are regulated differently in these species. That is, in this “regulatory hypothe-
sis,” a similar set of proteins may be produced but at different times
(heterochrony), in different locations (heterotopy), in different amounts
(heterometry), and in different usage (heterotypy) [2]. These regulatory changes in
gene expression seem to be evolutionarily parsimonious and, indeed, are supported
by comparative observations at phenotypic levels [3].
One line of support for the regulatory hypothesis comes from genomics and
developmental expression studies. Following the announcement of a human
genome release [4], the genomes of other great apes were sequenced [5–7]. Com-
parisons of DNA sequences between humans and chimpanzees have revealed that
nucleotide differences are only 1.23% in aligned sequences, and most of these
differences are thought to be functionally insignificant [5]. Further rigorous com-
parisons throughout these genomes have revealed that nucleotide differences are
4% and that they are mostly located in noncoding regions [8]. The expression
patterns of some genes are different between humans and chimpanzees during
development [9–12]. Differences in transcriptomes have revealed that species dif-
ferences in expression patterns are tissue-dependent and that testes have the
greatest difference [13, 14]. It has been speculated that the accumulation of small
expression or regulatory differences leads to large phenotypic differences between
humans and chimpanzees [14]. On the other hand, while these findings support the
regulatory hypothesis, they do not necessarily reject the constituent hypothesis
[15, 16]. RNA-mediated mechanisms for novel genes have been proposed together
with the “out of the testis” hypothesis, in which testis is considered a tissue for
experimenting with new genes [16]. Comparisons among transcriptomes in pri-
mates have revealed that many genes for spermatogenesis in testes, which likely
inhibit apoptosis when mutated, are positively selected [17, 18].
Although these genome comparison studies advance this field, there are a few
inherent problems. First, their results are heavily dependent on database quality
because of their methodological nature. Most genome sequences were draft
sequences at the time of public release, likely containing numerous sequencing and
assembling mistakes. For example, the previous chimpanzee genome was assembled
in reference to the human genome, which means that genomic regions in chimpan-
zees that are different from those in the human genome may have been assembled
to create false sequences, although continuous revisions have been made [19]. Even
in the human genome, many previous gene records generated by automated
assemblers have been removed after revisions. Moreover, population sampling bias
from the sequenced genome cannot be avoided when samples from a small number
of individuals are sequenced. The case of a transcription factor, FOXP2 (forkhead
box P2), is an object lesson: FOXP2 has been proposed to have played a key role in
human-specific evolution by assisting speech and language [20], but that evidence
is likely to be weak and probably incorrect because of sampling bias [21].
Second, such genome comparisons are largely based on sequence alignments
[22, 23]. Although sequence alignment methods are powerful and probably the most
important in comparison studies, sequences that do not contain relatively long
regions of similarity cannot be compared well. In other words, short sequences that
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do not extend to longer similarities are discarded as noise [22]. Although this
strategy is highly successful, it assumes that nonaligned short sequences are not
important, which may not always be true. There may still be important differences
undiscovered where alignments are not possible.
An approach to the second issue above is to develop alignment-free methods.
The advantage of the alignment-free approach is that any collections of proteins can
be compared quantitatively. Although various types of alignment-free approaches
have been developed [24, 25], including our previous attempts to use membrane
topology [26] and a self-organizing map [27], the alignment-free approach in the
present study is based on the “availability” (frequency bias) of short constituent
sequences (SCSs) of amino acids (aa) in proteins [28–33]. The length of SCSs can be
2 aa (doublet), 3 aa (triplet), 4 aa (quartet), 5 aa (pentat), and more in a given
protein. This SCS-based analysis is basically similar to other related analyses for
amino acid sequence patterns that were called under different terms with slightly
different mathematical operations: oligopeptide patterns [34–39], amino acid
sequence repertoire [40], peptide vocabulary [41], n-gram [42, 43], n-tuple [44],
and pseudo amino acid composition [45–47]. There are some noteworthy recent
studies that encourage this line of approach: for example, nonrandom distributions
of 5-aa SCS are demonstrated in the current proteome databases [38], confirming
the previous finding that biological bias occurs in protein coding [28, 29]. Among
these existing studies, our approach is operationally one of the simplest, and it
emphasizes analogies between languages and protein sequences [32, 33]. Encourag-
ingly, linguistic aspects of proteins have been noted in other studies [48, 49].
In our approach, protein sequences are considered to be composed of many
SCSs. Importantly, the number of possible SCSs is limited because a protein is
composed of just 20 kinds of amino acids; there are 400 (=202) permutations of 2-aa
SCSs (doublets), 8000 (=203) permutations of 3-aa SCSs (triplets), 160,000 (=204)
permutations of 4-aa SCSs (quartets), and 3,200,000 (=205) permutations of 5-aa
SCSs (pentats). Frequencies of individual SCSs in a given protein database can be
inferred theoretically based on frequencies of component amino acids, which is
called the expected frequency (E). On the other hand, real frequencies of individual
SCSs (R) in a given protein database can be obtained through database searches.
The availability score (A) of a given SCS in a protein database can be simply defined
as A = (R  E)/E. Availability scores thus indicate biological frequency bias that
might have occurred for functional or historical reasons during protein evolution. In
other words, availability scores (A) of SCSs are used instead of simple real frequen-
cies (R) of SCSs to exclude noise from random occurrence.
Among n-SCSs, we state that 5-aa SCSs (pentats) are optimal for analyses for the
following reasons [28, 29, 33]. First, they are practically manageable in number
(exactly 3,200,000 different pentats) in our computational system. Higher compu-
tational power, which is sometimes not practical, is required to use 6-aa or longer
SCSs. Second, the number of possible SCSs should be reasonably comparable to or
smaller than the number of existing SCSs in a biological database. The use of 6-aa or
longer SCSs would result in many nonexistent SCSs in the database because the
number of possible 6-aa (or longer) SCSs is much larger than the number of existing
SCSs in a given database. Third, 5-aa SCSs are likely structurally reasonable units
(or “blocks”) to build functional protein structures [50–54]. Fourth, it was
suggested that small stretches of proteins are often recognized in protein interac-
tions. For example, T-cell receptors recognize 5-aa SCSs as antigens in the process of
antigen presentation, and this fact relates to the frequency bias of SCSs in parasites
to avoid recognition by the T-cell receptors of the host [41]. Specificities of immune
responses are thus likely influenced by SCSs in expressed proteins in a given organ-
ism, as also suggested by usage of rare SCSs as immune adjuvant vaccines [39].
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Furthermore, rare SCS sequences evolved as untranslatable sequences in bacteria as
a mean of translational control [40].
Using this simple concept of availability score, secondary structure characteri-
zation has been performed; SCS frequencies (and thus availability scores) are dif-
ferent among different secondary structures [30]. Availability scores are also
different between parallel and antiparallel β-strands [31]. This approach is also
relevant to identifying sequence motifs in some, although not all, proteins [32]. It
has been shown that triplet compositions in proteomes may reflect phylogenetic
relationships [32, 37, 53]. We believe that this approach is applicable to under-
standing species specificity.
We have implemented several applications as the SCS Package that
informatically examine protein sequences [33]. Among them, we have built an
application for identifying species-specific SCSs. In the present study, we compared
human and other 9 mammalian proteomes based on availability analysis of 5-aa
SCSs (pentats) to identify human-specific pentats. We hypothesized that a protein
containing the identified human-specific pentat would be unique to humans and
might have played a role in human evolution.
2. Materials and methods
2.1 The SCS package
Assuming that small changes in amino acids in proteins (or corresponding
nucleotide changes in DNA) contribute significantly to phenotypic differences
between humans and chimpanzees, the concept of SCS-based methods is to detect
small amino acid usage differences between species in an alignment-independent
manner. The SCS package is an open web service containing six applications (plus
the latest application to analyze idiom networks under development [55]) for pro-
tein analyses (http://scspackage.ads.ie.u-ryukyu.ac.jp/) [33]. These applications run
in reference to the database downloaded from the nonredundant (nr) database of
the NCBI (National Center for Biotechnology Information, U.S. National Library of
Medicine, Bethesda), which was downloaded on August 20, 2015. Because T-cell
receptors, B-cell receptors, and antibodies are produced by somatic recombination
and hypermutation, protein records containing the following keywords in sequence
names were excluded: anti, IgG, IgM, IgA, IgD, IgE, BCR, TCR, B-cell receptor, T-
cell receptor, Ig, and immunoglobulin. A complete match, including spaces, was
required to be excluded. Frequencies and availability scores for all possible n-aa
SCSs (n = 3, 4, and 5 in the current SCS package) in the database were calculated
and stored in the database [56]. For species comparison, each record in the
downloaded database was sorted into its original species to produce species-specific
proteome databases.
In this study, we focused on 5-aa SCSs (pentats). For multiple species compari-
son, the availability score difference, ΔA, was calculated; for example, when a
human 5-aa SCS had an availability score of 10 and the availability scores of that
SCS in gorilla, pig, and mouse were 5, 3, and 2, respectively, the human ΔA was
calculated as follows: ΔA = 10  3  (5 + 3 + 2) = 20, where the multiplicative factor
(3) comes from the number of species to be compared. In this way, ΔA scores
were assigned to all 3,200,000 pentats. The following nine species were used to
obtain ΔA for human (Homo sapiens): chimpanzee (Pan troglodytes), gorilla (Gorilla
gorilla), orangutan (Pongo abelii), mouse (Mus musculus), rat (Rattus norvegicus),
opossum (Monodelphis domestica), platypus (Ornithorhynchus anatinus), cow (Bos
taurus), and pig (Sus scrofa).
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2.2 Bioinformatics web services
After identifying FAM75 using the SCS package, available information on
FAM75 and FAM205A was gathered using various web sites. The location FAM75/
FAM205A on chromosomes and their single nucleotide polymorphism (SNP) vari-
ants were searched using Map Viewer (www.ncbi.nlm.gov/mapview/) in the NCBI
server. For various information on human transcripts, we referred to H-InvDB
(www.h-invitational.jp/hinv/ahg-db/index_ja.jsp) [57]. This site provides curated
information on gene structure, splicing variants, functional RNAs, protein func-
tions, functional domains, intracellular distribution, metabolic pathways, three-
dimensional structures, disease relationships, genetic polymorphism (SNPs, indels,
microsatellites, and others), gene expression profiles, molecular evolutionary char-
acters, protein–protein interactions, and gene families. Tissue-specific expression
profiles were searched using H-ANGEL (http://www.h-invitational.jp/hinv/h-ange
l/wge_top.cgi?), a database for human gene expression profiles, in the H-InvDB
server. Information on alternative splicing variants of the nonhuman primates and
mouse was obtained from Map Viewer in NCBI. We referred to the following latest
annotations: chimpanzee (Annotation Release 103), western gorilla (Annotation
Release 100), Sumatran orangutan (Annotation Release 102), and laboratory mouse
(Annotation Release 106). We frequently used protein BLAST in the NCBI server
for conventional similarity search (blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Prote
ins) [22] and performed multiple sequence alignments when necessary using
MEGA7 (www.megasoftware.net/) [58]. In addition, the cDNA sequence of FAM75
was subjected to RegRNA analysis (regrna.mbc.nctu.edu.tw/html/about.html) to
identify any possible sequence motifs in FAM75 mRNA [59].
To further examine SNP variants in human populations, we used dbSNP (www.
ncbi.nlm.nih.gov/snp/) [60] and the 1000 Genome Project by IGSR (The Interna-
tional Genome Sample Resource) (www.internationalgenome.org) [61]. Protein
expression was examined using The Human Protein Atlas (www.proteinatlas.org)
[62, 63]. This site contains immunohistochemical data for various human tissues.
For identification of transmembrane domains in FAM75 and FAM205A, SOSUI
(harrier.nagahama-i-bio.ac.jp/sosui/) [64] and TMHMM (www.cbs.dtu.dk/service
s/TMHMM/) [65] were used. For the subcellular distributions of FAM75 and
FAM205A, PSORT II Prediction (psort.hgc.jp/form2.html) [66] was used. Pfam
(pfam.xfam.org) [67] was used for the identification of protein families. Two
applications of the SCS Package, “sequence analysis based on availability scores of
short constituent amino acid sequences” (scspackage.ads.ie.u-ryukyu.ac.
jp/sequence-analysis.php) [32, 33] and “extraction of idiomatic connections
between triplets in proteins” (scspackage.ads.ie.u-ryukyu.ac.jp/extraction-of--
idiomatic-connections.php) [33], were used to identify possible functional sites in
FAM75. EMBOSS Pepwindow (emboss.sourceforge.net/index.html) [68] was used
for the Kyte-Doolittle hydropathy plot. These web sites were accessed mainly in
2017 and 2018 and were reconfirmed in 2019.
2.3 Human cDNA samples for tissue expression profiling
For the cDNA template, we purchased human MTC (multiple tissue cDNA)
panels I and II (Takara Bio, Kusatsu, Shiga, Japan). The panels contain first-strand
cDNA from polyA+ RNA and are free from genomic DNA. The amounts of cDNA
are approximately 1.0 ng/μL and are normalized to four housekeeping genes, phos-
pholipase A2, G3PDH (glyceraldehyde-3-phosphate dehydrogenase), β-actin, and
α-tubulin, which makes it possible to compare expression levels among different
tissues. Panels I and II together contain cDNA samples from the following 16 human
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Furthermore, rare SCS sequences evolved as untranslatable sequences in bacteria as
a mean of translational control [40].
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SCSs (n = 3, 4, and 5 in the current SCS package) in the database were calculated
and stored in the database [56]. For species comparison, each record in the
downloaded database was sorted into its original species to produce species-specific
proteome databases.
In this study, we focused on 5-aa SCSs (pentats). For multiple species compari-
son, the availability score difference, ΔA, was calculated; for example, when a
human 5-aa SCS had an availability score of 10 and the availability scores of that
SCS in gorilla, pig, and mouse were 5, 3, and 2, respectively, the human ΔA was
calculated as follows: ΔA = 10  3  (5 + 3 + 2) = 20, where the multiplicative factor
(3) comes from the number of species to be compared. In this way, ΔA scores
were assigned to all 3,200,000 pentats. The following nine species were used to
obtain ΔA for human (Homo sapiens): chimpanzee (Pan troglodytes), gorilla (Gorilla
gorilla), orangutan (Pongo abelii), mouse (Mus musculus), rat (Rattus norvegicus),
opossum (Monodelphis domestica), platypus (Ornithorhynchus anatinus), cow (Bos
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ants were searched using Map Viewer (www.ncbi.nlm.gov/mapview/) in the NCBI
server. For various information on human transcripts, we referred to H-InvDB
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ins) [22] and performed multiple sequence alignments when necessary using
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was subjected to RegRNA analysis (regrna.mbc.nctu.edu.tw/html/about.html) to
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To further examine SNP variants in human populations, we used dbSNP (www.
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[62, 63]. This site contains immunohistochemical data for various human tissues.
For identification of transmembrane domains in FAM75 and FAM205A, SOSUI
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s/TMHMM/) [65] were used. For the subcellular distributions of FAM75 and
FAM205A, PSORT II Prediction (psort.hgc.jp/form2.html) [66] was used. Pfam
(pfam.xfam.org) [67] was used for the identification of protein families. Two
applications of the SCS Package, “sequence analysis based on availability scores of
short constituent amino acid sequences” (scspackage.ads.ie.u-ryukyu.ac.
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idiomatic-connections.php) [33], were used to identify possible functional sites in
FAM75. EMBOSS Pepwindow (emboss.sourceforge.net/index.html) [68] was used
for the Kyte-Doolittle hydropathy plot. These web sites were accessed mainly in
2017 and 2018 and were reconfirmed in 2019.
2.3 Human cDNA samples for tissue expression profiling
For the cDNA template, we purchased human MTC (multiple tissue cDNA)
panels I and II (Takara Bio, Kusatsu, Shiga, Japan). The panels contain first-strand
cDNA from polyA+ RNA and are free from genomic DNA. The amounts of cDNA
are approximately 1.0 ng/μL and are normalized to four housekeeping genes, phos-
pholipase A2, G3PDH (glyceraldehyde-3-phosphate dehydrogenase), β-actin, and
α-tubulin, which makes it possible to compare expression levels among different
tissues. Panels I and II together contain cDNA samples from the following 16 human
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tissues: heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen,
thymus, prostate, testis, ovary, small intestine without mucosal lining, colon with
mucosal lining, and peripheral blood leukocyte. Each tissue sample was pooled from
1 to 550 Caucasians, and the testis sample was pooled from 45 Caucasians aged 14–
64, according to the manufacturer’s specifications.
2.4 PCR primers
Based on the cDNA sequence of FAM75, we designed two sets of PCR primers
for nested PCR using Primer-BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast/).
The first set was to amplify both FAM75 and FAM205A from the consensus region,
and the second set was to amplify FAM205A from the region that is present only in
FAM205A. For the first set, the first-round forward primer was 5’-TTACCAGG-
TACTGTCACTGAACAC-30, and its paired reverse primer was 5’-TTCTGAAGC-
TAGACTCTGTAAGGC-30. This first round of PCR was expected to amplify
1387 bp. The second-round (nested) forward primer was 5’-AGTTGTACA-
GACGTTGCAAAAGAG-30, and its paired reverse primer was 5’-TTTCTGAAGC-
TAGACTCTGTAAGGC-30. This second round (nested) PCR was expected to
amplify 1097 bp.
For the second set, the first-round forward primer was 5’-ATATCCCTTATA-
CATCTATGGCTCCATCTTC-30, and its paired reverse primer was 5’-
TTTTATTTCTGAAGCTAGACTCTGTAAGGC-30. This round of PCR was expected
to amplify 3608 bp. The second-round (nested) forward primer was 5’-
GTATGTCTTTAGATCAGAGTCTGGAGTTTC-30, and its paired reverse primer
was 5’-TTTATTTCTGAAGCTAGACTCTGTAAGGCTG-30. This round of PCR was
expected to amplify 3206 bp.
2.5 PCR conditions
We used an Astec PC320 thermal cycler (Fukuoka, Japan) and Tks Gflex DNA
polymerase (Takara Bio) for PCR. According to the manufacturer’s specifications,
this DNA polymerase has high fidelity; the error rate was reported to be 0.0131%.
The original cDNA sample from the human MTC panels (Takara Bio) was
diluted 10 times to make PCR template samples. The following solutions were
mixed to start PCR: Gflex PCR buffer 12.5 μL, deionized water 8.5 μL, DNA poly-
merase 0.5 μL, forward primer 0.5 μL, reverse primer 0.5 μL, and cDNA template
2.5 μL in a total amount of 25.0 μL. The nested PCR was performed using 2.5 μL
reaction solution from the first-round PCR. In both the first and second (nested)
rounds, a negative control was performed using deionized water without template
cDNA.
The first PCR cycles were performed as follows: an initial denaturing step at
94°C (5 min); 10 cycles of 98°C (30 s), 60°C (30 s; �0.5°C/cycle), and 68°C
(1 min); 30 cycles of 98°C (30 s), 55°C (30 s), and 68°C (1 min); and a last
extension step at 68°C (30 s). The second (nested) PCR cycles were the same as the
first PCR cycles except the duration of the initial denaturing step at 94°C (1 min). In
both the first and second PCRs, the first 10 cycles were subjected to stepwise
temperature reduction (i.e., touch-down PCR); the first cycle was 60.0°C, the
second cycle was 59.5°C, and the third cycle was 59.0°C, and so on.
Positive controls were performed with G3PDH primers that were supplied in the
Human MTC Panels (Takara Bio) from the manufacturer. The PCR product was
expected to be 938 bp. The primer sequences were as follows: 5’-TGAAGGTCG-
GAGTCAACGGATTTGGT-30 for the forward primer and 5’-CATGTGGGCCAT-
GAGGTCCACCAC-30 for the paired reverse primer. PCR cycles were as follows: an
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initial denaturing step at 95°C (1 min); 38 cycles of 95°C (30 s) and 68°C (3 min);
and a final extension step at 68°C (3 min).
PCR products (1.0 μL) were subjected to 0.8% agarose gel electrophoresis in
TAE buffer and stained with ethidium bromide for visualization. The PCR products
were run with λHindIII DNA size marker (New England Biolabs, Ipswich, MA,
USA).
3. Results
3.1 Identifying candidate human-specific pentats
Availability scores (A) were given to all possible pentats in the human proteome
database. Among them, the top 10 pentats with the highest availability scores were
HHHHH (rank 1; A = 1837), MYGCD (rank 2; A = 1770), MRYFY (rank 3;
A = 1321), WYWHF (rank 4; A = 1262), PEYWD (rank 5; A = 1140), MYQWW
(rank 6; A = 1100), HSMRY (rank 7; A = 1096), NWHWA (rank 8; A = 1041),
WWNFG (rank 9; A = 1007), and AWWNF (rank 10; A = 928). Similarly, avail-
ability scores were given to all possible pentats in nine other mammalian proteome
databases. Using the “extraction of species-specific amino acid sequences” program
in the SCS Package, availability difference scores (ΔA) were calculated for the
human proteome. When pentats were ranked according to ΔA for humans, the top
10 pentats with the highest scores were MYGCD (rank 1; ΔA = 15,180), MRYFY
(rank 2; ΔA = 11,777), WYWHF (rank 3; ΔA = 10,683), PEYWD (rank 4;
ΔA = 9961), HSMRY (rank 5; ΔA = 9695), MYQWW (rank 6; ΔA = 9377), NWHWA
(rank 7; ΔA = 9337), GQWRW (rank 8; ΔA = 8255), AWWNF (rank 9; ΔA = 7939),
and EYWDR (rank 10; ΔA = 7878), showing similar but different rank orders from
the human proteome alone. These pentats had large ΔA values, indicating that they
are strongly preferred in human proteins.
Among the ΔA rank order of pentats, we focused on pentats that showed the
lowest possible availability scores (A = 1) in all other nine mammalian proteome
databases, meaning that these pentats did not exist in the nonhuman proteomes at
all. We found WRWSH at rank 204 (ΔA = 1720) and MMFGC at rank 226
(ΔA = 1594) that met this criterion. However, MMFGC was found to be a false-
positive, because this pentat was located exclusively in immunological proteins that
could be subject to somatic recombination and hypermutation. Therefore, we
decided to focus on WRWSH hereafter.
3.2 Human proteins containing WRWSH
Human proteins containing WRWSH were identified using the “search for
amino acid sequences of species” program, one of the SCS Package programs.
Among all 148 hits, 16 hits were related to “mucin-19-like isoform,” 55 hits to
“glycine-rich cell wall structural protein,” 28 hits to “RNA-binding protein,” 48 hits
to “uncharacterized transmembrane protein,” and 1 hit to “unnamed protein prod-
uct.” Unfortunately, these sequences except the last one, “unnamed protein prod-
uct,” were all “predicted” informatically as parts of “Homo sapiens Annotation
Release 106” [69], and they were all removed from the latest annotation, “Homo
sapiens Annotation Release 109” [70]. Because their status was uncertain at this
point (although they resembled real protein sequences with a long open reading
frame), they were not pursued in the present study. On the other hand, “unnamed
protein product [Homo sapiens] (Accession No. BAC86357.1)”, here called “FAM75”
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The first PCR cycles were performed as follows: an initial denaturing step at
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second cycle was 59.5°C, and the third cycle was 59.0°C, and so on.
Positive controls were performed with G3PDH primers that were supplied in the
Human MTC Panels (Takara Bio) from the manufacturer. The PCR product was
expected to be 938 bp. The primer sequences were as follows: 5’-TGAAGGTCG-
GAGTCAACGGATTTGGT-30 for the forward primer and 5’-CATGTGGGCCAT-
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uct,” were all “predicted” informatically as parts of “Homo sapiens Annotation
Release 106” [69], and they were all removed from the latest annotation, “Homo
sapiens Annotation Release 109” [70]. Because their status was uncertain at this
point (although they resembled real protein sequences with a long open reading
frame), they were not pursued in the present study. On the other hand, “unnamed
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based on the name of putative domain that it contained, was validated in the latest
annotation [70], and thus, we pursued this protein for further investigation.
3.3 FAM75 and its related FAM205A
According to the NCBI record, FAM75 is a protein containing 1014 aa, and its
cDNA coding sequence was 3274 bp (Accession No. AK125949.1). It is important to
stress that FAM75 has been identified as cDNA from NEDO human cDNA
sequencing project (www.nite.go.jp/en/nbrc/genome/project/annotation/cdna.h
tml), and thus this protein is not likely an error product from genome sequencing. A
protein BLAST search using FAM75 as a query identified the record “protein
FAM205A [Homo sapiens] (Accession No. NP_001135389.1).” This protein record
was closely related to the mRNA record “Homo sapiens family with sequence simi-
larity 205 member A (FAM205A), mRNA (Accession No. NM_001141917.1).” The
BLAST result showed that the identity score was 99%; 1003 aa were identical
among 1014 aa. The record showed that FAM205A contained 1335 aa, and its cDNA
coding sequence was 4311 bp. Thus, it was longer than FAM75. A DNA sequence
comparison between FAM75 and FAM205A revealed that 16 bases were different
(Table 1). When the FAM205A genomic DNA sequence (Accession No.
NG_052658.1) was compared with its cDNA sequence, these 16 bases were identical
(Table 1). Between FAM75 and FAM205A, 11 amino acids were different.
Table 1.
Different DNA bases and protein amino acids between FAM75 (unnamed protein product) and FAM205A in
the NCBI records.
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Interestingly, FAM205A in that record had WRWSR instead of WRWSH; the DNA
sequences corresponding to the last amino acid of WRWS (H/R) were A (adenine)
in FAM75 cDNA and G (guanine) in FAM205A cDNA and gDNA. These results
suggest that the two products are closely related and may be produced from the
same genomic site by alternative RNA splicing.
3.4 Gene structures: alternative splicing and polymorphism
A UniGene search revealed that the FAM7/FAM205A gene was located at 9p13.3
on chromosome 9 in the human genome [71]. As expected, their exon-intron struc-
tures were different (Figure 1). FAM75 had a single exon, whereas FAM205A had
four exons. The exon of FAM75 had high homology with the fourth exon of
FAM205A. The 5’-UTR of FAM75 also corresponded to the fourth exon of
FAM205A. Clearly, these two RNA transcripts and their proteins are products of
alternative splicing from the same genomic locus.
H-InvDB revealed two additional splicing variants (HIT000496944 and
HIT000496575) from the same locus at 9p13.3 (Figure 1). The record
HIT000496944 in the NCBI database was “Homo sapiens cDNA FLJ51393 complete
code (AK302320.1),” and the record HIT000496575 was “Homo sapiens cDNA
FLJ58301 complete code (AK301951.1),” both named “unnamed protein product.”
These are splicing variants, but among them, only FAM75 lacked the first 255-bp
exon, indicating that the translation initiation sites are different in these mRNAs.
Because not all RNA transcripts are translated into proteins, we used a RegRNA
search of UTRs (untranslated regions) to examine the integrity of the FAM75
mRNA. The RegRNA search revealed that the 5’-UTR of FAM75 had an internal
ribosome entry site (IRES) [72–74] among other motifs, suggesting that the FAM75
mRNA is likely translated into proteins.
3.5 WRWSH and WRWSR in human populations
The G/A difference in FAM75/FAM205A in genomic DNA (corresponding to the
H/R difference in WRWSH or WRWSR) was confirmed to be a SNP in humans,
according to dbSNP. We found that this SNP was widespread in the human
genome, and the G/A ratio was dependent on regional populations, as revealed by
the 1000 Genomes Project (Figure 2). Among human populations, African
populations had a high G frequency (i.e., WRWSR); the three highest G-frequency
populations were Gambian in Western Division (96.16%); Yoruba in Ibadan,
Figure 1.
mRNA structures of FAM75, FAM205A, and their related transcripts from the same genomic locus in the
human genome. (A) FAM205A from UniGene. (B) Unnamed protein (FAM75) from UniGene. (C)
HIT000496944 from H-InvDB. (D) HIT000496575 from H-InvDB.
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based on the name of putative domain that it contained, was validated in the latest
annotation [70], and thus, we pursued this protein for further investigation.
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According to the NCBI record, FAM75 is a protein containing 1014 aa, and its
cDNA coding sequence was 3274 bp (Accession No. AK125949.1). It is important to
stress that FAM75 has been identified as cDNA from NEDO human cDNA
sequencing project (www.nite.go.jp/en/nbrc/genome/project/annotation/cdna.h
tml), and thus this protein is not likely an error product from genome sequencing. A
protein BLAST search using FAM75 as a query identified the record “protein
FAM205A [Homo sapiens] (Accession No. NP_001135389.1).” This protein record
was closely related to the mRNA record “Homo sapiens family with sequence simi-
larity 205 member A (FAM205A), mRNA (Accession No. NM_001141917.1).” The
BLAST result showed that the identity score was 99%; 1003 aa were identical
among 1014 aa. The record showed that FAM205A contained 1335 aa, and its cDNA
coding sequence was 4311 bp. Thus, it was longer than FAM75. A DNA sequence
comparison between FAM75 and FAM205A revealed that 16 bases were different
(Table 1). When the FAM205A genomic DNA sequence (Accession No.
NG_052658.1) was compared with its cDNA sequence, these 16 bases were identical
(Table 1). Between FAM75 and FAM205A, 11 amino acids were different.
Table 1.
Different DNA bases and protein amino acids between FAM75 (unnamed protein product) and FAM205A in
the NCBI records.
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Interestingly, FAM205A in that record had WRWSR instead of WRWSH; the DNA
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Nigeria (96.30%); and Mende in Sierra Leone (93.53%). In contrast, Asian and
European populations had relatively high A frequency (i.e., WRWSH); the three
highest A-frequency populations were Chinese Dai in Xishuangbanna (70.43%);
Kinh in Ho Chi Minh City, Vietnam (67.17%); and Han Chinese South, China
(61.43%).
3.6 Homologous proteins and alternative splicing products in other animals
Here, we searched for homologous proteins for FAM75 and FAM205A in other
animals. Among the nine mammals used for the initial identification for WRWSH,
homologous proteins for FAM205A were identified by BLAST search (Table 2); all
proteins were FAM205A homologs, and all proteins in primates (chimpanzee,
gorilla, and orangutan) contained WRWSR (corresponding to FAM205A) but not
WRWSH (corresponding to FAM75), suggesting that WRWSH in FAM75 may be
unique in humans among primates. In other nonprimate animals that were exam-
ined here, this pentat sequence was either not conserved at all or nonexistent.
To further examine whether splicing variants exist in other great apes, we
checked the genome loci and transcript data using Map Viewer. In chimpanzees
(Figure 3) and gorillas (not shown), there were no alternative splicing transcripts
from this locus. In orangutans (not shown), there were three isoforms, the X1, X2,
Figure 2.
Genomic G/A ratio at the SNP site of the candidate human-specific pentat WRWSH in FAM75/FAM205A in
various human populations. Abbreviations of populations or samples: YRI (Yoruba in Ibadan, Nigeria),TSI
(Toscani, Italy), STU (Sri Lankan Tamil, UK), PUR (Puerto Rican, Puerto Rico), PJL (Punjabi in Lahore,
Pakistan), PEL (Peruvian in Lima, Peru), MXL (Maxican ancestry in Los Angeles, CA, USA), MSL (Mende,
Sierra Leone), LWK (Luhya in Webuye, Kenya), KHV (Kinh in Ho Chi Minh City, Vietnam), JPT (Japanese
in Tokyo, Japan), ITU (Indian Telugu, UK), IBS (Iberian populations, Spain), GWD (Gujarati Indians in
Houston,TX, USA), GBR (British from England and Scotland), FIN (Finnish, Finland), ESN (Esan,
Nigeria), CLM (Colombian in Medellín, Colombia), CHS (Han Chinese south, China), CHB (Han Chinese
in Beijing, China), CEU (Utah residents (CEPH) with northern and Western European ancestry), CDX
(Chinese Dai in Xishuangbanna), BEB (Bengali, Bangladesh), ASW (African ancestry in SW, USA), and
ABC (African Caribbean, Barbados).
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and X3 transcripts, from this locus. However, these transcripts were very similar to
one another, and they were all considered FAM205A homologs containing
WRWSR. We also examined the genome of the mouse as a representative
nonprimate mammal (not shown). There were three transcript variants: “predicted
gene 12429 isoform X1, X2” and “predicted gene 12429.” They all contained SLQAQ
instead of WRWSH in these proteins, and their splicing patterns were different
from those of FAM75. We confirmed that human splicing patterns (Figure 4) were
Name in FASTA file ID Pentat
Human unnamed protein BAC86357.1 WRWSH
Human protein FAM205A NG_052658.1 WRWSR
Chimpanzee protein FAM205A XP001164235.2 WRWSR
Gorilla protein FAM205A like XP_004048025.1 WRWSR
Orangutan protein FAM205A isoform XP_009242592.1 WRWSR
Mouse predicted gene 12,429 isoform XP_011248363.1 SLQAQ
Rat protein FAM205-A isoform XP_008774156.1 SQQGH
Opossum protein FAM205-A like isoform XP_007498908.1 HVGNR
Platypus protein FAM205A XP_007657228.1 :::::
Cow protein FAM205A XP_001253501.1 WQRRH
Pig — — —
Note: Amino acid sequences are conceptual translation from genomic data. Red letters indicate amino acids different
from those of the human pentat WRWSH. No corresponding pentat was found in the platypus (:::::), and no
homologous protein was found in the pig (—).
Table 2.
Amino acid pentat sequences from mammals that are homologous to the human WRWSH in FAM75.
Figure 3.
FAM205A and its surrounding locus of chromosome 9 in the chimpanzee genome.
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WRWSR. We also examined the genome of the mouse as a representative
nonprimate mammal (not shown). There were three transcript variants: “predicted
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instead of WRWSH in these proteins, and their splicing patterns were different
from those of FAM75. We confirmed that human splicing patterns (Figure 4) were
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different from those of these mammals. Therefore, we conclude that the FAM75
transcript was found only in humans.
3.7 Testis-specific expression of FAM75 and FAM205A
To examine its existence and expression in our laboratory, we performed RT-
PCR (reverse transcription polymerase chain reaction) using two sets of PCR
primers using 16 different human-tissue cDNA pools as templates. The first set of
primers was designed to amplify both FAM75 and FAM205A (Figure 5A), and the
second set was designed to amplify FAM205A only (Figure 5B). Due to their
overlapping nature, exclusive amplification of FAM75 was not possible. In both
primer sets, testis-specific expression was observed. A positive control using a
primer set for G3PDH showed amplification from all tissues (Figure 5C), and a
negative control (without cDNA template but with experimental primer sets) did
not show any amplification.
Our results were consistent with the H-ANGEL expression database; in this
database, FAM75 and FAM205A were not differentiated, but the database indicated
that the expression was testis-specific (Figure 6). The NCBI database also indicated
the testis-specific expression of FAM205A (not shown). The expression pattern of
FAM205A was also found in the Human Protein Atlas, in which FAM205A was
expressed in testis and in no other tissues examined at the mRNA level (not shown),
confirming our PCR-based data. According to the Human Protein Atlas, cells in the
seminiferous ducts (sperm and immature sperm cells) of the testis were clearly
detected, but Leydig cells were not stained immunohistochemically (Figure 7). As
mentioned in the Human Protein Atlas, staining was clearly detected in acrosomes
in spermatids (Figure 7). Considering that the antibody used in the Human Protein
Atlas could not differentiate FAM205A and FAM75 (because a recombinant C-
terminal 104 aa fragment that is almost identical in both FAM205A and FAM75 was
used as an antigen), both proteins were likely stained in the tissue sections.
3.8 Structural and functional predictions
We performed several sequence analyses to characterize the sequences of
FAM75 (Figure 8). When FAM75 and FAM205A were subjected to SOSUI, the
Figure 4.
FAM205A/FAM75 and its surrounding locus of chromosome 9 in the human genome. FAM75 is highlighted in
pink, and FAM205A is underlined in blue.
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Figure 5.
PCR products from human-tissue cDNA templates. (A) FAM75 and FAM205A. Primers were designed to
amplify both FAM75 and FAM205A. A DNA fragment with the expected size (1097 bp) was amplified only
from testis. (B) FAM205A. Primers were designed to amplify only FAM205A. A DNA fragment with the
expected size (3206 bp) was amplified only from testis. (C) G6PDH as a positive control. A DNA fragment
with the expected size (938 bp) was amplified from all tissues tested.
Figure 6.
Gene expression profile of FAM205A in human tissues (H-ANGEL). NM_001141917 indicates FAM205A,
and AK125949 indicates FAM75. http://www.h-invitational.jp/hinv/h-angel/wge_server.cgi?gpid=
HIX0025788.
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former was predicted as a soluble protein, but the latter was predicted as a mem-
brane protein with a single transmembrane helix. TMHMM also showed essentially
the same results. Indeed, the Human Protein Atlas considered FAM205A to be both
a membrane protein and a cytoplasmic protein based on immunohistochemical
results, suggesting that FAM75 and FAM205A may be detected in the cytoplasm and
in membranes, respectively, as predicted by SOSUI and TMHMM. In contrast, both
were predicted to be “nuclear” using PSORT II Prediction.
To search for possible functional sites, different amino acids between FAM75
and FAM205A (Table 1), conserved amino acids among FAM205A and similar
sequences (top 100 BLAST data) based on multiple alignment, Pfam domain data, a
hydropathy plot, an availability plot, and an idiom plot were aligned together
(Figure 8). Conserved amino acids were located mostly in the N-terminal side, in
which the “FAM75 domain” identified by Pfam was also located. WRWSH was
located at the center of the hydrophilic region in the C-terminal side and
Figure 7.
Immunohistochemical detection of FAM205A in a normal human testis section. FAM75 is also likely stained if
it is present, because the antibody was raised against a recombinant C-terminal 104-aa fragment, which is
found both in FAM205A and FAM75. Pictures were taken from the Human Protein Atlas (HPA071267,
male, age 41, testis (T-78000), normal tissue, NOS (M-00100), patient ID: 4485). Dark brown signals are
seen in spermatids and other differentiating cells in the seminiferous ducts. The crescent-like staining likely
represents developing acrosomes. Two additional samples (ages 25 and 65) are shown in the Human Protein
Atlas with essentially the same results. (A) Entire section. (B) High magnification of A.
Figure 8.
Identification of possible functional sites in FAM75. Shown are different amino acids from FAM205A (NCBI
GenBank record), conserved amino acids based on multiple alignment with FAM205A homologs, Pfam
domain, hydropathy, availability score, and idiom clusters. The location of the amino acid H in the candidate
human-specific pentat WRWSH is indicated by a vertical red line.
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corresponded to a high availability region and a high idiom region, although their
significance was not clear at this point.
4. Discussion
In this paper, we identified a WRWSH-containing protein, FAM75, as a candi-
date human-specific protein. We assumed that pentats with high availability scores
in humans and no occurrence (A = 1) in nine other mammals might be contained
in a human-specific protein. The current method based on this assumption indeed
identified FAM75. Although the DNA sequence coding for WRWSH is one of the
SNP variants in the human genome (i.e., WRWSH was not conserved in all human
populations), this fact does not exclude the candidacy of WRWSH as a human-
specific pentat, because we do not know when this SNP variant was created during
human history. Likely, not all point mutations are functionally equal; some point
mutations may incidentally create a rare pentat like WRWSH that may contribute
to functional novelty. Interestingly, the FAM75 transcript was found only in
humans as an alternative splicing transcript of FAM205A. In this sense, our SCS-
based search for human-specific proteins successfully identified what we wanted to
identify. The success of this study may simply be fortunate. On the other hand,
there are many other candidate human-specific pentats that we did not examine in
detail. Changing search conditions, including the length of amino acid sequences
(i.e., triplets, quartets, and longer SCSs), could identify further candidate human-
specific SCSs.
The present study showed that the SCS-based approach is a relevant addition to
a list of practical sequence comparison methods. As with other methods, the SCS-
based method is influenced by SNPs, accuracy, and the amount of information in
databases. For example, the human genome has numerous SNP variations, and
there is much less genomic information for other primates than for humans. A and
ΔA scores, which were used to search in this study, are dependent on databases.
WRWSH had high ΔA between humans and nine other mammals, and this is partly
because there were many human protein records that contained this pentat at the
time of the database search. Unfortunately, most of these records were later
removed from human databases (NCBI GenBank records) because of the uncer-
tainty of their status (although they were not rejected completely). This illustrates
the importance of database quality in genome comparison studies. However, what-
ever ΔA was, we focused on the pentats that were not used at all (A = 1) in the
nine other nonhuman mammals, which made the choice of pentats for further
investigation less sensitive to database quality.
FAM75 and FAM205A appear to be alternative splicing products from the same
genomic locus in humans (Figure 1). The relationship of the evolutionary invention
of FAM75 as an alternative splicing product with that of a SNP variant for WRWSH
is unclear. We cannot exclude the possibility that this may be a simple coincidence,
but this coincidence is in accordance with our starting hypothesis for this study:
proteins containing a human-specific pentat may indeed be human-specific as pro-
teins. We confirmed the expression of FAM205A and/or FAM75 at the mRNA level
in human tissues (Figure 5). At the protein level, the FAM205A protein (and
probably also the FAM75 protein) was shown to be located in cells in seminiferous
ducts and in acrosomes in spermatids in the testis (Figure 7). Interestingly,
FAM205A was also detected in the human sperm nucleus in a proteomic study [75].
Although it is difficult to distinguish FAM75 and FAM205A at the mRNA and
protein levels, it is demonstrated that the FAM75/FAM205A gene is not a
pseudogene, and protein products are actively produced in testis. The discovery of
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4. Discussion
In this paper, we identified a WRWSH-containing protein, FAM75, as a candi-
date human-specific protein. We assumed that pentats with high availability scores
in humans and no occurrence (A = 1) in nine other mammals might be contained
in a human-specific protein. The current method based on this assumption indeed
identified FAM75. Although the DNA sequence coding for WRWSH is one of the
SNP variants in the human genome (i.e., WRWSH was not conserved in all human
populations), this fact does not exclude the candidacy of WRWSH as a human-
specific pentat, because we do not know when this SNP variant was created during
human history. Likely, not all point mutations are functionally equal; some point
mutations may incidentally create a rare pentat like WRWSH that may contribute
to functional novelty. Interestingly, the FAM75 transcript was found only in
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databases. For example, the human genome has numerous SNP variations, and
there is much less genomic information for other primates than for humans. A and
ΔA scores, which were used to search in this study, are dependent on databases.
WRWSH had high ΔA between humans and nine other mammals, and this is partly
because there were many human protein records that contained this pentat at the
time of the database search. Unfortunately, most of these records were later
removed from human databases (NCBI GenBank records) because of the uncer-
tainty of their status (although they were not rejected completely). This illustrates
the importance of database quality in genome comparison studies. However, what-
ever ΔA was, we focused on the pentats that were not used at all (A = 1) in the
nine other nonhuman mammals, which made the choice of pentats for further
investigation less sensitive to database quality.
FAM75 and FAM205A appear to be alternative splicing products from the same
genomic locus in humans (Figure 1). The relationship of the evolutionary invention
of FAM75 as an alternative splicing product with that of a SNP variant for WRWSH
is unclear. We cannot exclude the possibility that this may be a simple coincidence,
but this coincidence is in accordance with our starting hypothesis for this study:
proteins containing a human-specific pentat may indeed be human-specific as pro-
teins. We confirmed the expression of FAM205A and/or FAM75 at the mRNA level
in human tissues (Figure 5). At the protein level, the FAM205A protein (and
probably also the FAM75 protein) was shown to be located in cells in seminiferous
ducts and in acrosomes in spermatids in the testis (Figure 7). Interestingly,
FAM205A was also detected in the human sperm nucleus in a proteomic study [75].
Although it is difficult to distinguish FAM75 and FAM205A at the mRNA and
protein levels, it is demonstrated that the FAM75/FAM205A gene is not a
pseudogene, and protein products are actively produced in testis. The discovery of
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the IRES element in FAM75 mRNA also supports the idea that FAM75 mRNA is
actively translated into proteins. On the other hand, we found two additional
alternative splicing products in H-InvDB (Figure 1). These additional mRNAs were
not examined in this paper, because of insufficient information. However, their
status is of interest if they really exist; they may have similar but slightly different
functions from FAM205A and FAM75.
Mechanistically, alternative splicing may be a relatively easy way to create a new
protein sequence. It may be considered not only a “regulatory change” (according
to the regulatory hypothesis, because the evolutionary invention of a new alterna-
tive splicing product conserves the original protein-coding DNA sequence and gene
function and thus is more conservative with respect to species evolution) but also a
“sequence change” (according to the constituent hypothesis, because the protein
sequence is changed). These two modes are likely intermingled in this case. To
extrapolate this argument, transcriptome studies of alternative splicing or RNA
processing may be fruitful to identify human-specific genes. The present discovery
of the IRES element in the FAM75 mRNA may be surprising because IRES elements
are mostly viral, and cellular elements are relatively rare [72–74]. A search for IRES
elements in the genome may also be fruitful.
The evolution of WRWSH and FAM75 in relation to human speciation is an
important but uncertain aspect to be discussed. There are two kinds of “human-
specific” proteins. First, a group of proteins may have been involved in the early
step of speciation of Homo sapiens from its ancestral species. Second, after the
establishment of Homo sapiens, additional changes in a group of proteins may occur
as a reinforcement process. In either case, these proteins may be called human-
specific. If the pentat WRWSH (or FAM75) played a role in these early or late steps
of human speciation, this pentat is human-specific, and it would be later mutated
back toWRWSR in African populations. In this case, WRWSHwas once assimilated
completely in the human population during speciation, and a new WRWSR
sequence is now assimilating, as genetic assimilation has been considered a key
process in species evolution [76–78]. However, because WRWSH is relatively rare
in African populations, it is more parsimonious to think that WRWSH evolved after
human speciation in Asian or European populations. We speculate that FAM75 may
have been invented from FAM205A to play a role in human speciation, but at least
in the early stage, FAM75 exclusively contained WRWSR, as in the other great apes.
WRWSH may then have been invented in FAM75 to reinforce human speciation.
Alternatively, WRWSH did not play any role in human speciation, and its rein-
forcement simply fortified the function of FAM75 in some populations relatively
recently.
What is the function of FAM75 in human testes? According to the results of
immunohistochemistry (the Human Protein Atlas), SOSUI, and TMHMM, we
speculate that FAM75 appears to function differently from FAM205A in different
cellular sites. Because FAM75 is likely located in acrosomes (Figure 7), this protein
may be involved in the process of fertilization. A possibility is that FAM75 confers
human specificity to prevent cross-species fertilization with ancestral species. The
FAM75/FAM205A genomic locus in humans has an additional two alternative splic-
ing products, which were not pursued in the present study, and orangutans and
mice appeared to have three transcripts from the same locus. It is tempting to
speculate that this locus partly contributes to speciation in primates and other
mammals by restricting cross-species fertilization in ancestral species.
Molecularly, the main function of FAM75 may be located in the “FAM75
domain” located at the N-terminal side of the molecule (Figure 8), but because
WRWSH is located in a hydrophilic region at the C-terminal side of the molecule,
this hydrophilic region may function in human specificity. Indeed, the conserved
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regions are mostly located at the N-terminal side, probably for the general function
of FAM75. The hydrophilic region also coincides with high availability and idiom-
cluster regions.
Testis is known to be the tissue of the fastest evolution among other tissues
based on gene expression comparisons in mammals, including the great apes
[13, 14, 16–18, 79]. This flexibility may reflect diverse species-specific sexual
behaviors. Mating is nonselective and frequent in chimpanzees, and only the
highest-ranked male can mate in gorillas [80]. These behaviors have been thought
to be related to testis-size differences; the chimpanzee has relatively large testes,
and the gorilla has small ones [80]. Human testis size lies between these extremes,
which may be related to the molecular evolution of FAM75 to modulate sperm
development in testes or to withstand moderate sperm competition.
A recent finding that the gene locus for FAM205A is a susceptible locus for
intracerebral hemorrhage (ICH) [81] is somewhat surprising. Either FAM205A or
FAM75 may be expressed in cerebral cells at low levels or in restricted regions of the
brain. It is tempting to speculate that a pleiotropic protein for both fertilization and
brain development, such as FAM75/FAM205A, might have played a role in human
evolution. The fact that the FAM205A/FAM75 gene is located not in a sex chromo-
some but in chromosome 9, despite its expression in the testis, might further
suggest its dual role in sexual and nonsexual aspects of human specificity.
5. Conclusions
Our SCS-based approach identified FAM75, a WRWSH-containing protein, as a
candidate human-specific protein. Its uniqueness in humans may be acquired not
only by a point mutation for WRWSH but also by novel alternative splicing.
Together with FAM205A, FAM75 is likely expressed in human testis, and its possi-
ble expression in acrosomes suggests its potential function in fertilization and thus
in human speciation. Its potential pleiotropic function in the brain is very interest-
ing and may also be investigated in the future.
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status is of interest if they really exist; they may have similar but slightly different
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“sequence change” (according to the constituent hypothesis, because the protein
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back toWRWSR in African populations. In this case, WRWSHwas once assimilated
completely in the human population during speciation, and a new WRWSR
sequence is now assimilating, as genetic assimilation has been considered a key
process in species evolution [76–78]. However, because WRWSH is relatively rare
in African populations, it is more parsimonious to think that WRWSH evolved after
human speciation in Asian or European populations. We speculate that FAM75 may
have been invented from FAM205A to play a role in human speciation, but at least
in the early stage, FAM75 exclusively contained WRWSR, as in the other great apes.
WRWSH may then have been invented in FAM75 to reinforce human speciation.
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forcement simply fortified the function of FAM75 in some populations relatively
recently.
What is the function of FAM75 in human testes? According to the results of
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[13, 14, 16–18, 79]. This flexibility may reflect diverse species-specific sexual
behaviors. Mating is nonselective and frequent in chimpanzees, and only the
highest-ranked male can mate in gorillas [80]. These behaviors have been thought
to be related to testis-size differences; the chimpanzee has relatively large testes,
and the gorilla has small ones [80]. Human testis size lies between these extremes,
which may be related to the molecular evolution of FAM75 to modulate sperm
development in testes or to withstand moderate sperm competition.
A recent finding that the gene locus for FAM205A is a susceptible locus for
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FAM75 may be expressed in cerebral cells at low levels or in restricted regions of the
brain. It is tempting to speculate that a pleiotropic protein for both fertilization and
brain development, such as FAM75/FAM205A, might have played a role in human
evolution. The fact that the FAM205A/FAM75 gene is located not in a sex chromo-
some but in chromosome 9, despite its expression in the testis, might further
suggest its dual role in sexual and nonsexual aspects of human specificity.
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Our SCS-based approach identified FAM75, a WRWSH-containing protein, as a
candidate human-specific protein. Its uniqueness in humans may be acquired not
only by a point mutation for WRWSH but also by novel alternative splicing.
Together with FAM205A, FAM75 is likely expressed in human testis, and its possi-
ble expression in acrosomes suggests its potential function in fertilization and thus
in human speciation. Its potential pleiotropic function in the brain is very interest-
ing and may also be investigated in the future.
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Abstract
This chapter deals with the topic of bioinformatics, computational, mathematics, 
and statistics tools applied to biology, essential for the analysis and characterization 
of biological molecules, in particular proteins, which play an important role in all 
cellular and evolutionary processes of the organisms. In recent decades, with the 
next generation sequencing technologies and bioinformatics, it has facilitated the 
collection and analysis of a large amount of genomic, transcriptomic, proteomic, 
and metabolomic data from different organisms that have allowed predictions on the 
regulation of expression, transcription, translation, structure, and mechanisms of 
action of proteins as well as homology, mutations, and evolutionary processes that 
generate structural and functional changes over time. Although the information in 
the databases is greater every day, all bioinformatics tools continue to be constantly 
modified to improve performance that leads to more accurate predictions regarding 
protein functionality, which is why bioinformatics research remains a great challenge.
Keywords: computational biology, databases, proteomics, transcriptomics, 
functional genomics, phylogeny
1. Introduction
The study to understand the functioning of the cell, as well as the molecules and 
processes that are carried out within it, originated the use of various disciplines 
and sciences to facilitate the progress in research for its characterization over time. 
In the 1950s, the sequencing of small biological molecules began, and in 1956, the 
sequencing of the first protein was achieved. Thus, Margaret O. Dyhoff determined 
that bovine insulin is a small peptide of 51 amino acids. With these advances and 
the constant production of biological information, there was a need to collect and 
organize all the information generated from these sequencing projects [1]. In 1965, 
the first biological sequence database was created, in which all the DNA and protein 
sequences described up to that time were stored and made available to the scientific 
community. Eight years later, the oldest known database was created, which is still 
in force today, Protein Data Bank (PDB) [2].
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In the 80s, bioinformatics had already gained a new meaning in scientific 
research, so several research groups such as Theoretical Biology and Biophysics 
Group attached to the American Institute The Alamos National Laboratory, together 
with Stanford University, gave rise to the best-known database in the world called 
GenBank. Almost at the same time, in 1981, Temple Smith and Michael Waterman 
extensively reviewed the mathematical algorithms for comparing biological 
sequences. As a result of their analysis, they generated the well-known local align-
ment algorithm that allowed to optimize the comparison of biological sequences, 
being the most important contribution for the direct comparison of sequences and 
cornerstone of the alignment by sequence pair [3].
A few years after the creation of GenBank, its European and Asian versions 
were generated, known as the EMBL database (European Molecular Biology 
Laboratory) and DDBJ (DNA Data Bank of Japan) in 1981 and 1984, respec-
tively. In 1985 the FASTA algorithm (FAST-AII) of sequence comparisons 
was reported, which operated as a search engine for similar sequences within 
the GenBank [4]. During the years from 1987 to 1990, databases for protein 
sequences were propelled which resulted in the creation of Swiss-Prot and 
PIR (Protein Information Resource). In 1990, another of the most important 
milestones in bioinformatics originated the BLAST algorithm (Basic Local 
Alignment Tool) that completely revolutionized the exploration and search of 
biological sequences in databases [5].
The National Center for Biotechnology Information (NCBI) makes the following 
definition:
Bioinformatics is a field of science in which various disciplines such as applied 
mathematics, statistics, artificial intelligence, chemistry, biochemistry, computing 
and information technology converge, whose objective is to facilitate the discovery 
of new biological ideas, as well as create global perspectives from which unifying 
principles in biology can be discerned [6].
It consists of two complementary subfields with each other:
1. The development of computer tools and databases.
2. The application of these in the generation of biological knowledge to better 
understand living systems [7].
According to the National Institute of Health of the United States, bioinformatics 
or also called computational biology, deals with the development and application 
of analytical data and theoretical methods, mathematical modeling and computer 
simulation techniques to study biological, behavioral and social systems [8]. The 
programs use public or private databases (with restricted access or with economic 
value) that have been created with information that is constantly growing and 
managed by institutions from various sectors. The main databases used in computa-
tional biology are described below:
1.1 Biological databases
• Primary databases contain original biological data. They are raw sequence files 
or structural data (for example, GenBankm y Protein Data Bank) [6].
• Secondary databases contain information processed computationally based 
on primary data. Translated protein sequence databases contain the func-
tional annotation belonging to this category (for example, Swiss-Prot and 
PIR) [6].
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• Specialized databases are those that serve a particular research interest (for 
example, Flybase). The HIV sequence database and Ribosomal Database 
Project are examples of databases that specialize in a particular organism or a 
certain type of data. Many of the problems detected in scientific research lie in 
the need to connect secondary and specialized databases to primary databases. 
It is desirable that entries in a database be cross-referenced or linked to related 
entries in other databases that contain additional information [6].
There are primary databases, which contain direct information on the sequence, 
structure or pattern of DNA or protein expression, and secondary, which contains 
data derived from primary databases, such as mutations, evolutionary relationships, 
grouping by families or by functions, involvement in diseases, etc.
1.2 Databases for protein analysis (amino acid sequence databases)
Swiss-Prot: It contains annotated or commented sequences, that is, each 
sequence has been reviewed, documented and linked to other databases. External 
link: Swiss-Prot in the EBI (http://www.ebi.ac.uk/swissprot/access.html), Swiss-Prot in 
ExPASy (http://us.expasy.org/sprot/) [9].
TrEMBL: Translation of EMBL Nucleotide Sequence Database includes the 
translation of all coding sequences derived from (EMBL-BANK) and which have 
not yet been annotated in Swiss-Prot. External link: TrEMBL (http://www.ebi.ac.uk/
trembl/) [9].
PIR: Protein Information Resource is divided into four sub-bases that have a 
decreasing annotation level. External link: PIR (http://pir.georgetown.edu/) [9].
ENZYME: It links the complete enzyme activity classification to the Swiss-Prot 
sequences. External link: ENZYME (http://us.expasy.org/enzyme/) [9].
PROSITE: It contains information on the secondary structure of proteins, 
families, domains, etc. External link: PROSITE (http://us.expasy.org/prosite/) [9].
INTERPRO: It integrates information from various secondary structure 
databases such as PROSITE, providing links to other databases and more exten-
sive information. External link: INTERPRO (http://www.ebi.ac.uk/interpro/index.
html) [9].
PDB: Protein Data Bank is the 3-D tertiary structure database of proteins that 
have been crystallized. External link: PDB (http://www.rcsb.org/pdb/) [9].
1.3 Data warehouse
A Data Warehouse (DW) is a set of integrated data oriented to a subject, which 
vary over time and are not transitory, which support the decision-making process of 
the administration [10]. From the review of the bioinformatics projects it is found 
that the requirements of this field require the storage of large volumes of data, with 
multiple dimensions, of extended periods of time and with heterogeneous formats 
as well as their sources. For example, Ligand Depot is an integrated data source for 
finding information about small molecules, proteins and nucleic acids. It focuses 
on providing chemical and structural information for small molecules. Accepts 
keyword-based queries, also provides a graphical interface for conducting chemical 
substructure searches, and allows access to a wide variety of web resources [11].
1.4 Data mining in bioinformatics
Data mining is oriented towards the study of techniques to extract valuable 
information from a large amount of biological data. For this, efficient software tools 
Computational Biology and Chemistry
38
In the 80s, bioinformatics had already gained a new meaning in scientific 
research, so several research groups such as Theoretical Biology and Biophysics 
Group attached to the American Institute The Alamos National Laboratory, together 
with Stanford University, gave rise to the best-known database in the world called 
GenBank. Almost at the same time, in 1981, Temple Smith and Michael Waterman 
extensively reviewed the mathematical algorithms for comparing biological 
sequences. As a result of their analysis, they generated the well-known local align-
ment algorithm that allowed to optimize the comparison of biological sequences, 
being the most important contribution for the direct comparison of sequences and 
cornerstone of the alignment by sequence pair [3].
A few years after the creation of GenBank, its European and Asian versions 
were generated, known as the EMBL database (European Molecular Biology 
Laboratory) and DDBJ (DNA Data Bank of Japan) in 1981 and 1984, respec-
tively. In 1985 the FASTA algorithm (FAST-AII) of sequence comparisons 
was reported, which operated as a search engine for similar sequences within 
the GenBank [4]. During the years from 1987 to 1990, databases for protein 
sequences were propelled which resulted in the creation of Swiss-Prot and 
PIR (Protein Information Resource). In 1990, another of the most important 
milestones in bioinformatics originated the BLAST algorithm (Basic Local 
Alignment Tool) that completely revolutionized the exploration and search of 
biological sequences in databases [5].
The National Center for Biotechnology Information (NCBI) makes the following 
definition:
Bioinformatics is a field of science in which various disciplines such as applied 
mathematics, statistics, artificial intelligence, chemistry, biochemistry, computing 
and information technology converge, whose objective is to facilitate the discovery 
of new biological ideas, as well as create global perspectives from which unifying 
principles in biology can be discerned [6].
It consists of two complementary subfields with each other:
1. The development of computer tools and databases.
2. The application of these in the generation of biological knowledge to better 
understand living systems [7].
According to the National Institute of Health of the United States, bioinformatics 
or also called computational biology, deals with the development and application 
of analytical data and theoretical methods, mathematical modeling and computer 
simulation techniques to study biological, behavioral and social systems [8]. The 
programs use public or private databases (with restricted access or with economic 
value) that have been created with information that is constantly growing and 
managed by institutions from various sectors. The main databases used in computa-
tional biology are described below:
1.1 Biological databases
• Primary databases contain original biological data. They are raw sequence files 
or structural data (for example, GenBankm y Protein Data Bank) [6].
• Secondary databases contain information processed computationally based 
on primary data. Translated protein sequence databases contain the func-
tional annotation belonging to this category (for example, Swiss-Prot and 
PIR) [6].
39
Bioinformatics as a Tool for the Structural and Evolutionary Analysis of Proteins
DOI: http://dx.doi.org/10.5772/intechopen.89594
• Specialized databases are those that serve a particular research interest (for 
example, Flybase). The HIV sequence database and Ribosomal Database 
Project are examples of databases that specialize in a particular organism or a 
certain type of data. Many of the problems detected in scientific research lie in 
the need to connect secondary and specialized databases to primary databases. 
It is desirable that entries in a database be cross-referenced or linked to related 
entries in other databases that contain additional information [6].
There are primary databases, which contain direct information on the sequence, 
structure or pattern of DNA or protein expression, and secondary, which contains 
data derived from primary databases, such as mutations, evolutionary relationships, 
grouping by families or by functions, involvement in diseases, etc.
1.2 Databases for protein analysis (amino acid sequence databases)
Swiss-Prot: It contains annotated or commented sequences, that is, each 
sequence has been reviewed, documented and linked to other databases. External 
link: Swiss-Prot in the EBI (http://www.ebi.ac.uk/swissprot/access.html), Swiss-Prot in 
ExPASy (http://us.expasy.org/sprot/) [9].
TrEMBL: Translation of EMBL Nucleotide Sequence Database includes the 
translation of all coding sequences derived from (EMBL-BANK) and which have 
not yet been annotated in Swiss-Prot. External link: TrEMBL (http://www.ebi.ac.uk/
trembl/) [9].
PIR: Protein Information Resource is divided into four sub-bases that have a 
decreasing annotation level. External link: PIR (http://pir.georgetown.edu/) [9].
ENZYME: It links the complete enzyme activity classification to the Swiss-Prot 
sequences. External link: ENZYME (http://us.expasy.org/enzyme/) [9].
PROSITE: It contains information on the secondary structure of proteins, 
families, domains, etc. External link: PROSITE (http://us.expasy.org/prosite/) [9].
INTERPRO: It integrates information from various secondary structure 
databases such as PROSITE, providing links to other databases and more exten-
sive information. External link: INTERPRO (http://www.ebi.ac.uk/interpro/index.
html) [9].
PDB: Protein Data Bank is the 3-D tertiary structure database of proteins that 
have been crystallized. External link: PDB (http://www.rcsb.org/pdb/) [9].
1.3 Data warehouse
A Data Warehouse (DW) is a set of integrated data oriented to a subject, which 
vary over time and are not transitory, which support the decision-making process of 
the administration [10]. From the review of the bioinformatics projects it is found 
that the requirements of this field require the storage of large volumes of data, with 
multiple dimensions, of extended periods of time and with heterogeneous formats 
as well as their sources. For example, Ligand Depot is an integrated data source for 
finding information about small molecules, proteins and nucleic acids. It focuses 
on providing chemical and structural information for small molecules. Accepts 
keyword-based queries, also provides a graphical interface for conducting chemical 
substructure searches, and allows access to a wide variety of web resources [11].
1.4 Data mining in bioinformatics
Data mining is oriented towards the study of techniques to extract valuable 
information from a large amount of biological data. For this, efficient software tools 
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are necessary to recover data, compare biological sequences, discover patterns and 
visualize the discovery of knowledge [8].
Among the most common data mining techniques in bioinformatics can be 
highlighted [8]:
KDD is the complete process of extracting knowledge, not trivial, previously 
unknown and potentially useful from a data set.
KDT is oriented to the extraction of knowledge from data (unstructured in 
natural language) stored in textual databases, is identified with the discovery of 
knowledge in the texts.
1.5 Applications of bioinformatics
The areas in which bioinformatics is currently developed are many and varied, 
ranging from simple tasks such as direct acquisition of data from DNA or protein 
sequencing assays (when techniques such as mass spectrophotometry are used), 
until the development of software for the storage and analysis of the data, which 
implies in many cases, the generation of algorithms that require both mathematical 
and biological knowledge. Within the areas in which bioinformatics takes place 
are genomics, proteomics, pharmacogenetics and phylogeny. The plant genome 
databases and gene expression analysis of this profile have played an important role 
in the development of new crop varieties that have higher productivity and more 
disease resistance [7].
Specifically, bioinformatics encompasses the development of databases or 
knowledge to store and retrieve biological data, algorithms to analyze and deter-
mine their relationships with biological data, and the statistical tools to identify and 
interpret data sets. The following describes in detail what refers to metabolomics, 
transcriptomics, proteomics, comparative genomics, functional genomics, phylog-
eny and protein modeling.
2. Metabolomic data analysis
The metabolomics was originally proposed as a tool of functional genomics, but 
its use has been extended much more, as it has had great advances like other omics 
sciences, such as transcriptomics and proteomics; because the metabolomic work 
is determined by physical-chemical characteristics of organic molecules unlike the 
genes, mRNA and proteins that come from a specific sequence, so the success of the 
characterization of these biopolymers is thanks to bioinformatics technology and 
tools that help sequence characterization [12]. Its objective is to detect, quantify 
and interpret the overall analysis of all metabolites; these studies are used in various 
areas and, like proteomics, one of its main contributions is biomarkers, helping to 
identify metabolites that are correlated with diseases and environmental exposures 
[13]. Metabolites are chemical entities that do not come from a transfer of informa-
tion within the cell, coupled with this, they are also characterized by being diverse 
as they are substrates and metabolism products that drive essential cellular func-
tions, such as energy production and storage, signal transduction and cell apopto-
sis; in this great diversity of chemical structures we find endogenous and exogenous 
metabolites, the former are produced naturally by an organism and the latter come 
from interaction with the outside. The great diversity of molecules reflects in a wide 
range of polarities, molecular weights, functional groups, stability and chemical 
reactivity, etc. [12, 13].
Among the first reports of metabolite detection are those where mass spectrom-
etry (MS) was used to separate a wide range of metabolites present in urine and 
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tissue extracts [14]. In addition, multicomponent analyzes were described to obtain 
the metabolic profile for three types of urinary constituents: steroids, acids, drugs 
and drug metabolism [15]. On the other hand, there are reports where physical, 
chemical or psychological changes can cause biological responses such as oxidative 
stress and inflammation; among the biomarkers that are the result of a chemical 
reaction are lipoperoxides or oxidized proteins that are the result of the reaction of 
molecules with reactive oxygen species (ROS) and those that represent the biologi-
cal response to stress, such as the transcription factor NRF2 or inflammation and 
inflammatory cytokines [16]. Among the best known and clinically used examples 
we find glucose as a marker of diabetes [17] and phenylalanine as a marker of 
congenital metabolic disorder [18].
Because metabolites play important roles in the biological pathways; its differen-
tial flow or regulation can reveal new knowledge about diseases and environmental 
influences, so one of the most important objectives of the metabolic analysis has 
been to assign the identity of the metabolite within a metabolic pathway [19, 20]; 
generating a large amount of data; requiring for its processing an arduous math-
ematical, statistical and bioinformatic work [12, 21, 22], this last area is crucial for 
the development of metabolomics as it helps in the handling of data and informa-
tion, analytical data processing, metabolomic standards, ontology, statistical 
analysis, mining and data integration, and mathematical modeling of metabolomic 
networks with antecedents of biological systems [12], it is also necessary to decide 
which metabolites are biologically more significant. This can be achieved by helping 
the identification process, reducing the redundancy of characteristics, presenting 
better candidates for the MS, accelerating or automating the workflow, recovering 
data through characteristics through meta-analysis or multigroup analysis, or using 
stable isotopes and mapping of pathways. For all the above, in recent years, the 
technologies for analyzing metabolites have undergone improvements, establishing 
more efficient protocols for experimental design, as well as better sample extrac-
tion techniques and data acquisition that have been worthwhile in providing sets of 
complex and solid data [20].
The database management system for metabolomics requires the collection 
of raw and processed metadata, some important aspects for comparing data and 
obtaining results in different laboratories and reproducing experimental condi-
tions are: The nature and treatment of samples prior to study. Among the bases and 
tools for the analysis and visualization of available data are: Kyoto Encyclopedia of 
Genes and Genomes (KEGG; http://www.genome.ad.jp/kegg/) [23] and Metabolic 
Pathways From all Domains of Life (MetaCyc; http://metacyc.org/) [24].
3. Transcriptome data analysis
The genes response to intracellular or extracellular stimuli includes a hierarchy 
of signals that allows genes encoded in the DNA to be expressed or repressed by 
the transcription process. The total set of transcripts (RNA molecules) produced 
by a cell under a given condition and time, is defined as a transcriptome [25]. Unlike 
the genome, the transcriptome is highly dynamic and actively changes as a con-
sequence of factors that influence the stage of development of organisms, as well 
as the surrounding environmental conditions. In this sense, transcriptomics is an 
essential tool to interpret the functional elements of the genome, having as object 
of study, all species of transcripts, messenger RNA, non-coding RNA and small 
RNAs [26]. Its main purpose being to determine transcriptional structure of genes, 
that is, where a gene begins and ends (start sites 5′ and 3′ end), posttranscriptional 
modifications, splicing patterns and differential expression analysis [27].  
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chemical or psychological changes can cause biological responses such as oxidative 
stress and inflammation; among the biomarkers that are the result of a chemical 
reaction are lipoperoxides or oxidized proteins that are the result of the reaction of 
molecules with reactive oxygen species (ROS) and those that represent the biologi-
cal response to stress, such as the transcription factor NRF2 or inflammation and 
inflammatory cytokines [16]. Among the best known and clinically used examples 
we find glucose as a marker of diabetes [17] and phenylalanine as a marker of 
congenital metabolic disorder [18].
Because metabolites play important roles in the biological pathways; its differen-
tial flow or regulation can reveal new knowledge about diseases and environmental 
influences, so one of the most important objectives of the metabolic analysis has 
been to assign the identity of the metabolite within a metabolic pathway [19, 20]; 
generating a large amount of data; requiring for its processing an arduous math-
ematical, statistical and bioinformatic work [12, 21, 22], this last area is crucial for 
the development of metabolomics as it helps in the handling of data and informa-
tion, analytical data processing, metabolomic standards, ontology, statistical 
analysis, mining and data integration, and mathematical modeling of metabolomic 
networks with antecedents of biological systems [12], it is also necessary to decide 
which metabolites are biologically more significant. This can be achieved by helping 
the identification process, reducing the redundancy of characteristics, presenting 
better candidates for the MS, accelerating or automating the workflow, recovering 
data through characteristics through meta-analysis or multigroup analysis, or using 
stable isotopes and mapping of pathways. For all the above, in recent years, the 
technologies for analyzing metabolites have undergone improvements, establishing 
more efficient protocols for experimental design, as well as better sample extrac-
tion techniques and data acquisition that have been worthwhile in providing sets of 
complex and solid data [20].
The database management system for metabolomics requires the collection 
of raw and processed metadata, some important aspects for comparing data and 
obtaining results in different laboratories and reproducing experimental condi-
tions are: The nature and treatment of samples prior to study. Among the bases and 
tools for the analysis and visualization of available data are: Kyoto Encyclopedia of 
Genes and Genomes (KEGG; http://www.genome.ad.jp/kegg/) [23] and Metabolic 
Pathways From all Domains of Life (MetaCyc; http://metacyc.org/) [24].
3. Transcriptome data analysis
The genes response to intracellular or extracellular stimuli includes a hierarchy 
of signals that allows genes encoded in the DNA to be expressed or repressed by 
the transcription process. The total set of transcripts (RNA molecules) produced 
by a cell under a given condition and time, is defined as a transcriptome [25]. Unlike 
the genome, the transcriptome is highly dynamic and actively changes as a con-
sequence of factors that influence the stage of development of organisms, as well 
as the surrounding environmental conditions. In this sense, transcriptomics is an 
essential tool to interpret the functional elements of the genome, having as object 
of study, all species of transcripts, messenger RNA, non-coding RNA and small 
RNAs [26]. Its main purpose being to determine transcriptional structure of genes, 
that is, where a gene begins and ends (start sites 5′ and 3′ end), posttranscriptional 
modifications, splicing patterns and differential expression analysis [27].  
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The RNA molecules synthesized by a cell have a specific function in a given cellular 
process, the transcripts include: (a) messenger RNA (mRNA) that is the intermedi-
ary between the gene information and the proteome. In this way, the amount of 
mRNA molecules makes it possible to elucidate expression patterns and in turn 
correlate the abundance of mRNA molecules with changes in protein abundance 
[28]; (b) non-coding RNA (cRNA) that is responsible for the regulation of gene 
expression [29]. Determining where, how and when a transcript is generated is 
essential to know the biological activity of a gene [28]. Analyzing the transcripts 
that coexist at any given time gives us global information on the cellular state under 
a certain condition, which has allowed us to establish patterns of gene regulation 
coordinated with the consequent identification of promoter elements common to 
several genes [30].
3.1 RNA study technologies and tools in bioinformatic analysis
The RNA study approach has changed from the sequencing of the first deter-
mined RNA molecule, to the sequencing of the transcriptome using new generation 
technologies [25]. Northern blot is a technique based on hybridization and radioac-
tive labeling, cDNA microarrays (complementary DNA obtained from mRNA) and 
cDNA-AFLP tools widely used in studies of expression levels and serial analysis 
of gene expression (SAGE), at the time they provided relevant information, being 
Microarrays widely used today [31–35]. However, these techniques require prior 
knowledge of the genome, have low coverage and are based on hybridization, in this 
sense the abundance of transcripts is inferred by the intensity of hybridization and 
the results obtained are noisy, which directly interferes with the reproducibility of 
the results, besides being insufficient techniques to detect new transcripts [25].
The growing importance of DNA sequencing in model organisms, as well as 
in the quest to understand the dogma of biology, the NGS technologies (Next 
Generation Sequencing) arise, which have high yields in the treatment of the sam-
ple, are reproducible and highly reliable, as well as accessible and economical, to the 
point of being more profitable than sequencing by SANGER. These next-generation 
technologies are based on sequencing by synthesis (SBS) known as pyrosequencing, 
the transcriptomic variant of pyrosequencing technology is known as short-reading 
massive parallel sequencing (RNA-seq). The availability of this technology has 
revolutionized the approach of transcriptome study, having commercially available 
Roche/454; Applied Biosystems SOLID; HeliScope e Illumina [36].
From the first RNA studies based on sequencing by SANGER to NGS tech-
nologies, bioinformatics has been a key tool in the analysis process. Initially the 
differential expression based on the analysis by Microarrays presented its own com-
putational challenges [36], currently while the reads are shorter than those created 
by sequencing by SANGER, NGS has a higher performance and generates data set of 
up to 50 gigabases per run [37], this requires algorithms capable of processing this 
amount of data in the shortest time possible and with a high degree of reliability.
The study of the transcriptome by RNAseq involves different stages ranging 
from RNA extraction, library construction, sequencing and data analysis. In this 
last step four main stages are distinguished (a) Quality analysis of the reads, this 
allows to determine possible problems in the reads. FastQC is a next-generation data 
quality control tool, which reports graphs and tables providing quality informa-
tion based on the reads (per base sequence quality); check the quality of subsets of 
reads (per sequence quality scores); it also shows the proportion of each nucleotide 
base of the DNA in each base of the reads (per base sequence content); presents the 
average GC content in the reads and compares that content with the normal distri-
bution (per sequence GC content); shows the proportion of N, that is, unknown 
43
Bioinformatics as a Tool for the Structural and Evolutionary Analysis of Proteins
DOI: http://dx.doi.org/10.5772/intechopen.89594
nucleotide observed in each reading position (per base N content); shows the size 
distribution of reads (sequence length distribution); detects adapters in the reads 
(adapter content); detects possible sequencing problems introduced in the reads 
after the adapter (k-mer content) https://rtsf.natsci.msu.edu/genomics/tech-notes/
fastqc-tutorial-and-faq/ [38]. Is advisable that the length of the reads to be analyzed 
is the same, also if there is a poor quality in the reads, the procedure to follow is 
to cut those bases where there is poor quality. Tools such as Fastx-toolkit (https://
bio.tools/fastx-toolkit) [39], Trimmomatic [40], PRINSEq [41], Flexbar [42] and 
others can be used to cut or filter reads, ensuring reliable data for alignment. (b) 
Mapping and identification of transcripts: at this stage the location of the reads with 
respect to a reference genome is known or a Novo assembly is made. There are three 
study strategies: (1) the reads are aligned with allocator with gaps to a reference 
genome (example TopHat, STAR) which allows the identification of new transcripts 
[43, 44]; (2) If the discovery of new transcripts is not sought, the reads can be 
aligned to the reference genome using an aligner without gaps for example RSEM 
[45]; (3) When the genome is not available, the reads are mounted on transcripts 
what is known as Novo assembly (example TRINITY) [46]. In the transcription 
level analyzes, the isoforms that a gene presents are considered separately. On the 
contrary, in the level analyzes of gene, the isoforms that it presents form a unit [47]. 
(c) Quantification of reads: Sample reads are quantified in relation to the transcripts 
that appear in the reference genome or by Novo assembly. The tools used in quan-
tification can be based on alignment or without alignment. Alignment-based tools 
map all reads of a sample, to a genome or to transcriptome. Subsequently, quantify 
the reads that are assigned to a transcript, in the case of TopHat and RSEM [43, 45]. 
Tools that skip sequence alignment like HTSEq and featureCounts [48, 49], use the 
k-mer count, that is, they count all the k-mer in a sequencing library without align-
ing them to any reference, in this way the k-mer are counted and the unique k-mer 
are selected to quantify the expression and finally, these unique k-mer are assigned 
to the transcriptome to identify the transcription. (d) Differential Expression 
Analysis: At this stage, it is analyzed if the expression of a gene is different between 
different conditions. To determine if in a specific gene there are significant differ-
ences in the number of mapped reads corresponding to that gene, there are a large 
number of tools that are based on the comparison of the reading count for each 
transcript/gene under different biological conditions, by statistical analysis, which 
implies normalization methods since transcripts are synthesized at different levels 
(genes or transcripts with low or high level of expression), probabilistic models, 
modeling of reading counts at given distribution etc. In the differential expression 
analysis by RNA-seq, should be considered that the longer transcripts generate more 
reads compared to shorter transcripts. In addition, the technical noise introduced 
into the data during the sequencing process, as part of the variability in the number 
of reads produced by execution causes fluctuations in the number of mapped ele-
ments in the sample. To reduce the technical noise introduced into the data during 
the sequencing process, the number of reads must be normalized in order to obtain 
significant estimates of the expression. Among the statistical parameters used for 
this process are the metric of reads per kilobase per million mapped reads (RPKM), 
fragments per kilobase per million mapped reads (FPKM) [50, 51]. With these 
parameters it is possible to quantify transcription levels and make the comparison 
between samples. On the other hand, fold change allows us to evaluate the rate of 
change of a transcript in both conditions [52]. Within the challenges of transcrip-
tome analysis, it is important to understand how the levels of expression differ in 
each situation studied, to achieve this objective, different methods try to model 
the biological variability such as EdgeR, DESeq, Cuffdiff [48, 53, 54]. In this way, 
there are currently different computational tools suitable for the overall study of 
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the transcriptome suitable for each stage of analysis and specialized for each type of 
transcript under study (Table 1).
3.2  Bioinformatics tools in the study of coding RNA, non-coding RNA and 
microRNAs
The identification of non-coding RNAs and small RNAs is a vital issue in 
genetic analysis [29], in this sense algorithms have been developed for the analysis 
of this type of RNAs in particular (Table 1). Currently, the tools used to classify 
Process Tools Objective References




It analyzes the quality of the 
reads
It debugs poor quality reads
[38–42]




Assembly of reads without 
genome or reference 
transcriptome
Assembly of reads with genome 
or reference transcriptome
[46, 55, 56]




BLAST, BLAT, GMAT, 
AUGUSTUS
CPAT, FEELnc, NRC, 
lncRScan-SVM
It identifies coding transcripts 




Mapping TOPHAT, STAR, HISAT, 
HISAT2, Bowtie
It aligns reads with a reference 
genome or transcriptome
[43, 44, 58, 
66]
Quantification RSEM, Feature Count 
StringTie, Salmon, 
Kallisto
It estimates the number of 





coding and non-coding 
transcripts
BEDTools, glbase It determines the coordinates of 
the reference genome
[70]
BLAST, BLAT, GMAP, 
AUGUSTUS
Through homology it manages 
to determine known sequences 





It evaluates characteristics 
of coding and non-coding 
transcripts
[62–65]
Small RNA analysis miRDeep
Pic Tar
It quantifies known micro 
RNAs and identify new RNAs
[71–73]
PiPMir It identifies new micros RNAs 
in plants
[74]
DARIO It allows the recognition of 
micro RNAs, snoRNA and 
tRNA
[73]
IntaRNA It analyzes micro RNAs in 
eukaryotes and small bacterial 
RNAs
[75, 76]
CopraRNA It makes comparative 
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coding and non-coding sequences have two aspects, those that classify transcripts 
according to similarity and those that use known coding and non-coding proper-
ties [47]. Similarity-based tools classify transcripts, taking as reference the amino 
acid sequences of their transcripts translated with known protein coding genes, 
for example BLAST [5], BLATS [59], GMAP [60]. On the other hand, tools focused 
on coding and non-coding characteristics are based on the properties of known 
transcripts to predict whether a transcript encodes or not for a protein. The coding 
potential can be estimated using automatic learning approaches such as CPAT [62], 
FEELnc [63], lncRScan-SVM [64] and NRC [65]. These exclude transcripts based 
on properties such as transcription length, length of open reading frame (ORF), 
ORF coverage, k-mer frequency, codon usage bias, in addition to being optimized 
for different techniques [47]. In the choice of the tool to be used to evaluate the cod-
ing potential of a transcript, it will depend on what is sought in the study, if there is 
a good annotation and reference genome the tools based on similarity are practical 
and feasible in the analysis. However, in organisms that lack good gene annotations 
it is advisable to use tools based on coding and non-coding characteristics, which 
also allow to identify new genes. On the other hand, the availability of small read-
ings opened a new field of study for small RNAs such as microRNAs (miRNAs), 
small RNAs of interference (siRNA) and piwiRNAs (piRNAs); Currently there are 
specialized tools for this type of RNA that provide additional biological knowledge. 
In this case miRDeep and its varieties are widely used to quantify known and novel 
RNA (miRNA), from the sequencing of small RNA by RNAseq [71, 72]; PiPMir [74] 
has been used for the detection of miRNA in plants. DARIO (http://dario.bioinf.
uni-leipzig.de/index.py) is a web service that allows not only the recognition of new 
microRNAs but also small RNAs derived from other types of parental RNAs, such 
as snoRNA and tRNA [73]. Pic Tar is an algorithm for the identification of micro 
RNAs, which is based on functional interactions of micro RNA [78, 79]. IntaRNA 
has been designed for the study of micro RNAs in eukaryotes and small bacterial 
RNAs (RNAs) [75, 76]. CopraRNA is a comparative prediction algorithm that is 
complemented by post-processing methods that includes functional enrichment 
analysis [76, 77]. Finally, after analyzing the data, the biological conclusions must 
be carefully interpreted.
4. Proteomics data analysis
Transcriptome sequences provide resources for gene expression profile studies, 
as well as for the identification of mutations, sequence aberrations and RNA editing 
events [25], the above is possible to the existence of the open reading frame (ORF), 
however, in genomic data this does not imply the existence of a functional gene; 
despite the great advances in bioinformatics that facilitate the analysis and predic-
tion of genes with the help of comparative genomics, and although they are years 
of development of molecular simulation methods, attempts to improve models 
that are already relatively close to the structure native, they have had little success, 
which may be due to inaccuracies in the potential functions used in simulations, 
such as the treatment of electrostatic and solvation effects or it may be necessary to 
improve sampling strategies due to the relatively long folding time scale of proteins; 
the combination of chemistry and physics with the large amount of information 
in known protein structures could provide a better route for the development of 
enhanced potential functions. Currently, it is difficult to accurately predict protein 
structures from genes, the success rate for the correct prediction of structures 
remains low [25, 80, 81]. Proteomics involves various technologies for deep pro-
teome analysis, thus achieving quantification and identification of these proteins; 
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the transcriptome suitable for each stage of analysis and specialized for each type of 
transcript under study (Table 1).
3.2  Bioinformatics tools in the study of coding RNA, non-coding RNA and 
microRNAs
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of this type of RNAs in particular (Table 1). Currently, the tools used to classify 
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coding and non-coding sequences have two aspects, those that classify transcripts 
according to similarity and those that use known coding and non-coding proper-
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acid sequences of their transcripts translated with known protein coding genes, 
for example BLAST [5], BLATS [59], GMAP [60]. On the other hand, tools focused 
on coding and non-coding characteristics are based on the properties of known 
transcripts to predict whether a transcript encodes or not for a protein. The coding 
potential can be estimated using automatic learning approaches such as CPAT [62], 
FEELnc [63], lncRScan-SVM [64] and NRC [65]. These exclude transcripts based 
on properties such as transcription length, length of open reading frame (ORF), 
ORF coverage, k-mer frequency, codon usage bias, in addition to being optimized 
for different techniques [47]. In the choice of the tool to be used to evaluate the cod-
ing potential of a transcript, it will depend on what is sought in the study, if there is 
a good annotation and reference genome the tools based on similarity are practical 
and feasible in the analysis. However, in organisms that lack good gene annotations 
it is advisable to use tools based on coding and non-coding characteristics, which 
also allow to identify new genes. On the other hand, the availability of small read-
ings opened a new field of study for small RNAs such as microRNAs (miRNAs), 
small RNAs of interference (siRNA) and piwiRNAs (piRNAs); Currently there are 
specialized tools for this type of RNA that provide additional biological knowledge. 
In this case miRDeep and its varieties are widely used to quantify known and novel 
RNA (miRNA), from the sequencing of small RNA by RNAseq [71, 72]; PiPMir [74] 
has been used for the detection of miRNA in plants. DARIO (http://dario.bioinf.
uni-leipzig.de/index.py) is a web service that allows not only the recognition of new 
microRNAs but also small RNAs derived from other types of parental RNAs, such 
as snoRNA and tRNA [73]. Pic Tar is an algorithm for the identification of micro 
RNAs, which is based on functional interactions of micro RNA [78, 79]. IntaRNA 
has been designed for the study of micro RNAs in eukaryotes and small bacterial 
RNAs (RNAs) [75, 76]. CopraRNA is a comparative prediction algorithm that is 
complemented by post-processing methods that includes functional enrichment 
analysis [76, 77]. Finally, after analyzing the data, the biological conclusions must 
be carefully interpreted.
4. Proteomics data analysis
Transcriptome sequences provide resources for gene expression profile studies, 
as well as for the identification of mutations, sequence aberrations and RNA editing 
events [25], the above is possible to the existence of the open reading frame (ORF), 
however, in genomic data this does not imply the existence of a functional gene; 
despite the great advances in bioinformatics that facilitate the analysis and predic-
tion of genes with the help of comparative genomics, and although they are years 
of development of molecular simulation methods, attempts to improve models 
that are already relatively close to the structure native, they have had little success, 
which may be due to inaccuracies in the potential functions used in simulations, 
such as the treatment of electrostatic and solvation effects or it may be necessary to 
improve sampling strategies due to the relatively long folding time scale of proteins; 
the combination of chemistry and physics with the large amount of information 
in known protein structures could provide a better route for the development of 
enhanced potential functions. Currently, it is difficult to accurately predict protein 
structures from genes, the success rate for the correct prediction of structures 
remains low [25, 80, 81]. Proteomics involves various technologies for deep pro-
teome analysis, thus achieving quantification and identification of these proteins; 
Computational Biology and Chemistry
46
covering the part of functional analysis of genetic products, interaction studies, and 
protein localization, which helps explain the identity of an organism’s proteins to 
know the structure and function. However, considering that the proteome is highly 
dynamic due to the complex regulatory systems that control the levels of protein 
expression, its use is limited, since in addition to the use of specialized personnel, 
facilities and equipment, software is also included for equipment, and databases, 
which increases costs [80, 82, 83]. Proteomics is constantly updated, generating 
challenges ranging from sample preparation to data collection. A large amount of 
information is generated from protein folding models, three-dimensional struc-
tures, prediction of unknown protein structures and functions, data obtained from 
the separation of proteins by electrophoresis in two-dimensional gels, isoelectric 
focusing, 2D protein visualization, peptide mass fingerprinting (PMF), MS, MS 
in tandem, etc., the above generates high performance proteomes with the help 
of bioinformatics, which introduces new algorithms to handle a large amount of 
heterogeneous data [84–86].
Some of the most used platforms in proteomics are: The Basic Local Alignment 
Search Tool (BLAST), Expert Protein Analysis System (ExPASy) and Protein 
Data Bank (PDB); BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi). It is one of 
the most used and updated platforms, which uses simple but powerful methods 
for protein analysis comparing amino acid sequences, which makes it possible to 
determine homology between proteins, where the algorithms used to perform this 
procedure guarantee the best possible alignment, however, it does not guarantee 
the best structure [5, 86–90]. ExPASy gives access to a wide variety of databases 
and analytical tools dedicated to proteins and proteomics. On the other hand, PDB 
(https://www.wwpdb.org/) is the global repository of three-dimensional structures 
of macromolecules that is updated weekly and contains more than 153,000 protein 
structures, resulting from crystallographic studies, X-rays or nuclear magnetic 
resonance (NMR) created by modeling software, all these platforms contain various 
servers that help classify proteins according to their sequence, structure and func-
tion [86, 91, 92].
All this information is of great help, since it is used in different research areas, 
such as detection of diagnostic markers, candidates for vaccine production, under-
standing the mechanisms of pathogenicity, alteration of expression patterns in 
response to different signals and interpretation of functional protein pathways in 
different diseases [93–98].
5. Comparative genomics
Comparative genomics is a broad field of study that identifies differences 
between genomes and elucidates which of them are responsible for phenotypic 
changes in organisms [99]. In contrast to ‘traditional’ genomic studies that focus 
on a single genome per study [100], comparative genomics provides additional 
detailed information to that obtained from the analysis of a single genome, which 
can reveal the encoded functional potential of an organism compared to another 
[101–103]. Comparisons between different genomes of organisms lead to more 
rapid identification of different underlying mechanisms are shared between 
organisms and others that are different among them [104–106]. Likewise, compar-
ative genomics allows a better understanding of how species have evolved [107]. 
In this sense, the concept of pangenome (Figure 1) refers to the set of genes in a 
particular species [106]. The commonly used partition of a pangenome considers 
three main parts: the central genome, the expendable or accessory genome and 
the singleton genome [108]. The central genes are responsible for the basic aspects 
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of the biology of the species and its main phenotypic features; while accessory 
genes and singletons generally belong to supplementary biochemical pathways and 
functions that can confer selective advantages such as ecological adaptation [108]. 
While the global analysis of gene content (as in pangenome studies) provides 
information on differences in functional potential and possible phenotypic differ-
ences between organisms, specific central gene analyzes have also been used for 
studies of phylogenetic diversity [99, 108].
Initially, the concept of pangenome was used to refer to bacterial genomes, 
however, over time it has been used to refer to genomes of eukaryotic organisms 
such as yeasts [106, 109], plants [108, 110, 111], and viruses [108, 112]. Different 
organisms can be compared despite their phenotypic differences and with respect 
to their relationship of kinship (phylogenetic distances) [105, 113]. The assembly 
of genomes from sequencing data by Illumina or PacBio methods [114] involves 
five important stages, these steps are described in Figure 2, as well as some of the 
tools used [106].
Figure 1. 
Pangenome diagram of three different genomes.
Figure 2. 
Workflow for the de novo genome comparative analysis.
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covering the part of functional analysis of genetic products, interaction studies, and 
protein localization, which helps explain the identity of an organism’s proteins to 
know the structure and function. However, considering that the proteome is highly 
dynamic due to the complex regulatory systems that control the levels of protein 
expression, its use is limited, since in addition to the use of specialized personnel, 
facilities and equipment, software is also included for equipment, and databases, 
which increases costs [80, 82, 83]. Proteomics is constantly updated, generating 
challenges ranging from sample preparation to data collection. A large amount of 
information is generated from protein folding models, three-dimensional struc-
tures, prediction of unknown protein structures and functions, data obtained from 
the separation of proteins by electrophoresis in two-dimensional gels, isoelectric 
focusing, 2D protein visualization, peptide mass fingerprinting (PMF), MS, MS 
in tandem, etc., the above generates high performance proteomes with the help 
of bioinformatics, which introduces new algorithms to handle a large amount of 
heterogeneous data [84–86].
Some of the most used platforms in proteomics are: The Basic Local Alignment 
Search Tool (BLAST), Expert Protein Analysis System (ExPASy) and Protein 
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the most used and updated platforms, which uses simple but powerful methods 
for protein analysis comparing amino acid sequences, which makes it possible to 
determine homology between proteins, where the algorithms used to perform this 
procedure guarantee the best possible alignment, however, it does not guarantee 
the best structure [5, 86–90]. ExPASy gives access to a wide variety of databases 
and analytical tools dedicated to proteins and proteomics. On the other hand, PDB 
(https://www.wwpdb.org/) is the global repository of three-dimensional structures 
of macromolecules that is updated weekly and contains more than 153,000 protein 
structures, resulting from crystallographic studies, X-rays or nuclear magnetic 
resonance (NMR) created by modeling software, all these platforms contain various 
servers that help classify proteins according to their sequence, structure and func-
tion [86, 91, 92].
All this information is of great help, since it is used in different research areas, 
such as detection of diagnostic markers, candidates for vaccine production, under-
standing the mechanisms of pathogenicity, alteration of expression patterns in 
response to different signals and interpretation of functional protein pathways in 
different diseases [93–98].
5. Comparative genomics
Comparative genomics is a broad field of study that identifies differences 
between genomes and elucidates which of them are responsible for phenotypic 
changes in organisms [99]. In contrast to ‘traditional’ genomic studies that focus 
on a single genome per study [100], comparative genomics provides additional 
detailed information to that obtained from the analysis of a single genome, which 
can reveal the encoded functional potential of an organism compared to another 
[101–103]. Comparisons between different genomes of organisms lead to more 
rapid identification of different underlying mechanisms are shared between 
organisms and others that are different among them [104–106]. Likewise, compar-
ative genomics allows a better understanding of how species have evolved [107]. 
In this sense, the concept of pangenome (Figure 1) refers to the set of genes in a 
particular species [106]. The commonly used partition of a pangenome considers 
three main parts: the central genome, the expendable or accessory genome and 
the singleton genome [108]. The central genes are responsible for the basic aspects 
47
Bioinformatics as a Tool for the Structural and Evolutionary Analysis of Proteins
DOI: http://dx.doi.org/10.5772/intechopen.89594
of the biology of the species and its main phenotypic features; while accessory 
genes and singletons generally belong to supplementary biochemical pathways and 
functions that can confer selective advantages such as ecological adaptation [108]. 
While the global analysis of gene content (as in pangenome studies) provides 
information on differences in functional potential and possible phenotypic differ-
ences between organisms, specific central gene analyzes have also been used for 
studies of phylogenetic diversity [99, 108].
Initially, the concept of pangenome was used to refer to bacterial genomes, 
however, over time it has been used to refer to genomes of eukaryotic organisms 
such as yeasts [106, 109], plants [108, 110, 111], and viruses [108, 112]. Different 
organisms can be compared despite their phenotypic differences and with respect 
to their relationship of kinship (phylogenetic distances) [105, 113]. The assembly 
of genomes from sequencing data by Illumina or PacBio methods [114] involves 
five important stages, these steps are described in Figure 2, as well as some of the 
tools used [106].
Figure 1. 
Pangenome diagram of three different genomes.
Figure 2. 
Workflow for the de novo genome comparative analysis.
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For gene comparisons databases with different characteristics are used, for 
example, to obtain gene families and identify their orthology the EDGAR database 
[108, 115] is used, as well as, the prokaryotic-genome analysis tool (PGAT) for the 
analysis of bacterial genomes [108, 116]. There are independent applications such as 
the Pan-genome analysis pipeline (PGAP) that have specific modules to perform the 
functional analysis of genes, the analysis and determination of each of the compo-
nents of the pangenome, the detection of genetic variation as well as the analysis of 
Species evolution [108, 117], PanFunPro is a tool that allows pangenome analysis in 
protein prediction from genetic information [96]. There are tools that allow you to 
work with large amounts of data such as PanGP [118] and the large acale BSR [119].
The bacterial pan genome analysis tool (BPGA) [120] is a recently published 
package for pangenome analysis with seven functional modules; In addition to 
routine analysis, it presents a series of novel features for subsequent analyzes such 
as phylogeny, as well as tools that allow determining the presence and absence of 
certain genes in specific strains, another module to perform subset analysis, content 
analysis atypical G+C and KEGG & COG mapping of central, accessory and unique 
genes [108, 121–124].
6. Functional genomics
Functional genomics studies and assigns functions to the genome of an 
organism, including genes and non-genetic elements [125, 126], with the sup-
port of molecular and cellular biology studies, focused on the dynamic aspects 
of transcriptomics, proteomics and metabolomics [127], that allow to know 
the relationship of genes, their transcription, translation and protein-protein 
interactions [128, 129], that promote the phenotypic characteristics of each 
organism [125, 126]. A functional genomic approach can use multiple techniques 
for data analysis in a single study [129]. Apart from the tools of transcriptomics 
and proteomics, functional genomics needs of studies that allow us to know 
gene interactions [130, 131], genetic variations (polymorphisms) in different 
individuals through the study of SNPs [126, 132]. Likewise, it is important to 
know the regulation of genes in the expression of proteins that first carries out 
the analysis of promoter sequences, followed by the expression of the promoters 
and subsequently the expression of proteins [126, 133, 134]. Another study used 
for a rapid and systematic analysis of the expression of a large number of genes 
is the microarrays, which make it easier to observe the differential expression of 
genes from DNA or cDNA, as well as, allowing the finding gene functions novel 
and unexpected [135]. In addition, compare the pattern of gene expression under 
different conditions [136]. SAGE serial analysis of gene expression based on the 
study of cDNA allows to examine gene expression in a cell [126]. To perform a 
functional genomic observation, an assembled and identified genome must be 
had, which does not contain gaps, to avoid erroneous annotations. Subsequently, 
the assembled genome is compared with a reference genome, which together 
allows to predict genes. Next, the mapped elements are combined, and the 
biological information that allows to define an optimal set of annotations or func-
tions is assigned. At the end, the data will have to be validated, this is achieved 
through manual inspections, experimental checks and quality measures [137]. To 
perform the genome annotation there are computational tools, one of the most 
used and friendly is Blast2GO which is a bioinformatics platform for high quality 
functional annotations and analysis of genomic data sets [138]. The data obtained 
can be shared with the public through databases so that other researchers can 
access them. Currently, GEO of NCBI is the public functional genomics database 
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that provides tools that help users in the consultation and download of data [139]. 
Likewise, KEGG is a database that is used as a tool to understand the high-level 
functions and utilities of the biological system, such as the cell, the organism or 
the ecosystem, based on molecular level information, generated by sequencing of 
the genome and other high performance [140]. There are also databases that store 
specific information on each of the most important model organisms (Table 2).
7. Phylogeny in the protein evolutionary process
The sequencing of the genome of an organism, has allowed to know the set of 
all its genes, elucidating the functions and products that they express, as well as the 
mechanisms of regulation in different metabolic processes, where endless proteins 
participate. To determine their possible functions, biochemical and genetic analyzes 
are used in a classical way, however, sequencing has contributed to the knowledge 
about the type of amino acids that make it up, and through the use of software 
multiple sequences have been aligned, where they have those that have been 
fully characterized as well as proteins where their biochemical characteristics are 
unknown and by homology between amino acids can be inferred in the functions 
that these proteins can present [149]. The use of bioinformatics, in protein analysis 
is a challenge, in recent years, phylogenetic profiles have been fundamental to 
relate homologous proteins by aligning their sequences, where it has been revealed 
that many share highly conserved regions and similar structures [150]. Phylogeny 
analyzes the changes that occur within the sequences and groups them in a diagram 
with ramifications, called a phylogenetic tree, all those sequences that belong to the 
same family can be grouped into a clade and in turn into subfamilies, providing data 
on their evolution and functional diversity [151].
Eukaryotic cells during their evolution have captured microorganisms that origi-
nated mitochondria, chloroplasts and other organelles, where their genes have been 
transferred to the nuclear genome, allowing the transport of encoded proteins in 
the nucleus. The different locations of proteins in the cell, and the different proteins 
that participate in cellular processes, have originated phylogenetic analyzes on the 
location of proteins in the cell, finding that they are closely related to prokaryotic 
proteins that have eukaryotes. The proteins of chloroplasts and mitochondria have 
a composition of amino acids, length, sequences and conserved regions very similar 
to those of prokaryotes [152, 153]. One of the limitations to analyze proteins among 




Saccharomyces cerevisiae https://www.yeastgenome.org/ [142]
Arabidopsis thaliana https://www.arabidopsis.org/ [143]
Caenorhabditis elegans https://wormbase.org/#012-34-5 [144]
Drosophila melanogaster http://www.flybase.org/ [145]
Danio rerio http://zfin.org/ [146]
Mus musculus http://www.informatics.jax.org/ [147]
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For gene comparisons databases with different characteristics are used, for 
example, to obtain gene families and identify their orthology the EDGAR database 
[108, 115] is used, as well as, the prokaryotic-genome analysis tool (PGAT) for the 
analysis of bacterial genomes [108, 116]. There are independent applications such as 
the Pan-genome analysis pipeline (PGAP) that have specific modules to perform the 
functional analysis of genes, the analysis and determination of each of the compo-
nents of the pangenome, the detection of genetic variation as well as the analysis of 
Species evolution [108, 117], PanFunPro is a tool that allows pangenome analysis in 
protein prediction from genetic information [96]. There are tools that allow you to 
work with large amounts of data such as PanGP [118] and the large acale BSR [119].
The bacterial pan genome analysis tool (BPGA) [120] is a recently published 
package for pangenome analysis with seven functional modules; In addition to 
routine analysis, it presents a series of novel features for subsequent analyzes such 
as phylogeny, as well as tools that allow determining the presence and absence of 
certain genes in specific strains, another module to perform subset analysis, content 
analysis atypical G+C and KEGG & COG mapping of central, accessory and unique 
genes [108, 121–124].
6. Functional genomics
Functional genomics studies and assigns functions to the genome of an 
organism, including genes and non-genetic elements [125, 126], with the sup-
port of molecular and cellular biology studies, focused on the dynamic aspects 
of transcriptomics, proteomics and metabolomics [127], that allow to know 
the relationship of genes, their transcription, translation and protein-protein 
interactions [128, 129], that promote the phenotypic characteristics of each 
organism [125, 126]. A functional genomic approach can use multiple techniques 
for data analysis in a single study [129]. Apart from the tools of transcriptomics 
and proteomics, functional genomics needs of studies that allow us to know 
gene interactions [130, 131], genetic variations (polymorphisms) in different 
individuals through the study of SNPs [126, 132]. Likewise, it is important to 
know the regulation of genes in the expression of proteins that first carries out 
the analysis of promoter sequences, followed by the expression of the promoters 
and subsequently the expression of proteins [126, 133, 134]. Another study used 
for a rapid and systematic analysis of the expression of a large number of genes 
is the microarrays, which make it easier to observe the differential expression of 
genes from DNA or cDNA, as well as, allowing the finding gene functions novel 
and unexpected [135]. In addition, compare the pattern of gene expression under 
different conditions [136]. SAGE serial analysis of gene expression based on the 
study of cDNA allows to examine gene expression in a cell [126]. To perform a 
functional genomic observation, an assembled and identified genome must be 
had, which does not contain gaps, to avoid erroneous annotations. Subsequently, 
the assembled genome is compared with a reference genome, which together 
allows to predict genes. Next, the mapped elements are combined, and the 
biological information that allows to define an optimal set of annotations or func-
tions is assigned. At the end, the data will have to be validated, this is achieved 
through manual inspections, experimental checks and quality measures [137]. To 
perform the genome annotation there are computational tools, one of the most 
used and friendly is Blast2GO which is a bioinformatics platform for high quality 
functional annotations and analysis of genomic data sets [138]. The data obtained 
can be shared with the public through databases so that other researchers can 
access them. Currently, GEO of NCBI is the public functional genomics database 
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that provides tools that help users in the consultation and download of data [139]. 
Likewise, KEGG is a database that is used as a tool to understand the high-level 
functions and utilities of the biological system, such as the cell, the organism or 
the ecosystem, based on molecular level information, generated by sequencing of 
the genome and other high performance [140]. There are also databases that store 
specific information on each of the most important model organisms (Table 2).
7. Phylogeny in the protein evolutionary process
The sequencing of the genome of an organism, has allowed to know the set of 
all its genes, elucidating the functions and products that they express, as well as the 
mechanisms of regulation in different metabolic processes, where endless proteins 
participate. To determine their possible functions, biochemical and genetic analyzes 
are used in a classical way, however, sequencing has contributed to the knowledge 
about the type of amino acids that make it up, and through the use of software 
multiple sequences have been aligned, where they have those that have been 
fully characterized as well as proteins where their biochemical characteristics are 
unknown and by homology between amino acids can be inferred in the functions 
that these proteins can present [149]. The use of bioinformatics, in protein analysis 
is a challenge, in recent years, phylogenetic profiles have been fundamental to 
relate homologous proteins by aligning their sequences, where it has been revealed 
that many share highly conserved regions and similar structures [150]. Phylogeny 
analyzes the changes that occur within the sequences and groups them in a diagram 
with ramifications, called a phylogenetic tree, all those sequences that belong to the 
same family can be grouped into a clade and in turn into subfamilies, providing data 
on their evolution and functional diversity [151].
Eukaryotic cells during their evolution have captured microorganisms that origi-
nated mitochondria, chloroplasts and other organelles, where their genes have been 
transferred to the nuclear genome, allowing the transport of encoded proteins in 
the nucleus. The different locations of proteins in the cell, and the different proteins 
that participate in cellular processes, have originated phylogenetic analyzes on the 
location of proteins in the cell, finding that they are closely related to prokaryotic 
proteins that have eukaryotes. The proteins of chloroplasts and mitochondria have 
a composition of amino acids, length, sequences and conserved regions very similar 
to those of prokaryotes [152, 153]. One of the limitations to analyze proteins among 
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related organisms is that genomes must be complete, in order to determine the pres-
ence or absence of genes in these species [154].
The high number of sequences that are stored in the different databases, have 
allowed to infer in the evolutionary relationships of different proteins, which when 
presenting homology retain their function during long evolutionary times, however, 
homologous proteins can perform the same activity, but the substrates they use can 
come from different routes [155]. When organisms adapt to different environmental 
conditions they cause mutational changes in genome sequences, causing amino acid 
substitutions in enzymes, making them improve their efficiency and specificity, to 
maintain their catalytic function. Not all genes that code for proteins are susceptible 
to mutation, due to the presence of essential amino acids in function, stability and 
folding, and therefore a restriction is generated. Many of the mutations are usually 
random and, in those proteins, where these changes have been observed, it is due to 
an evolutionary pressure. If the protein plays an important role in the functions of 
the organism and the mutation brings improvements in activity, the change in the 
genome is maintained and optimized, favored by selective pressure, otherwise, when 
the function of the protein is not relevant. In the cell, the mutant gene is removed 
from the genome by random deletions. Evolutionary mechanisms have given rise 
to homologous protein families, which share a common ancestor [155]. The study 
of ancestral enzymes has suggested that these presented a high thermostability, 
due to the Precambrian era that was thermophilic, in addition to the fact that most 
microorganisms and other organisms adapted to these environments with high 
temperatures. The ancestral protein alignments with the current ones show evidence 
of a slow evolution in structure, but not in amino acids [156]. Therefore, enzymes 
are the product of years of evolution, where they have undergone changes to obtain a 
specific function, as well as greater affinity with the substrate and/or act on multi-
substrates. Therefore, the genetic variability has generated homologous genes (they 
descend from a common ancestor and are called orthologs) that encode adapted 
proteins to perform their catalysis in extreme conditions. However, there are also 
paralogous genes, which have diverged, to encode proteins with different activi-
ties [157], many times a particular characteristic is preserved, such as the binding 
of a molecule or reaction mechanism, but they specialize in carrying out the same 
reaction but on different substrates, different regulation mechanisms, as well as cell 
localization. On the other hand, orthologous proteins tend to have the same function 
and their sequences have a high conservation [155].
To analyze these changes in the sequences, bioinformatics programs use 
algorithms and mathematical models, based on empirical matrices of amino acid 
substitution, as well as those that incorporate structural properties of the native 
state, such as secondary structure and accessibility [158]. Protein phylogeny 
studies are currently necessary to know protein-protein interactions in biological 
systems. Molecular or structural analyzes on proteins will require more informa-
tion to respond if a protein is present in one or several species, as well as to predict 
the common ancestor and evolution times [159]. There are different methods to 
estimate the genetic distance of proteins, among the most used are the minimum 
distance, which predicts the phylogenetic relationship minimizing the total distance 
of the pairs of sequences adjacent nodes tree. While those of maximum parsimony 
and maximum likelihood, use the multiple sequence alignment, however, the 
maximum parsimony maximum builds a tree minimizing the total evolutionary 
changes between adjacent proteins and the maximum likelihood tries to minimize 
the probability of making such changes. The bioinformatics tools that use these 
algorithms are: TOPAL, Hennig86 and PAML, the computational packages that 
allow to occupy any of these are PHYLIP and PAUP, as well as MOLPHY, PASSML, 
PUZZLE, TAAR [160].
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8. Protein modeling
One of the challenges of protein engineering and biology is to improve indus-
trial processes, to achieve this it is necessary to determine the tertiary structure of 
proteins from the amino acid sequence, in order to design new proteins and even 
new medicines. Many of the protein structures that we know today have been 
obtained through experimentation by X-ray crystallography, NMR spectroscopy 
or cryo-EM, however, the large amount of proteins, makes these processes require 
more time and increase costs [161]. Modeling through bioinformatics programs 
has managed to predict the atomic structure of several proteins from their amino 
acid sequence, by comparison with known protein structures, commonly called 
templates, although these do not present an accuracy with traditional techniques, 
the processes are faster and more economical in addition to providing low resolu-
tion data during sequence comparison [162, 163]. If the protein studied presents a 
homolog of known structure, the analysis is easier and the generated model is of 
higher resolution, but if the homologs do not exist or are not identified, the model-
ing is constructed from scratch [164]. De novo modeling is based on the assembly of 
proteins using short peptide fragments, originating from known proteins based on 
similarity, although advances have been made using this process, it has only worked 
on proteins that contain less than 100 amino acids, on large proteins size is difficult 
to analyze due to lack of information, as well as the type of software used [161, 165].
The 3D protein structures provide data at the molecular level, functions and 
properties, among which are the study of the catalytic mechanism, design and 
improvement of ligands, union of macromolecules with proteins, functional 
relationships through structural similarity and identification of conserved residues 
[55]. The interest in finding new protein models is generating a large amount of 
data, which is being stored in different databases, including Protein Data Bank, 
where the coordinates of the experimentally obtained atoms are stored; until 
2014 this base contained more than 80 million sequences and more than 100,000 
experimentally obtained 3D structures [166, 167]. These data have allowed the 
classification of proteins in different hierarchical levels as family, superfamily and 
fold in relation to their structure and evolution. All those that are grouped into a 
family are evolutionarily related to high sequence similarity. It is suggested that 
the different families that maintain a structure and function, present a common 
ancestor and are grouped into superfamilies and the difference between these is 
due to the folds or secondary structure that they possess [160]. In the last decade, 
the predictions by computational models have revealed the structure and function 
of many proteins, but the advances have been in some cases slow and expensive, 
due to the programming methods used and the precision of these during modeling. 
Currently working on automated bioinformatics servers that will generate models 
with a high percentage of accuracy [168, 169]. One of the most used servers world-
wide is SWIIS-MODEL, which was the first to model proteins through homology, 
and in recent years has been automated allowing complex modeling, as well as the 
introduction of the modeling engines ProMod3 and QMEAN [167, 170, 171].  
Most modeling algorithms use the following steps: (1) Identification of related 
structures, (2) template choice, (3) target sequence alignment with templates, 
(4) molding construction, (5) model evaluation. However, one of the limitations 
during homology protein modeling is the choice of model proteins or templates as 
well as alignments against the problem sequences [172, 173]. When the similarity 
of the sequences between the problem protein and that of the databases is low, the 
relationship and alignment can be improved if structural information is included 
during the analysis [166]. Advances in biocomputing have allowed the generation 
of tools for modeling proteins that are more reliable and easier to use, reducing 
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related organisms is that genomes must be complete, in order to determine the pres-
ence or absence of genes in these species [154].
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descend from a common ancestor and are called orthologs) that encode adapted 
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of tools for modeling proteins that are more reliable and easier to use, reducing 
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time and cost in the analysis. However, it is necessary to carry out experimentation 
to confirm that the prediction is correct, in addition to improving the efficiency 
of the techniques and with more known protein sequences and stored in the data-
bases, therefore the different bioinformatics tools will play an important role in the 
postgenomic era [160].
9. Conclusions
Bioinformatics has evolved with daily work, which has allowed us to know how 
the biological molecules of a cell interact for their proper functioning, in addition 
to predicting various biological phenomena. In the last decade, the omic sciences 
have generated a great amount of data increasing the knowledge of the biological 
functions so that in the future they are able to predict diseases or formulate drugs 
with greater efficiency, however it is still necessary, to have a higher percentage of 
sequenced genes of the different organisms, as well as protein sequences, that allow 
enriching the databases, and with this more precise mathematical models are gener-
ated, which will benefit the computer programs so that they are more efficient, 
reliable, easy to use, reducing time and cost in the analyzes. This discipline becomes 
an essential part of biological studies every day, so its expansion and growth will be 
infinite, due to the evolutionary changes that are taking place in the cells caused by 
the different environmental phenomena.
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Abstract
Scaffolding is an important step of the genome assembly and its function is to
order and orient the contigs in the assembly of a draft genome into larger scaffolds.
Several single reference-based scaffolders have currently been proposed. However,
a single reference genome may not be sufficient alone for a scaffolder to correctly
scaffold a target draft genome, especially when the target genome and the reference
genome have distant evolutionary relationship or some rearrangements. This moti-
vates researchers to develop the so-called multiple reference-based scaffolders that
can utilize multiple reference genomes, which may provide different but comple-
mentary types of scaffolding information, to scaffold the target draft genome. In
this chapter, we will review some of the state-of-the-art multiple reference-based
scaffolders, such as Ragout, MeDuSa and Multi-CAR, and give a complete intro-
duction to Multi-CSAR, an improved extension of Multi-CAR.
Keywords: bioinformatics, sequencing, contig, scaffolding, multiple reference
genomes
1. Introduction
Due to recent advances in next-generation sequencing (NGS) technologies,
more and more genomes of organisms can be sequenced quickly at a moderate cost
[1]. However, assembling a large number of reads generated from current NGS
sequencing platforms into a complete genome still is a challenging job [2]. Largely
because of repetitive sequences, whose lengths are often larger than those of the
reads, most of assembled sequences are just draft genomes that usually consists of
several hundreds or even thousands of contigs (contiguous sequences). The avail-
ability of complete genomes actually is significant to the downstream analysis and
interpretation of their sequences in many biological applications [3]. To further
obtain more complete sequences of draft genomes, therefore, the contigs of the
draft genomes usually are required to be ordered and oriented into scaffolds, which
actually are larger gap-containing sequences whose gaps between the scaffolded
contigs can be closed later in the gap-filling process [4].
The scaffolding process utilizes a genomic sequence available from a related
organism to serve as a reference to scaffold the contigs of a draft genome. So far,
many such reference-based scaffolders have been proposed [5–14]. The algorithms
used to develop all these scaffolders can be classified into two main categories: the
alignment-based algorithms [5–10] and the rearrangement-based algorithms [11–14].
The alignment-based scaffolding algorithms first align contigs in a target draft
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1. Introduction
Due to recent advances in next-generation sequencing (NGS) technologies,
more and more genomes of organisms can be sequenced quickly at a moderate cost
[1]. However, assembling a large number of reads generated from current NGS
sequencing platforms into a complete genome still is a challenging job [2]. Largely
because of repetitive sequences, whose lengths are often larger than those of the
reads, most of assembled sequences are just draft genomes that usually consists of
several hundreds or even thousands of contigs (contiguous sequences). The avail-
ability of complete genomes actually is significant to the downstream analysis and
interpretation of their sequences in many biological applications [3]. To further
obtain more complete sequences of draft genomes, therefore, the contigs of the
draft genomes usually are required to be ordered and oriented into scaffolds, which
actually are larger gap-containing sequences whose gaps between the scaffolded
contigs can be closed later in the gap-filling process [4].
The scaffolding process utilizes a genomic sequence available from a related
organism to serve as a reference to scaffold the contigs of a draft genome. So far,
many such reference-based scaffolders have been proposed [5–14]. The algorithms
used to develop all these scaffolders can be classified into two main categories: the
alignment-based algorithms [5–10] and the rearrangement-based algorithms [11–14].
The alignment-based scaffolding algorithms first align contigs in a target draft
genome against a reference sequence and then scaffold the contigs according to the
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positions of their matches in the reference. On the other hand, the rearrangement-
based scaffolding algorithms utilize the concept of genome rearrangements to scaf-
fold the contigs of the target draft genome such that the sequence markers (or
genes) shared between the scaffolded target and reference genomes have similar
order and orientation as much as possible.
In some cases, it may be insufficient for a scaffolder to utilize only one single
genome as the reference for correctly computing the scaffolds of a target draft
genome, in particular when the target and reference genomes have a distant phylo-
genetic relationship or they have undergone some kinds of rearrangements, such as
reversals, transpositions, block-interchanges and translocations. This situation
inspires the requirement for developing multiple reference-based scaffolders,
expecting that they can refer to several different but complementary genomes to
order and orient the contigs of the target genome.
2. State-of-the-art multiple reference-based scaffolders
Below, we review three state-of-the-art multiple reference-based scaffolders:
Ragout [15], MeDuSa [16] and Multi-CAR [17].
2.1 Ragout
Ragout (Reference-Assisted Genome Ordering UTility) is a rearrangement-
based scaffolder for ordering and orienting the contigs of a draft genome using
multiple reference genomes [15]. The input of Ragout includes a target draft
genome, multiple reference genomes, and a phylogenetic tree between them.
Ragout uses different colors to display the target and reference genomes and further
represents all of these genomes as sequences of synteny blocks. Ragout then creates a
so-called incomplete multi-color breakpoint graph, in which vertices represent the
ends of synteny blocks and edges denote adjacencies of two synteny blocks occur-
ring in the target and reference genomes. For the purpose of distinction, the edges
are also colored by Ragout using the colors of the corresponding genomes. Because
the target genome is already fragmented into contigs, some adjacencies of synteny
blocks in the target genome are missing. Ragout tries to recover these missing
adjacencies by using other existing adjacencies from the reference genomes. In the
recovery process, Ragout computes the parsimony costs of all possible missing
adjacencies by solving a so-called half-breakpoint state parsimony problem on the
given phylogenetic tree, which actually is an NP-hard (non-deterministic polyno-
mial time-hard) problem, meaning that it is hard to compute its optimal solution in
polynomial time. Therefore, a heuristic approach is applied by Ragout to calculate
the approximate parsimony costs of all the missing adjacencies. A perfect matching
with minimum cost is then computed by Ragout on a graph created by using the
missing adjacencies and is further used to scaffold the contigs of the target genome.
Actually, the above procedure is repeated by Ragout multiple times with using
different sizes of synteny blocks and moreover the scaffolding results obtained from
all these iterations are then combined into a single set of scaffolds. Finally, a
refinement is performed by Ragout to insert a number of small but repetitive
contigs back to the resulting scaffolds.
2.2 MeDuSa
MeDuSa (Multi-Draft based Scaffolder) is a multiple reference-based scaffolder
that does not require a given phylogenetic tree for the target and references
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genomes [16]. From the given target and reference genomes, MeDuSa constructs a
so-called scaffolding graph, which denotes by vertices the contigs of the target
genome and by edges the adjacencies between any two contigs when they can be
mapped to the reference genomes. Moreover, each edge in the scaffolding graph is
associated with a weight to represent the number of reference genomes supporting
the existence of the edge. As a result, it is not hard to see that a path cover, which is a
set vertex-disjoint paths covering all the vertices of the scaffolding graph, denotes a
set of scaffolds in the target genome. Unfortunately, however, finding a path cover
of maximum weight in a graph is already known as an NP-hard problem. Therefore,
MeDuSa utilizes a 2-approximation algorithm to find an approximate path cover
from the scaffolding graph. Finally, MeDuSa applies a majority rule to determine
the orientations of contigs on each path of the approximate path cover.
2.3 Multi-CAR
Multi-CAR (Multiple reference-based Contig Assembly using Rearrangements)
is multiple-reference version of CAR (Contig Assembly using Rearrangements)
[17]. CAR actually is a single reference-based scaffolder that utilizes a complete
reference genome to scaffold the contigs of a target draft genome [13]. Like
MeDuSa, Multi-CAR does not require prior knowledge concerning phylogenetic
relationships among target and reference genomes. However, in contrast to Ragout
and MeDuSa, both attempting to solve an NP-hard problem in their scaffolding
processes, the algorithm behind Multi-CAR involves only polynomially solvable
problems, as described as follows. First, Multi-CAR utilizes CAR to compute a
single reference-derived scaffolding result for a target draft genome based on each
of multiple reference genomes. Second, Multi-CAR uses all single reference-derived
scaffolds to build an edge-weighted contig adjacency graph. In this contig adjacency
graph, the vertices denote extremities of contigs (i.e., each contig is represented by
two vertices) and the edges represent whether two contigs are ordered consecu-
tively in a scaffold returned by CAR based on a single reference genome (if so, the
adjacent extremities of these two contigs are connected by an edge). In addition, if
there are multiple reference genomes to support an edge connection, then this edge
will be assigned a weight that equals to the sum of the weights of the supporting
reference genomes. The weight of each reference genome is given by the users in
advance; otherwise, it is defaulted to one. Third, Multi-CAR continues to find a
maximum weighted perfect matching from the contig adjacency graph. Finally,
Multi-CAR constructs a multiple reference-derived scaffold for the target draft
genome according to the maximum weighted perfect matching.
3. A recent multiple reference-based scaffolder
In this section, we give a detailed introduction to a recent multiple reference-
based scaffolder, called Multi-CSAR (Multiple reference-based Contig Scaffolder
using Algebraic Rearrangements), which is an improved extension of Multi-CAR
[18]. Unlike Ragout and MeDuSa, Multi-CAR actually can not accept incomplete
genomes as references, which greatly limits the widespread adoption of Multi-CAR
because complete reference genomes are not always available for a target draft
genome in practical usage [19]. In addition, the weight of all reference genomes
used by Multi-CAR must be assigned by the users; otherwise, they are defaulted to
one. However, it is usually not easy for the ordinary users to correctly determine
these weights. Therefore, Multi-CSAR has been developed to further overcome
these limitations of Multi-CAR. In principle, the main steps of the algorithm in
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positions of their matches in the reference. On the other hand, the rearrangement-
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Multi-CSAR is the same as those in Multi-CAR, except that Multi-CSAR utilizes
CSAR [14], instead of CAR [13], to compute the single reference-derived scaffold-
ing result for the target draft genome, and also designs a sequence identity-based
weighting scheme to automatically derive the weights of all the reference genomes.
CSAR actually is an improved version of CAR and their main difference in usage is
that the reference genome used by CAR needs to be complete, but the one used by
CSAR can be incomplete.
3.1 Algorithm of multi-CSAR
Suppose that T denotes a target draft genome with n contigs c1, c2,… , cn and
R1,R2, … ,Rk denote k reference genomes with weights w1,w2,… ,wk, respectively.
Contigs actually are fragmented linear DNA sequences with two extremities, called
head and tail, respectively. Multi-CSAR performs the following steps to scaffold the
contigs in the target genome T using the multiple reference genomes R1,R2,… ,Rk.
First, Multi-CSAR utilizes CSAR to obtain a single reference-derived scaffold Si of T
based on each Ri, where 1≤ i≤ k. Second, Multi-CSAR constructs a contig adjacency
graph G ¼ V,Eð Þ such that there are two vertices chj and ctj for representing the head
and tail of each contig c j, respectively, and there also is an edge for linking any two
vertices if they are the extremities coming from the different contigs. An edge in E
is said to be supported by a reference genome Ri if its two vertices are adjacent
extremities from two distinct but continuous contigs in scaffold Si. If an edge in E is
supported by several reference genomes at the same time, then this edge receives a
weight equal to the sum of the weights of all these supporting reference genomes.
However, if an edge in E is not supported by any reference genome, then it has a
weight of zero. Third, Multi-CSAR utilizes the Blossom V [20] to find a maximum
weighted perfect matching M in G, where a subset of edges in G is called a perfect







and M0 denote a subset of M (i.e., M0 ⊆M) with the minimum
weight such that there is no cycle in M0∪C. Finally, Multi-CSAR makes use of the
edge connections inM0 to scaffold the contigs of T. Figure 1 displays an example for
illustrating how the algorithm of Multi-CSAR works.
Note that CSAR was developed based on on a near-linear time algorithm [21]
and Blossom V based on an O n4ð Þ-time algorithm [20], where n is the number of
vertices in a graph. Therefore, all the steps in the Multi-CSAR algorithm described
previously can be implemented in polynomial time. In addition, Multi-CSAR uti-
lizes the following sequence identity-based weighting scheme to automatically compute
the weights w1,w2,… ,wk of the k reference genomes. First, Multi-CSAR applies
either NUCmer or PROmer for identifying those sequence markers that actually are
aligned regions between the target genome T and each reference genome Ri, where
1≤ i≤ k. Note that both NUCmer and PROmer come from the MUMmer package
[22]. The main difference between NUCmer and PROmer is that the former finds
the sequence markers directly on input DNA sequences, while the latter recognizes
them on the six-frame protein translation of the input DNA sequences. Suppose that





are used to denote the alignment length of each m j and its percent identity,
respectively. Next, Multi-CSAR calculates the weight of each reference genome Ri
by the formula wi ¼
Pτ
j¼1L m j
� �� I m j
� �
. The principle of the sequence identity-
based weighting scheme is that the more similar the reference genome Ri is to the
target genome T, the more weight Ri receives.
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Figure 1.
Schematic workflow of multi-CSAR: (a) a target genome T ¼ c1, c2, c3, c4
� �
and three single reference-derived
scaffolds S1 ¼ þc1,þc2,þc3
� �
, S2 ¼ þc2,þc3,þc4
� �
and S3 ¼ �c2,�c1,�c4,�c3
� �
that are supposed to be
computed by applying CSAR on three reference genomes R1,R2 and R3, respectively, with w1 ¼ w2 ¼ w3 ¼ 1.
(b) The contig adjacency graph G constructed by using S1, S2 and S3, where zero-weighted edges are denoted by





























with minimum weight from M such that M0∪C contains no cycles, where the dotted lines denote the
edges in C. (e) The final scaffold þc1,þc2,þc3,þc4
� �
of T constructed based on the edge connections in M0.
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3.2 Usage of multi-CSAR
Currently, Multi-CSAR offers a web server1 with an easy-to-operate interface
(see Figure 2) to the users. To run Multi-CSAR, the users first need to upload a
target genome and one or more reference genomes in multi-FASTA format. If
needed, the users can click the “plus” (respectively, “minus”) button to add
(respectively, remove) a reference genome field. Second, the users can determine
whether or not to utilize the sequence identity-based weighting scheme provided by
Multi-CSAR for automatically calculating the weights of reference genomes. If the
weighting scheme is not used, then the weights of all the reference genomes are
defaulted to one. Third, the users can choose either NUCmer or PROmer to identify
sequence markers between the target genome and each of the reference genomes.
Fourth, the users can enter an email address, which is optional, if they would like to
run Multi-CSAR in a batch way. When running Multi-CSAR in this batch way, the
users will be notified of the scaffolding result via email when the submitted job is
finished by the web server of Multi-CSAR.
Multi-CSAR outputs its scaffolding results in four tab pages: (a) input data &
parameters, (b) Circos plot validation, (c) dotplot validation, and (d) scaffolds of
target. In the “Input data & parameters” page (see Figure 3 for an example), Multi-
CSAR simply shows the information of the input target and reference genomes, the
user-specified program (either NUCmer or PROmer) for identifying their sequence
markers, and whether the weighting scheme of reference genomes is used or not. By
clicking on the links of the target and reference genomes in this page, Multi-CSAR
Figure 2.
Interface of multi-CSAR web server.
1 The web server of Multi-CSAR is available at http://genome.cs.nthu.edu.tw/Multi-CSAR/.
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will also display their input DNA sequences. By clicking on the link “Dotplot against
target genome” on the reference genomes, Multi-CSAR will display a dotplot that
allows the users to visually inspect sequence markers shared between un-scaffolded
target genome and a reference genome. In the dotplot (see Figure 4 for an
instance), the un-scaffolded target genome and a selected reference genome are
represented on the y and x axes, respectively. Note that the contigs and scaffolds in
the dotplot are separated by horizontal and vertical dashed lines. Moreover, each
forward (respectively, reverse) sequence marker is shown by a red (respectively,
blue) line and its begin and end are represented by two unfilled circles. The users
can sort the contigs of the input target genome based on their sizes by clicking on
Figure 3.
A display of the “Input data & parameters” tab page.
Figure 4.
A display of a dotplot between un-scaffolded target genome and a reference genome.
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the toggle switch “Sort by contig size”. The users also can show or hide the IDs of
contigs and scaffolds used in Multi-CSAR by using the toggle switch “Show scaf-
fold/contig IDs.” The format of contig (respectively, scaffold) IDs begins with
three-letter prefix CTG (respectively, SCF) followed by an underscore (_) and at
least one digit (e.g., CTG_1 and SCF_1). In addition, the users can click the “Save as
SVG file” button to download a copy of the dotplot in scalable vector graphics
(SVG) format.
In the “Circos plot validation” page, (see Figure 5 for an example), Multi-CSAR
displays its total running time, as well as its scaffolding result by a Circos plot
between scaffolded target genome and all reference genomes. In the initial Circos
plot, the scaffolds of target genome (displayed in purple) and all the reference
genomes (displayed in other colors) are arranged in a circle with the inner links
connecting corresponding sequence markers between the target genome and each
of reference genomes. The color of an inner link comes from the reference genome
it connects. In the Circos plot, the number of crossing inner links can be viewed as a
Figure 5.
A display of a Circos plot between scaffolded target genome and all reference genomes.
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accuracy measure for a scaffolding result. That is, if the contigs of the target
genome are scaffolded well according to a reference genome, the number of cross-
ing inner links between them should be low. For this purpose, Multi-CSAR allows
the users to select any reference genome (by clicking the checkbox next to it) from
the top of the tab page to display (by clicking the “Display Circos plot” button) its
Circos plot against the scaffolded target genome (see Figure 6 for an instance).
In this Circos plot, the inner circle displays the sequence markers shared between
the target genome and the selected reference genome. As demonstrated in
Figure 6, the Circos plots of the scaffolding result are convenient and helpful for
the users to visually validate whether the contigs of the target genome are properly
scaffolded according to the reference genomes, as well as to visually identify
whether there are any genome rearrangements between the scaffolded target and
reference genomes. In addition, Multi-CSAR allows the users to the Circos plots of
the scaffolds in portable network graphics (PNG) format by clicking the “Save as
PNG file” button.
Figure 6.
A display of a Circos plot between scaffolded target genome and a selected reference genome, where the sequence
markers are arranged in alternating layers along the two-layer inner circle.
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In the “Dotplot validation” page (see Figure 7 for an example), Multi-CSAR
displays its its scaffolding result by a dotplot between the scaffolded target
genome and a selected reference genome (the default is the first reference
genome). In fact, the matched sequence regions of sequence markers should be
displayed from the bottom left to the top right in the dotplot (as shown in
Figure 7) or from the top left to the bottom right, if the contigs from the target
genome are scaffolded perfectly based on the selected reference genome. Showing
the scaffolding result in the dotplot display is another way to conveniently help
the users to visually verify whether the contigs of the target genome are scaffolded
properly based on the reference genomes or not. The users can click the “Save as
PNG file” button to download the dotplot of a scaffold in portable network
graphics (PNG) format.
In the “Scaffolds of target” page (see Figure 8 for an instance), Multi-CSAR
displays its scaffolding result in tabular format for the purpose of allowing the users
to view the scaffolds of the target genome in detail. The scaffolds in the table are
sorted according to their sizes, which equals to the sum of contig sizes. In each
scaffold, the ordered contigs, as well as their orientations (forward orientation
denoted by 0 and reverse orientation by 1), sequences and lengths, are listed in a
table. The users can click on the “Download scaffolds (.txt)” and “Download scaf-
folds (.csv)” buttons to download the scaffolds of the target genome in the tab-
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sequences in the text format, in which the sequences of contigs are separated by 100
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4. Results and discussion
4.1 Testing datasets
The three multiple reference-based scaffolders Multi-CSAR, Ragout (version
1.0) and MeDuSa (version 1.6), we introduced in this chapter, were tested on a
benchmark of five real bacterial datasets as shown in Table 1. In fact, these five
testing datasets were originally prepared by Bosi et al. when they studied MeDuSa
[16]. Basically, each testing dataset consists of a target draft genome to be
scaffolded and two or more reference genomes that can be either complete or
incomplete.
4.2 Evaluation metrics
For each testing dataset, Bosi et al. [16] also provided a reference order for the
contigs of the target genome that can be used a truth standard to evaluate the
Figure 8.
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multiple reference-based scaffolders. The evaluation metrics of the scaffolders
include sensitivity, precision, F‐score , genome coverage, NGA50, scaffold number
and running time. Basically, sensitivity, precision and F‐score are used to estimate
the scaffold accuracy, genome coverage to estimate the scaffold coverage, and
NGA50 and scaffold number to estimate the scaffold contiguity. Below, we
introduced their detailed definitions.
Note that if any two contigs in a scaffold appear in continuous order and correct
orientation in the reference order, then they are viewed as a correct join. Let S
denote the result obtained by applying a scaffolder on a target genome T and P
denote the number of all contig joins in the reference order. The number of the
correct contig joins in S is then called as true positive (TP) and the number of the
others (i.e., incorrect joins) as false positive (FP). In addition, the sensitivity of S is
defined as TP=P, its precision as TP= TPþ FPð Þ, and its F‐score as
2� sensitivity� precision = sensitivityþ precision . Actually, F‐score is a
balanced measure between sensitivity and precision and F‐score is high only when
both sensitivity and precision are high.
Suppose that the target genome T contains only circular DNAs and C is a contig in
S. If the both sides of C are joined correctly with two contigs, then the whole length of
Cwill be counted in the genome coverage that will be defined later. If exactly one side
of C is joined correctly with one contig, then half of the whole length of C will be
counted. If the both sides of C are joined incorrectly with two contigs, then the whole
length of C will be ignored. Based on the above discussion, the genome coverage of S is
defined to be the ratio of the sum of the contig lengths counted according to the
above-mentioned rules to the sum of all contig lengths. On the other hands, suppose
that there are linear DNAs in the target genome T. Then in the reference order of
each linear DNA, the first and last contigs have just one neighbor contig and thus only
half of their lengths will be counted in the calculation of the genome coverage if these
two contigs are correctly joined with neighbor contigs.
The NGA50 value of S is computed as follows [23]. First, the scaffolds of S are
aligned with the complete sequence of the target genome T to find the mis-
assembly breakpoints. Second, the scaffolds of S are broken at the mis-assembly
breakpoints and their unaligned regions are also removed. Finally, the NGA50 value
is equal to the NG50 value of the resulting scaffolds, which is the size of the shortest
scaffold with longer and equal length scaffolds covering at least 50% of the target
genome.
4.3 Comparison of multiple reference-based scaffolding results
All the three evaluated scaffolders Multi-CSAR, Ragout (version 1.0) and













4 1223 4 8.05 65.9
E. coli K12 1 451 25 4.64 50.8
M. tuberculosis 1 116 13 4.41 65.6
R. sphaeroides 2.4.1 7 564 2 4.60 67.4
S. aureus 3 170 35 2.90 32.0
Table 1.
Summary of the five testing datasets.
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tree was used in Ragout to serve as the phylogenetic tree for each testing dataset
because reliable phylogenetic trees were still unknown. Table 2 displays their
average performance results over the five bacterial datasets, by showing the values
of sensitivity (Sen), precision (Pre), F‐score and genome coverage (Cov) in per-
centage (%) and the size of NGA50 in base pairs (bp). In addition, Table 2 shows
the numbers of scaffolds computed by all evaluated scaffolders in the column
‘#Scaf’ and their running times in minutes in the column ‘Time’. The best result in
each column of Table 2 is shown in bold.
As shown in Table 2, Multi-CSAR running with NUCmer achieves the best
sensitivity, F‐score , genome coverage, NGA50 and running time, and the second
best precision and scaffold number. On the other hands, Multi-CSAR running with
PROmer has the best result in terms of scaffold number and the second best results
in terms of sensitivity, F‐score , genome coverage and NGA50. From the precision
point of view, the performance of Ragout is the best among all the tested multiple
reference-based scaffolders. However, the sensitivity of Ragout is substantially
inferior to that of Multi-CSAR when either running with NUCmer or PROmer. This
negative result also leads to that Ragout is much inferior to Multi-CSAR in the
performance of F‐score . Moreover, Ragout yields the worst results in terms of both
scaffold number and running time. Compared Multi-CSAR and Ragout, MeDuSa
gives the worst performance in sensitivity, precision, F‐score , genome coverage and
NGA50, although it has the second best performance in running time.
Table 3 shows the average performance results of Multi-CSAR on the five
bacterial datasets when using the sequence identity-based weighting scheme, where
the best performance in each column is also displayed in bold. As compared to the
results of Multi-CSAR as shown in Table 2, several performance measures of Multi-
CSAR can be further improved if it is run with the sequence identity-based
weighting scheme of reference genomes, such as sensitivity, precision, F‐score ,
genome coverage and NGA50.
5. Conclusions
Scaffolders are useful tools for sequencing projects to obtain more complete
sequences of genomes being sequenced. In this chapter, we mainly introduced some
state-of-the-art multiple reference-based scaffolders, such as Ragout, MeDuSa and
Scaffolder Sen Pre F-score Cov NGA50 #Scaf Time
Ragout 79.0 92.5 84.4 87.4 992,966 84 24.8
MeDuSa 78.2 81.9 80.0 83.3 671,001 26 3.8
Multi-CSAR (PROmer) 89.3 90.4 89.8 92.5 1,016,308 7 6.3
Multi-CSAR (NUCmer) 89.6 90.8 90.2 93.2 1,038,257 9 1.7
Table 2.
Average performance of the evaluated multiple reference-based scaffolders on the five testing datasets.
Scaffolder Sen Pre F-score Cov NGA50 #Scaf Time
Multi-CSAR (PROmer) 89.4 90.5 89.9 92.8 1,045,489 7 6.3
Multi-CSAR (NUCmer) 89.9 91.3 90.6 93.5 1,046,288 10 1.7
Table 3.
Average performance of multi-CSAR on the five testing datasets when using the sequence identity-based
weighting scheme.
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tree was used in Ragout to serve as the phylogenetic tree for each testing dataset
because reliable phylogenetic trees were still unknown. Table 2 displays their
average performance results over the five bacterial datasets, by showing the values
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centage (%) and the size of NGA50 in base pairs (bp). In addition, Table 2 shows
the numbers of scaffolds computed by all evaluated scaffolders in the column
‘#Scaf’ and their running times in minutes in the column ‘Time’. The best result in
each column of Table 2 is shown in bold.
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PROmer has the best result in terms of scaffold number and the second best results
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point of view, the performance of Ragout is the best among all the tested multiple
reference-based scaffolders. However, the sensitivity of Ragout is substantially
inferior to that of Multi-CSAR when either running with NUCmer or PROmer. This
negative result also leads to that Ragout is much inferior to Multi-CSAR in the
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Table 3 shows the average performance results of Multi-CSAR on the five
bacterial datasets when using the sequence identity-based weighting scheme, where
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Multi-CSAR (improved extension of Multi-CAR), that can efficiently produce more
accurate scaffolds of a target draft genome by referring to multiple complete and/or
incomplete genomes of related organisms. By testing on five real prokaryotic
datasets, Multi-CSAR outperforms Ragout and MeDuSa in terms of average sensi-
tivity, precision, F‐score , genome coverage, NGA50, scaffold number and running
time. Currently, Multi-CSAR provides the users with a web interface that is intui-
tive and easy to operate. In addition, it displays its scaffolding result in a graphical
mode that allows the users to visually validate the correctness of scaffolded contigs
and in a tabular mode that allows the users to view the details of scaffolds.
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Abstract
The third-generation ionic liquids (ILs), which are being used to produce double 
active pharmaceutical ingredients (d-APIs) with tunable biological activity along with 
novel performance, enhancement, and delivery options, have been revolutionizing the 
area of drug discovery since the past few decades. Herein we report the in vitro anti-
bacterial and anti-inflammatory activity of benzalkonium ibuprofenate (BaIb) that are 
being used as in-house d-API, with a particular focus on its interaction with respective 
protein target through molecular docking study. The evaluation of the biological activ-
ity of BaIb with the antibacterial and anti-inflammatory target at the molecular level 
revealed that the synthesized BaIb could be designed as a potential double active drug 
since it retains the antibacterial and anti-inflammatory activity of its parent drugs, 
benzalkonium chloride (BaCl) and sodium ibuprofenate (NaIb), respectively.
Keywords: benzalkonium ibuprofenate, double active pharmaceutical ingredient, 
molecular docking studies, anti-inflammatory, antibacterial activities
1. Introduction
In the pharmaceutical field, ionic liquids (ILs) by salification of drugs were 
widely applied to improve the performance of drugs on its oral administration, 
especially, their solubility, bioavailability, and stability. The research on the antimi-
crobial activity of ILs is a growing field because of its unprecedented flexibility for 
chemical diversity in a severely drained arsenal of antimicrobial. The third-gener-
ation ionic liquids give us the freedom to tune the biological properties in addition 
to its physical and chemical properties. The proper selection of ions with synergetic 
effects may result in the formation of double active pharmaceutical ingredient 
(d-API). Thus the d-APIs are composed of asymmetric organic ions, which prevent 
the formation of the stable crystal lattice and are liquid at unusually low tempera-
tures. Such d-APIs can be used for the ailment situations where the two activities are 
required. This strategy will reduce the excess in taking of unwanted chemicals and 
will enhance the solubility and bioavailability [1, 2].
Benzalkonium ibuprofenate (BaIb) is a double active pharmaceutical ingredient 
designed by combining benzalkonium cations with ibuprofen. Benzalkonium chloride 
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(BaCl) is a potential antibacterial drug and sodium ibuprofen is a prospective anti-
inflammatory drug [3]. It is important to evaluate the pharmaceutical profiles of the 
d-API to confirm the retainity of the biological activities of the parent drugs. We have 
synthesized a d-API, benzalkonium ibuprofenate, carried out its quantum mechanical 
calculations using density functional theory, characterized different experimental 
techniques, and reported glass-forming ability in earlier works [4, 5]. Now, in this 
work, the biological evaluations, in particular, the antibacterial and anti-inflamma-
tory activities, were performed and the results with the activity of parent drugs, BaCl 
and sodium ibuprofenate (NaIb), compared. The molecular docking of all the samples 
was done to get a better understanding of the mode of interaction between the drugs 
and respective targeted proteins and to trace their binding pores and cites.
2. Materials and method
2.1 Materials
The benzalkonium chloride and sodium ibuprofenate were purchased from 
Sigma-Aldrich (USA). Cell culture plastic flasks, test tubes, and culture plates were 
purchased from Borosil (India).
2.2 Experimental
2.2.1 Synthesis
The double active pharmaceutical ingredient, benzalkonium ibuprofenate, 
was synthesized using stoichiometric metathesis reaction. Solid (1 mmol) BaCl 
and NaIb were dissolved in 50 mL distilled water, each taken in two beakers and 
stirred separately with gentle heating (40–60°C). Then the two solutions were 
mixed together and again stirred for another 30 min with heating (around 80°C) 
and then cooled to room temperature. 60 mL of chloroform was added to separate 
the organic and inorganic part; then the chloroform phase was washed with cold 
distilled water until it removes the inorganic salt completely. AgNO3 test was used to 
confirm the absence of chloride anions in the product. This is followed by continu-
ous washing of the chloroform phase with deionized (DI) water until the water 
washings tested negative for NaCl or NaBr via AgNO3 test. The chloroform was then 
evaporated using rotary evaporator, and the BaIb was dried under high vacuum for 
12 h with gentle heating (50–60°C) [4, 6].
The double active pharmaceutical ingredient, BaIb was characterized well using 
Nuclear Magnetic Resonance using Bruker Avance III, 400MHzwith a 9.4 Tesla 
super-conducting magnet in an operating temperature at 309 K, Fourier transform 
infrared spectroscopy JASCO FTIR-4100 spectrophotometer, Fourier Transform-
Raman spectroscopy and UV–visible spectroscopy using Jasco UV–Visible 
Spectrophotometer model V-550 (USA) and are reported in earlier works [4, 5].
2.2.2 Biological evaluation
2.2.2.1 Antibacterial activity
The synthesized double active pharmaceutical ingredient BaIb was screened 
against Gram-negative bacteria to confirm the retainity of the biological activity of 
its parent drug BaCl, which is a potential germicide. For this study, we have chosen 
Pseudomonas aeruginosa and E. coli as Gram-positive, while DMSO is considered as 
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Gram-negative. Paper disk method was used for the in vitro analysis. The experi-
ment was started with the preparation of nutrient agar (28 g in 100 mL) and was 
sterilized by autoclaving. This nutrient agar media was cooled without solidifying 
and incubated overnight. P. aeruginosa and E. coli were prepared. 15–20 mL of this 
media was poured into sterilized Petri plate and allowed to solidify. Then sterilized 
disks were placed in this solidified agar plate; each plate contains three disks. 10 μL 
negative controls on to one disk, 10 μL standard parent drugs on to the second disk, 
and 10 μL samples on to the third disk were added and appropriately labeled. After 
incubating the Petri dishes in 310 K for 24 h, the plates were checked for the zone of 
inhibition, and the zone diameter was measured using a scale [4, 7].
                             Formula for ABA =  sample diameter  ____________+ ve control × 100                           (1)
2.2.2.2 Anti-inflammatory activity
2.2.2.2.1 In chick albumin
The anti-inflammatory activity of BaIb and NaIb was done using an egg albu-
min. For this, a reaction mixture of 5 mL was made with fresh hen’s egg (0.2 mL) 
and phosphate buffer saline with pH = 6.4 of 2 mL with varying concentrations 
of extract for preparing the concentrations of 100, 200, 300, 400, and 500 μg/
mL. The same steps were repeated for the preparation of double distilled water, 
which served as control. Then the prepared mixtures were incubated in BOD incu-
bator (Labline Technologies, India) at 210 ± 2 K for 15 min; after that, it is heated to 
343 K and was hold for 5 min. The absorbance was measured after incubating using 
Shimadzu (Japan), UV 1800 at 660 nm. At the final concentration of 100, 200, 300, 
400, and 500 μg/mL, acetyl salicylic acid was used as reference drug. The protein 
denaturation inhibition percentage was calculated using the following formulae:
                                  %inhibition =   Abs control−  Abs test   ____________ Abs control 
 × 100                                 (2)
2.2.2.2.2 In human serum albumin
In addition, the synthesized drug BaIb was screened for its anti-inflammatory 
activity, and its efficiency with the parent drug NaIb and drug diclofenac was 
compared. For this, blood samples from a healthy donor (male) were collected and 
mixed with sterilized Alsever’s solution before centrifuging it at 3000 rpm. The 
suspension of packed cells was made with isoline. This suspension with phosphate 
buffer, hyposaline, was mixed with diclofenac at varying concentration, where the 
distilled water is taken as control while diclofenac as standard. Then the mixtures 
were incubated for 30 min at 303 K and centrifuged. Spectrophotometric analysis 
was used for hemolysis at 560 nm and its percentage recorded [4, 8, 9].
2.3 Computational
The input structures of BaCl (PubChem: 2330), NaIb (PubChem: 5338317), 
and BaIb (PubChem: 86612072) were taken from the PubChem database [9] 
and optimized using density functional theory with B3LYP level of theory and 
631-G+(d,p) [10] basis sets using Gaussian software packages [11]. Further, the 
molecular docking was also conducted using Schrodinger Maestro software package 
[10]. The optimized structures and downloaded Protein Data Bank (PDB) files [12] 
of proteins were used for molecular docking studies.
Computational Biology and Chemistry
84
(BaCl) is a potential antibacterial drug and sodium ibuprofen is a prospective anti-
inflammatory drug [3]. It is important to evaluate the pharmaceutical profiles of the 
d-API to confirm the retainity of the biological activities of the parent drugs. We have 
synthesized a d-API, benzalkonium ibuprofenate, carried out its quantum mechanical 
calculations using density functional theory, characterized different experimental 
techniques, and reported glass-forming ability in earlier works [4, 5]. Now, in this 
work, the biological evaluations, in particular, the antibacterial and anti-inflamma-
tory activities, were performed and the results with the activity of parent drugs, BaCl 
and sodium ibuprofenate (NaIb), compared. The molecular docking of all the samples 
was done to get a better understanding of the mode of interaction between the drugs 
and respective targeted proteins and to trace their binding pores and cites.
2. Materials and method
2.1 Materials
The benzalkonium chloride and sodium ibuprofenate were purchased from 
Sigma-Aldrich (USA). Cell culture plastic flasks, test tubes, and culture plates were 
purchased from Borosil (India).
2.2 Experimental
2.2.1 Synthesis
The double active pharmaceutical ingredient, benzalkonium ibuprofenate, 
was synthesized using stoichiometric metathesis reaction. Solid (1 mmol) BaCl 
and NaIb were dissolved in 50 mL distilled water, each taken in two beakers and 
stirred separately with gentle heating (40–60°C). Then the two solutions were 
mixed together and again stirred for another 30 min with heating (around 80°C) 
and then cooled to room temperature. 60 mL of chloroform was added to separate 
the organic and inorganic part; then the chloroform phase was washed with cold 
distilled water until it removes the inorganic salt completely. AgNO3 test was used to 
confirm the absence of chloride anions in the product. This is followed by continu-
ous washing of the chloroform phase with deionized (DI) water until the water 
washings tested negative for NaCl or NaBr via AgNO3 test. The chloroform was then 
evaporated using rotary evaporator, and the BaIb was dried under high vacuum for 
12 h with gentle heating (50–60°C) [4, 6].
The double active pharmaceutical ingredient, BaIb was characterized well using 
Nuclear Magnetic Resonance using Bruker Avance III, 400MHzwith a 9.4 Tesla 
super-conducting magnet in an operating temperature at 309 K, Fourier transform 
infrared spectroscopy JASCO FTIR-4100 spectrophotometer, Fourier Transform-
Raman spectroscopy and UV–visible spectroscopy using Jasco UV–Visible 
Spectrophotometer model V-550 (USA) and are reported in earlier works [4, 5].
2.2.2 Biological evaluation
2.2.2.1 Antibacterial activity
The synthesized double active pharmaceutical ingredient BaIb was screened 
against Gram-negative bacteria to confirm the retainity of the biological activity of 
its parent drug BaCl, which is a potential germicide. For this study, we have chosen 
Pseudomonas aeruginosa and E. coli as Gram-positive, while DMSO is considered as 
85
Biological Evaluation and Molecular Docking Studies of Benzalkonium Ibuprofenate
DOI: http://dx.doi.org/10.5772/intechopen.90191
Gram-negative. Paper disk method was used for the in vitro analysis. The experi-
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sterilized by autoclaving. This nutrient agar media was cooled without solidifying 
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media was poured into sterilized Petri plate and allowed to solidify. Then sterilized 
disks were placed in this solidified agar plate; each plate contains three disks. 10 μL 
negative controls on to one disk, 10 μL standard parent drugs on to the second disk, 
and 10 μL samples on to the third disk were added and appropriately labeled. After 
incubating the Petri dishes in 310 K for 24 h, the plates were checked for the zone of 
inhibition, and the zone diameter was measured using a scale [4, 7].
                             Formula for ABA =  sample diameter  ____________+ ve control × 100                           (1)
2.2.2.2 Anti-inflammatory activity
2.2.2.2.1 In chick albumin
The anti-inflammatory activity of BaIb and NaIb was done using an egg albu-
min. For this, a reaction mixture of 5 mL was made with fresh hen’s egg (0.2 mL) 
and phosphate buffer saline with pH = 6.4 of 2 mL with varying concentrations 
of extract for preparing the concentrations of 100, 200, 300, 400, and 500 μg/
mL. The same steps were repeated for the preparation of double distilled water, 
which served as control. Then the prepared mixtures were incubated in BOD incu-
bator (Labline Technologies, India) at 210 ± 2 K for 15 min; after that, it is heated to 
343 K and was hold for 5 min. The absorbance was measured after incubating using 
Shimadzu (Japan), UV 1800 at 660 nm. At the final concentration of 100, 200, 300, 
400, and 500 μg/mL, acetyl salicylic acid was used as reference drug. The protein 
denaturation inhibition percentage was calculated using the following formulae:
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 × 100                                 (2)
2.2.2.2.2 In human serum albumin
In addition, the synthesized drug BaIb was screened for its anti-inflammatory 
activity, and its efficiency with the parent drug NaIb and drug diclofenac was 
compared. For this, blood samples from a healthy donor (male) were collected and 
mixed with sterilized Alsever’s solution before centrifuging it at 3000 rpm. The 
suspension of packed cells was made with isoline. This suspension with phosphate 
buffer, hyposaline, was mixed with diclofenac at varying concentration, where the 
distilled water is taken as control while diclofenac as standard. Then the mixtures 
were incubated for 30 min at 303 K and centrifuged. Spectrophotometric analysis 
was used for hemolysis at 560 nm and its percentage recorded [4, 8, 9].
2.3 Computational
The input structures of BaCl (PubChem: 2330), NaIb (PubChem: 5338317), 
and BaIb (PubChem: 86612072) were taken from the PubChem database [9] 
and optimized using density functional theory with B3LYP level of theory and 
631-G+(d,p) [10] basis sets using Gaussian software packages [11]. Further, the 
molecular docking was also conducted using Schrodinger Maestro software package 
[10]. The optimized structures and downloaded Protein Data Bank (PDB) files [12] 
of proteins were used for molecular docking studies.
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The Schrodinger’s Glide module was used for docking analysis of the present 
work. Glide offers the full range of speed vs. accuracy options, from the HTVS 
(high-throughput virtual screening) mode for efficiently enriching million com-
pound libraries, to the SP (standard precision) mode for reliably docking tens to 
hundreds of thousands of ligand with high accuracy, and to the extra precision (XP) 
mode where further elimination of false positives is accomplished by more exten-
sive sampling and advanced scoring, resulting in even higher enrichment. Many 
researchers carried out extensive comparisons of several docking programs and 
scoring functions using an extensive data set of pharmaceutically attractive targets 
and active compounds [13–18]. All the study leads to the same result that Glide XP 
methodology was shown to yield enrichments superior to the alternative methods 
consistently. Glide SP scoring also shows improvement as compared to the scoring 
in GOLD and DOCK. The drawbacks of Glide come from the fact that it’s increas-
ing computational time. From computational efficiency, the CPU time required on 
average for Glide XP calculations (7.0 min per ligand) is larger than other methods 
except for the most accurate version of Goldscore (8.5 min per ligand). This extra 
cost for Glide XP is the trade-off for the higher enrichment factors obtained. Glide 
SP delivers the second best overall enrichment performance while providing a 
considerable speedup (0.42 min per ligand) as compared to all approaches except 
for the fast version of GOLD Chemscore setting.
2.3.1 Molecular docking studies
The structure-based drug design always promotes the in silico method for 
molecular docking before going to lab screening. In silico methods can site the bind-
ing pores and predict the mechanism of protein-ligand interactions as well as target 
binding.
Moreover, the analysis and interpretation of the binding behavior play a crucial 
role in rational drug designs and in elucidating fundamentals of biochemical 
processes. The antibacterial activity of BaCl and BaIb was studied using LpxC 
enzymes since the enzyme LpxC places an important role in the lipid A biosyn-
thesis. Lipid A acts as a hydrophobic membrane of lipopolysaccharide (LPS) in 
the outer leaflet of the outer membrane of Gram-negative bacteria; however, the 
bacteria is with a defective lipid. A synthesis reduces its hydrophobicity and shows 
increased membrane permeability, which in turn increase the sensitivity to the 
antibiotics, and hence, it results in cell death. For this work, we have selected LpxC 
from Escherichia coli and P. aeruginosa. In the same way, the targeted protein for 
the anti-inflammatory activity of NaIb and BaIb were studied using human serum 
albumin (HSA).
Thus the structures of proteins used in this work were downloaded from the 
Protein Data Bank [12]. The detailed information of the selected proteins, their 
PDB IDs, inbuilt inhibitor, X-ray resolution, etc., were given in Table 1. Molecular 
docking study has been carried out by the Glide docking program [19–21] provided 
by Schrodinger suite. Protein preparation is done by using the Protein Preparation 
Wizard module of Glide [22, 23]. Initially, all the protein structures must be pre-
processed to be used as a receptor for docking. Some of the typical operations in 
preprocessing include (i) addition of hydrogen atoms, (ii) assignment of atomic 
charges, and (iii) elimination of water molecules that are not involved in ligand 
binding. Missing chains and loops can also be added if necessary. Preprocessed 
protein was optimized with PROPKA and then minimized with OPSL3 force field 
function, which is followed by a convergence of heavy atoms of RMSD 0.3 Å.
Then, the Glide’s receptor grid generation wizard was used to generate a three-
dimensional (3D) grid with a maximal size of 20 × 20 × 20 Å with 0.5 Å spacing. 
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There is enough option to apply any constraints such as precision constraints, 
H-bond constraint, etc., in the receptor grid generation wizard. At last, flexible 
docking was performed with extra precision docking mode in Glide docking 
module.
3. Results and discussions
3.1 Antibacterial activities of BaCl and BaIb
3.1.1 In vitro studies
As we know, benzalkonium chloride is a prominent germicide widely used in 
medicinal chemistry [24]. It is mandatory to confirm the retainity of BaCl’s anti-
bacterial effect in the synthesized d-API, BaIb. The inhibition zone method using 
agar diffusion was used to screen the antibacterial activity of the prepared as well as 
parent drug against P. aeruginosa and E. coli bacterial strains [25]. The percentage of 
inhibition and its diameter are listed in Table 2. The results emphasized that BaIb 
retains the antibacterial activity of parent drug BaCl, though it had less inhibitory 
action against E. coli and P. aeruginosa than the parent drug [25].
3.1.2 Molecular docking studies with LpxC (E. coli)
Here, molecular docking of the parent and daughter drugs, BaCl and BaIb with 
Escherichia coli LpxC/LPC-009 complex, has been employed to trace its binding 
pore and binding affinity. The docking scores and binding free energies of lowest 
energy pose of its inbuilt inhibitor, 3p3 and the samples under study, BaCl, and BaIb 
in active sites on chain A of the LpxC/LPC-009 X-ray crystal structures have been 
computed after deleting the unwanted ligands and amino acids (So4 at 501, 502, 
504, 505, 506; dimethyl sulfide (DMS) at 701; and UKW) using Schrodinger Glide 
module and are given in Table 3. The docking result points out that the drugs BaCl 
and BaIb show considerable binding affinity scores compared to the inbuilt ligand. 
However, interestingly the d-API BaIb exhibits high docking score compared to the 
parent drug BaCl, which emphasize that the interaction between the ligand and 
protein increases on double active formation with ibuprofen.
Figure 1 demonstrates the three-dimensional protein-ligand interaction of the 
three samples under study in the dynamic site of LpxC/LPC-009 obtained from 
graphical interface Maestro. All the ligands are found to be buried in the deep bind-
ing pocket of LpxC/LPC-009 in the same way. The d-API BaIb interacts with the 









1 LpxC Escherichia 
coli
3P3G 3p3 1.65 Å BaCl, 
BaIb
Antibacterial
2 LpxC Pseudomonas 
aeruginosa
5U3B NVS 2.00 Å BaCl, 
BaIb
Antibacterial
3 HSA Homo 
sapiens





Detailed information regarding the proteins under study.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with the 
E. coli LpxC in the 2D image, as shown in Figure 2. The ligands were encompassed 
by active site amino acids THR191, PHE192, SER211, PHE212, CYS214, LYS239, 
HIS238, HIS265, etc., of LpxC. The co-crystallized ligand 3P3 occupied the deep 
cavity by forming three hydrogen bonds and one π-π interaction with active site 
amino acid PHE212. Though the parent ligand BaCl occupied the deep cavity of 
Compound Schrodinger software





Docking scores and binding free energies of inbuilt inhibitor 3P3, BaCl, and BaIb to the LpxC/LPC-009 using 
Schrodinger Maestro software.
The diameter of zone of inhibition (mm) Percentage of inhibition (%)
E. coli P. aeruginosa E. coli P. aeruginosa
Standard BaCl 19 38 Standard BaCl 21.11 42.22
Sample BaIb 14 31 Sample BaIb 15.55 34.44
Negative (DMSO) 0 0 Negative (DMSO) 0 0
Table 2. 
Preliminary in vitro antibacterial screening activity of BaIb.
Figure 1. 
Three-dimensional (3D) protein-ligand interactions diagram using Schrodinger software (I) with LpxC 
protein of E. coli using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and (c) double active pharmaceutical 
ingredient BaIb; (II) with LpxC (P. aeruginosa) using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and 
(c) double active pharmaceutical ingredient BaIb; and (III) with human serum albumin using (a) inbuilt 
ligand ibuprofen and (b) double active pharmaceutical ingredient BaIb.
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LpxC with the support of salt bridges between them, the daughter ligand BaIb 
formed one hydrogen bond with the active amino acid LYS239.
Despite the binding energy and docking score difference between parent and 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand 3P3 by forming a hydrogen bond with active 
site amino acids. Besides, the binding energy and docking score emphasize that 
the d-API has a higher binding affinity with LpxC than the parent drug BaCl. This 
indicates that BaIb can be considered as a potential inhibitor of LpxC protein with 
antibacterial activity.
3.1.3 Molecular docking studies with LpxC (P. aeruginosa)
Here, molecular docking of the parent and daughter drugs, BaCl and BaIb with 
LpxC protein of Pseudomonas aeruginosa, has been employed to trace the nature of 
its binding interaction and binding affinity value. The docking scores and binding 
free energies of lowest energy pose of its inbuilt inhibitor, NVS-LpxC-01 and the 
samples under study, BaCl, and BaIb in active sites on chain B of the NVS-LpxC 
X-ray crystal structures, have been computed after deleting the unwanted ligands 
and amino acids and including the Zn2+ using Schrodinger Maestro software and 
are given in Table 4. The docking result points out that the drugs BaCl and BaIb 
show considerable binding affinity scores compared to the inbuilt ligand. However, 
Figure 2. 
Schematic representations of ligand-protein interaction and binding interaction using stick mode. (a) 3P3 with 
LpxC, (b) BaCl with LpxC, and (c) BaIb with LpxC.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with the 
E. coli LpxC in the 2D image, as shown in Figure 2. The ligands were encompassed 
by active site amino acids THR191, PHE192, SER211, PHE212, CYS214, LYS239, 
HIS238, HIS265, etc., of LpxC. The co-crystallized ligand 3P3 occupied the deep 
cavity by forming three hydrogen bonds and one π-π interaction with active site 
amino acid PHE212. Though the parent ligand BaCl occupied the deep cavity of 
Compound Schrodinger software





Docking scores and binding free energies of inbuilt inhibitor 3P3, BaCl, and BaIb to the LpxC/LPC-009 using 
Schrodinger Maestro software.
The diameter of zone of inhibition (mm) Percentage of inhibition (%)
E. coli P. aeruginosa E. coli P. aeruginosa
Standard BaCl 19 38 Standard BaCl 21.11 42.22
Sample BaIb 14 31 Sample BaIb 15.55 34.44
Negative (DMSO) 0 0 Negative (DMSO) 0 0
Table 2. 
Preliminary in vitro antibacterial screening activity of BaIb.
Figure 1. 
Three-dimensional (3D) protein-ligand interactions diagram using Schrodinger software (I) with LpxC 
protein of E. coli using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and (c) double active pharmaceutical 
ingredient BaIb; (II) with LpxC (P. aeruginosa) using (a) inbuilt ligand 3P3, (b) parent ligand BaCl, and 
(c) double active pharmaceutical ingredient BaIb; and (III) with human serum albumin using (a) inbuilt 
ligand ibuprofen and (b) double active pharmaceutical ingredient BaIb.
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LpxC with the support of salt bridges between them, the daughter ligand BaIb 
formed one hydrogen bond with the active amino acid LYS239.
Despite the binding energy and docking score difference between parent and 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand 3P3 by forming a hydrogen bond with active 
site amino acids. Besides, the binding energy and docking score emphasize that 
the d-API has a higher binding affinity with LpxC than the parent drug BaCl. This 
indicates that BaIb can be considered as a potential inhibitor of LpxC protein with 
antibacterial activity.
3.1.3 Molecular docking studies with LpxC (P. aeruginosa)
Here, molecular docking of the parent and daughter drugs, BaCl and BaIb with 
LpxC protein of Pseudomonas aeruginosa, has been employed to trace the nature of 
its binding interaction and binding affinity value. The docking scores and binding 
free energies of lowest energy pose of its inbuilt inhibitor, NVS-LpxC-01 and the 
samples under study, BaCl, and BaIb in active sites on chain B of the NVS-LpxC 
X-ray crystal structures, have been computed after deleting the unwanted ligands 
and amino acids and including the Zn2+ using Schrodinger Maestro software and 
are given in Table 4. The docking result points out that the drugs BaCl and BaIb 
show considerable binding affinity scores compared to the inbuilt ligand. However, 
Figure 2. 
Schematic representations of ligand-protein interaction and binding interaction using stick mode. (a) 3P3 with 
LpxC, (b) BaCl with LpxC, and (c) BaIb with LpxC.
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interestingly the d-API BaIb exhibits high docking score compared to the parent 
drug BaCl, which emphasizes that the interaction between the ligand and protein 
increased on double active formation with ibuprofen.
Figure 1 demonstrates the three-dimensional protein-ligand interaction of three 
samples under study in the active site of LpxC in complex obtained from graphical 
interface Maestro. All the ligands are found to be buried in the deep binding pocket 
of LpxC in the complex in an indistinguishable way. The d-API BaIb interact with 
the active site’s amino acids of the protein by H-bonding, which is depicted in red 
and dotted lines.
Compound Schrodinger software





Docking scores and binding free energies of inbuilt inhibitor NVS, BaCl, and BaIb to the LpxC/LPC-009 using 
Schrodinger Maestro software.
Figure 3. 
Schematic representations of ligand-protein interaction and binding interaction using stick mode. (a) 3P3 with 
LpxC, (b) BaCl with LpxC, and (c) BaIb with LpxC using Schrodinger software.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with 
the Pseudomonas aeruginosa LpxC in the 2D image as shown in Figure 3. The ligands 
were surrounded by active site amino acids THR190, GLY192, PHE191, SER211, 
PHE193, MET194, ASP196, DLE197, LEU200, ARG201, VAL216, etc., of LpxC. The 
co-crystallized ligand NVS occupied the deep cavity by forming five hydrogen 
bonds in addition to its salt bridge. Though the parent ligand BaCl occupied the 
deep cavity of LpxC with the support of salt bridges between them, the daughter 
ligand BaIb formed one hydrogen bond with the active amino acid LYS238 and a 
π-cation interaction with active site amino acid PHE191.
Despite the binding energy and docking score difference of parent as well as the 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand NVS with hydrogen bonding with active site 
amino acids. Also, the binding energy and docking score emphasize that the d-API 
has a higher binding affinity with LpxC than the parent drug BaCl. This indicates 
the BaIb can be considered as a potential inhibitor of LpxC protein with antibacte-
rial activity.
3.2 Anti-inflammatory activities of NaIb and BaIb
3.2.1 In vitro studies using chick albumin
The anti-inflammatory properties of the synthesized drug BaIb and parent drug 
NaIb were studied in chick albumin membrane. Figure 4 depicts the bar diagram 
of the percentage inhibition of inflammation against the concentration of NaIb and 
BaIb. Sample NaIb and BaIb have almost the same inhibitory activity in all concen-
tration, which is around 95%. Thus from this analysis, one can confirm that BaIb 
retains the anti-inflammatory activity of NaIb and states.
3.2.2 In vitro studies using human serum albumin
The anti-inflammatory properties of the synthesized drug BaIb, parent drug 
NaIb, and drug diclofenac as standard samples were given in Table 5. Among 
samples provided, diclofenac shows maximum inhibitory activity, whereas the 
NaIb and BaIb are less active than the reference compound, but still, its activity is 
significant as an inflammatory agent. This fact suggests that the anti-inflammatory 
activity of NaIb was retained in the double active pharmaceutical ingredient. Thus 
the in vitro study confirms that the synthesized BaIb is a double active pharmaceu-
tical ingredient by retaining the biological activities of the parent drugs.
3.2.3 Molecular docking studies of NaIb and BaIb with HSA
Here, molecular docking of the parent and daughter drugs, NaIb and BaIb, 
respectively, with human serum albumin complex has been employed to analyze its 
binding mode and binding affinity value. The docking scores and binding free ener-
gies of lowest energy pose of its inbuilt inhibitor, ibuprofen and the BaIb in active 
sites on chain A of the 2BXG X-ray crystal structures, have been computed after 
deleting the unwanted ligands and amino acids using Schrodinger Maestro software 
and are given in Table 6. The docking result points out that the drugs ibuprofen 
and BaIb show considerable binding affinity scores compared to the inbuilt ligand. 
However, interestingly the d-API BaIb exhibited almost similar docking score to 
the parent drug Ib, which emphasizes that the interaction between the ligand and 
protein is still functional on double active formation with ibuprofen.
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In addition to the 3D binding orientations of the ligands in the protein, the dock-
ing results provide further insights into selective interactions of the ligands with 
the Pseudomonas aeruginosa LpxC in the 2D image as shown in Figure 3. The ligands 
were surrounded by active site amino acids THR190, GLY192, PHE191, SER211, 
PHE193, MET194, ASP196, DLE197, LEU200, ARG201, VAL216, etc., of LpxC. The 
co-crystallized ligand NVS occupied the deep cavity by forming five hydrogen 
bonds in addition to its salt bridge. Though the parent ligand BaCl occupied the 
deep cavity of LpxC with the support of salt bridges between them, the daughter 
ligand BaIb formed one hydrogen bond with the active amino acid LYS238 and a 
π-cation interaction with active site amino acid PHE191.
Despite the binding energy and docking score difference of parent as well as the 
daughter drugs, BaCl and BaIb were well occupied in the binding site of the LpxC 
protein as similar to the native ligand NVS with hydrogen bonding with active site 
amino acids. Also, the binding energy and docking score emphasize that the d-API 
has a higher binding affinity with LpxC than the parent drug BaCl. This indicates 
the BaIb can be considered as a potential inhibitor of LpxC protein with antibacte-
rial activity.
3.2 Anti-inflammatory activities of NaIb and BaIb
3.2.1 In vitro studies using chick albumin
The anti-inflammatory properties of the synthesized drug BaIb and parent drug 
NaIb were studied in chick albumin membrane. Figure 4 depicts the bar diagram 
of the percentage inhibition of inflammation against the concentration of NaIb and 
BaIb. Sample NaIb and BaIb have almost the same inhibitory activity in all concen-
tration, which is around 95%. Thus from this analysis, one can confirm that BaIb 
retains the anti-inflammatory activity of NaIb and states.
3.2.2 In vitro studies using human serum albumin
The anti-inflammatory properties of the synthesized drug BaIb, parent drug 
NaIb, and drug diclofenac as standard samples were given in Table 5. Among 
samples provided, diclofenac shows maximum inhibitory activity, whereas the 
NaIb and BaIb are less active than the reference compound, but still, its activity is 
significant as an inflammatory agent. This fact suggests that the anti-inflammatory 
activity of NaIb was retained in the double active pharmaceutical ingredient. Thus 
the in vitro study confirms that the synthesized BaIb is a double active pharmaceu-
tical ingredient by retaining the biological activities of the parent drugs.
3.2.3 Molecular docking studies of NaIb and BaIb with HSA
Here, molecular docking of the parent and daughter drugs, NaIb and BaIb, 
respectively, with human serum albumin complex has been employed to analyze its 
binding mode and binding affinity value. The docking scores and binding free ener-
gies of lowest energy pose of its inbuilt inhibitor, ibuprofen and the BaIb in active 
sites on chain A of the 2BXG X-ray crystal structures, have been computed after 
deleting the unwanted ligands and amino acids using Schrodinger Maestro software 
and are given in Table 6. The docking result points out that the drugs ibuprofen 
and BaIb show considerable binding affinity scores compared to the inbuilt ligand. 
However, interestingly the d-API BaIb exhibited almost similar docking score to 
the parent drug Ib, which emphasizes that the interaction between the ligand and 
protein is still functional on double active formation with ibuprofen.
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Figure 1 demonstrates the three-dimensional protein-ligand interaction of three 
samples under study in the dynamic site of 2BXG obtained from graphical interface 
Maestro. All the ligands are found to be well occupied in the deep binding pocket of 
2BXG in the same way. The d-API BaIb interact with the active site’s amino acids 
of the protein by H-bonding, which is depicted in red and dotted lines. Interaction 
of amino acids at the active site of HAS with the studied compound is displayed in 
the 2D image (Figure 5). The ligands were encircled by amino acids like SER480, 
LBU481, VAL482, ASN483, PHE205, ARG209, ALA210, ALA213, etc., of HSA. The 
co-crystallized ligand ibuprofen occupies the deep cavity by forming three hydro-
gen bonds with active sites of amino acids SER480, LBU481, VAL482, and one 
π-anion interaction with active site amino acid LYS351. The daughter ligand BaIb 
forms only one hydrogen bond with the amino acid LYS239.
Despite the binding energy and docking score difference of parent as well as the 
daughter drug, the daughter drug, BaIb, was well occupied in the binding site of the 
Percentage of inhibition of hemolysis (%)
Diclofenac 92.16
Standard sample NaIb 88.47
Sample BaIb 88.59
Table 5. 
Preliminary in vitro anti-inflammatory properties of BaIb.
Figure 4. 
Plot of percentage inhibition of inflammation against the concentration of NaIb and BaIb studied in chick 
albumin membrane.
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Docking scores and binding free energies of inbuilt inhibitor ibuprofen and BaIb to the 2BXG using Schrodinger 
Maestro software.
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HSA protein as similar to the native ligand ibuprofen by forming a hydrogen bond 
with active site amino acid.
4. Conclusions
In this work, the biological evaluations of a synthesized double active pharma-
ceutical ingredient BaIb were done to confirm the retainity of the biological activi-
ties of its parent drugs and to elucidate information regarding its potential activities 
against their respective ailments. Further molecular docking studies were done to 
get a better understanding about the mode of interaction of the parent as well as 
daughter drugs with the targeted proteins and trace out the binding pore and cites 
in the targeted proteins.
The in vitro studies revealed that the synthesized BaIb could be designed as 
a potential double active drug since it retained the antibacterial activity of its 
parent BaCl with considerable inhibitory action against E. coli and P. aeruginosa 
compared to the parent drug. The binding energy and docking score of BaCl and 
BaIb again confirm that the prepared d-API BaIb docks well into the LpxC pro-
teins of E. coli and P. aeruginosa with high docking and Glide score compared to 
the parent drug BaCl.
Similarly, the results from both in vitro and in silico method emphasize that 
the prepared d-API retained the anti-inflammatory action of its parent NaIb and 
bound well to the deep pocket of the active site in the human serum albumin. Thus, 
in total, one can conclude that the prepared BaIb can be used as a potential double 
active drug with antibacterial and anti-inflammatory actions.
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HSA protein as similar to the native ligand ibuprofen by forming a hydrogen bond 
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The in vitro studies revealed that the synthesized BaIb could be designed as 
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compared to the parent drug. The binding energy and docking score of BaCl and 
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1. Introduction
Hydrazone-based molecular structures are ubiquitous in many research fields, 
such as medicinal chemistry [1], organic synthesis [2], supramolecular chemistry 
[3], metal-organic coordination [4], dyes [5], fluorescent sensors, and molecular 
machines [6], besides others applications [7]. Over the last decades, the popularity 
of hydrazone group has increased due to its easy and direct-obtaining synthesis, 
stability toward hydrolysis in comparison with imines, modularity, and mainly, 
functional diversity of C═N▬N useful in several fields (Figure 1). In terms of 
structure, hydrazones are considered as azomethine compounds; however they are 
distinguished from imines and oximes, for example, by the presence of additional 
linked nitrogen atom [8]. Hydrazone backbone has an imine carbon that has an 
Figure 1. 
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of hydrazone group has increased due to its easy and direct-obtaining synthesis, 
stability toward hydrolysis in comparison with imines, modularity, and mainly, 
functional diversity of C═N▬N useful in several fields (Figure 1). In terms of 
structure, hydrazones are considered as azomethine compounds; however they are 
distinguished from imines and oximes, for example, by the presence of additional 
linked nitrogen atom [8]. Hydrazone backbone has an imine carbon that has an 
Figure 1. 
General molecular structure of hydrazones.
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electrophile character, two nucleophilic nitrogen in both imine and amine groups 
and a possible isomerization of C═N double bond typically from the conjugation of 
imine and the acid N▬H. These structural properties play a crucial role to determine 
the specificity of applications which hydrazone group can be involved [6, 9].
The main synthesis of hydrazones is carried out from acid-catalyzed condensa-
tion between hydrazines (R1NHNH2) and activated carbonyl aldehydes or ketones, 
generally in alcoholic media. Other forms to obtain hydrazones are from Japp-
Klingemann reaction (i.e., aryl diazonium salts coupling with β-keto esters or acids) 
and coupling between aryl halides and non-substituted hydrazones [9].
1.1 Hydrazone-based compounds as fluorescent chemosensors
Most hydrazone derivative fluorescent chemosensors were designed combining 
fluorophores or aromatic structures with this functional group. The wide range 
of chemical reactivity of hydrazones allows their application in the detection of 
anions, cations, and other species [10].
Some hydrazone-based chemosensors have weak fluorescence because of 
quenching effects such as E/Z double bond isomerization in the excited state; 
photoinduced electron transfer (PET) process (excited electron is transferred from 
donor to acceptor; generating a charge separation, i.e., redox reaction takes place 
in excited state); [11] excited state intramolecular proton transfer (ESIPT) process 
(photoexcited molecule relax their energy through tautomerization by transfer a 
proton); and others [12, 13]. The main objective for this class of chemosensors is 
inhibiting the quenching effects after interaction with some analytes promoting a 
fluorescence state. Other possible mechanisms are based on nucleophilic addition or 
induced N▬H and O▬H deprotonation. These mechanisms will be detailed after.
A quick literature survey using Scopus database has shown few reviews on the 
chemistry of hydrazones, most of them focusing on medicinal chemistry [14] or 
organic synthesis [15]. Only one review on hydrazone compounds describes some 
examples of hydrazone-based fluorescent chemosensor, which covered some results 
reported before 2014 [6].
This chapter book aims to present the progress of fluorescent and colorimetric 
chemosensor based on hydrazone scaffold, as reported in the literature in the 
period of 2006 until 2019. We hope that this chapter book helps in the design and 
development of new and selective fluorescent and colorimetric chemosensors for a 
broad range of applications.
2. Fluorescent chemosensors for anions
Anions, such as cyanide (CN−), fluoride (F−), chlorine (Cl−), and acetate 
(AcO−), play an important role in many environmental, clinical, chemical, and 
biological processes. Due to these important roles, anion recognition is an area with 
growing interest in supramolecular chemistry, and considerable efforts has been 
focused on the design of receptors (compounds) that are able to recognize anions. 
The detection and quantification of anions is a challenge, especially in biological 
systems. Some aspects as microenvironmental sensitivity, specificity, basicity, and 
nucleophilicity are among the main complicating factors in the detection of anions. 
One way to solve these problems is to develop chemosensors with high specificity 
for individual anions [16, 17]. Among different types of anions, fluoride and cya-
nide aroused great interest. The optimum concentration of F− anions in the human 
body is a positive aspect to our health and can prevent dental caries and osteoporo-




damage, and bone diseases [18–20]. Additionally, F− is known as a test index for 
residues of some nerve agents, being also associated with certain drugs, Alzheimer 
disease, and drinking water. The level of F− recommended in potable water by the 
US Environmental Protection Agency (EPA) is about 2 ppm [18–21].
Commonly involved in chemicals and industrial processes, cyanide is highly 
toxic and its exposure to live organisms and environment is extremely detrimental. 
Moreover, cyanide anion has a strong affinity with cytochrome a3 which can lead 
to cell death because of respiratory arrest [22]. According to the World Health 
Organization (WHO), the permissible level of cyanide in drinking water is 1.9 
× 10−6 M [18]. Therefore, considering the notorious toxicity of CN− and F−, the 
development of sensitive sensors for the accurate detection and quantification of 
anions is of great importance.
2.1 Hydrazone derivatives as chemosensors for CN−
The main mechanisms of fluorescent sensing CN− in hydrazone derivatives 
are based on nucleophilic addition to polarized C═N [23, 24] and C═O [25] bonds, 
which leads to disruption of C═N and C═O double bond to C▬NH or C▬OH forms, 
deprotonation of NH or OH by means of acid-base reactions [26–28], and the 
displacement of fluorescent hydrazones from hydrazone-copper complexes.
2.1.1 Nucleophilic addition of CN−
Two highly selective CN− chemosensors 1–2 based on hydrazones functionalized 
with salicylaldehyde were described as capable of detecting this anion in aqueous 
solution at very low concentrations (Figure 2A). The ability of 1–2 complexing 
with several anions was tested by means of UV-vis absorption and fluorescence 
spectrometry. Among these anions, only CN− caused spectral changes due to its 
nucleophilic attack to the imine group (Figure 2B), and spectroscopy analysis (H1 
NMR and MS studies) confirmed a 1:1 binding stoichiometry. In the presence of 
CN− (0–120 equivalents), a new intramolecular hydrogen bond network is formed, 
resulting in a turn-on fluorescence response for probe 1 and colorimetric naked-eye 
Figure 2. 
(A) Molecular structures of CN− chemosensors 1–3 with polarized C═N bond as sensing sites. (B) Proposed 
cyanide sensing mechanism of 1. (C) Proposed CN− sensing mechanism for 4 based on polarized C═O bond.
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cyanide sensing mechanism of 1. (C) Proposed CN− sensing mechanism for 4 based on polarized C═O bond.
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changes for probe 2 [23]. With the same sensing mechanism based on nucleophilic 
attack of CN− on the imine group, a remarkably and selective fluorescent and 
colorimetric chemosensor 3 was reported (Figure 2A). Among various anions, 
sensor 3 responded to only CN−, resulting in a color change from colorless to yellow. 
Moreover, a fluorescence analysis showed 3 has a weak fluorescence, and after addi-
tion of CN− (0–120 equivalents), the fluorescence emission has increased to a bright 
green fluorescence [24].
Exploring the same principle of nucleophilic attack, a highly selective and 
sensitive naphthalene-acylhydrazone chemosensor for CN− in aqueous media was 
designed. By this time, the mechanism proposed was the nucleophilic attack on the 
carbonyl group instead of the imine one, according to 1H NMR, 13C NMR, ESI-MS, 
and DFT calculations data (Figure 2C). Among several anions tested, only CN− 
could induce a remarkable color change from colorless to yellow and increase of 
fluorescence emission in DMSO/H2O solution. Moreover, the detection limits were 
5.0 × 10−7 M and 2.0 × 10−9 M of CN− for color and fluorescence changes respec-
tively, far lower than the WHO guideline of 1.9 × 10−6 M [25].
2.1.2 Deprotonation mechanism
Cyanide anion is a Lewis base and can form hydrogen bonds with hydrogen bond 
donors as hydroxyl and amines usually followed by deprotonation.
The highly selective and sensitive chemosensor (5) based on acyl hydrazone 
could detect CN− in aqueous solution with colorimetric and fluorimetric turn-on 
response (Figure 3A). The detection limit of CN− was 1.2 × 10−9 M, which is lower 
than the maximum level of 1.9 × 10−6 M for cyanide in drinking water according to 
WHO guidelines. Additionally, test strips based on 5 were fabricated and demon-
strated that it could be used as an efficient CN− sensing in aqueous solution [26].
Another deprotonation mechanism was reported in the design of a two-dimen-
sional carbazole-based chromophore 6 as chemosensor for the measurement of 
CN−. In terms of structure, this compound possesses two types of donor-π-acceptor 
(D-π-A) chromophores, where carbazole moiety is a donor for the two branches, 
each one with an accepting group (Figure 3B). Addition of CN− to the solution of 6 
in DMSO/H2O (95/5, v/v) redshifted from 440 nm to 500 nm its absorption, chang-
ing its naked-eye observed color from yellow to violet. The sensing mechanism 
proposed was based on proton abstraction of ▬NH▬ when this group reacts with 
CN− resulting in the obvious color change [27].
Like compound 5, a rhodamine B hydrazone derivative (7) was reported 
as highly selective chemosensor for CN− by means of a phenol deprotonation. 
Figure 3. 




The complete sensing mechanism proposed was deprotonation followed by an 
intramolecular charge transfer (ICT), supported by 1H NMR studies and DFT 
calculations (Figure 3C). This compound is a fluorescence and colorimetric sen-
sor in DMSO/H2O (1:9) medium with a significant color change after addition of 
CN− to a chemosensor solution from colorless to pale yellow visible to the naked 
eye, and the fluorescence increased to strong green fluorescence. The good detec-
tion limit observed of 5.81 × 10−8 is lower than the maximum level of 1.9 × 10−6 M 
for cyanide according to WHO guidelines, leading this compound to be applied  
in the detection of CN− in germinated potatoes and also in tests strips for CN− 
detection [28].
2.2 Hydrazone derivatives as chemosensors for F−
2.2.1 Hydrogen bond interactions and deprotonation
Fluoride is a weak Lewis base and can form hydrogen bonds with hydrogen bond 
donors. This coordination usually promotes deprotonation.
A Ru-bpy-based quinone hydrazone was designed as chromo-fluorogenic hybrid 
chemosensor (8) for F− (Figure 4A). This compound contains a quinone-hydrazone 
group that can be converted to azophenol tautomer in 8-F− induced by the proton 
transfer from 8 to F− causing a color change from orange to blue-violet. Only F− was 
capable of inducing color change to 8 in MeCN, suggesting the high selectivity could 
be attributed to the strong intramolecular N▬H▬O hydrogen bond interaction in 8, 
which means only the most electronegative anion could form an additional hydrogen 
bond. Generally, anion sensors based on hydrogen bond interactions cannot serve 
as good sensors in aqueous media due to hydrogen bond competition with water. To 
avoid this problem, a filter paper impregnated with acetonitrile solution of 8 and 
dried in air has been prepared. Immersing this paper into aqueous fluoride solution 
was successful, and fluoride solution exhibited color changes [29].
A thiocarbonohydrazone anion chemosensor 9 was described and rationally 
designed based on previously reported anion chemosensors, where the presence 
of strong electron withdrawing ▬NO2 group enhanced the acidity of the thioamide 
protons and stabilized the negative deprotonated species (Figure 4B). After 
successive addition of F−, the UV-vis absorption band with maximum at 360 nm 
has decreased, whereas new peaks at 407 and 495 nm appeared. The absorption at 
360 nm is attributed to the Ar▬CH═N▬NH conjugation moiety, and its bathochro-
mic shift clearly indicated an interaction/reaction of fluoride with this portion. 
After addition of more than four equivalents of F−, a new absorption band at 
600 nm appeared with a new isosbestic point at 535 nm. The significant changes in 
UV-vis spectra of chemosensor 9 was attributed to the deprotonation of thioamide 
protons in a three-step process (Figure 4B) confirmed by 1H NMR titration analysis 
from the observed peak of the FHF− at δ = 16.13 ppm [30].
Figure 4. 
Molecular structure of F− chemosensor 8 (A) and 9 (B) and their proposed sensing mechanism.
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was successful, and fluoride solution exhibited color changes [29].
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of strong electron withdrawing ▬NO2 group enhanced the acidity of the thioamide 
protons and stabilized the negative deprotonated species (Figure 4B). After 
successive addition of F−, the UV-vis absorption band with maximum at 360 nm 
has decreased, whereas new peaks at 407 and 495 nm appeared. The absorption at 
360 nm is attributed to the Ar▬CH═N▬NH conjugation moiety, and its bathochro-
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protons in a three-step process (Figure 4B) confirmed by 1H NMR titration analysis 
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Figure 4. 
Molecular structure of F− chemosensor 8 (A) and 9 (B) and their proposed sensing mechanism.
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Still exploring the N▬H acidity of hydrazones, a new series of diketopyrrolo-
pyrrole (DPP) derivatives 10–14 bearing phenylhydrazone group was described 
presenting a ESIPT-PET fluoride sensing mechanism. The authors aimed to study 
the effect of nitro substituent of phenylhydrazone on their photophysical property 
and optical fluoride sensing. The anion sensing capabilities of 10–14 were evaluated 
in DMSO by the addition of several anions. The presence of nitro substituent at 
ortho-position of phenylhydrazone in 11 and 14 significantly altered the electronic 
properties through intramolecular hydrogen bonding and furnished an excited 
state intramolecular proton transfer (Figure 5). So, o-NO2-DPPH (11) has a weak 
fluorescence, partly attributed to the photoinduced electron transfer from the imine 
and similar situation was found in o, p-NO2-DPPH (14) (Figure 5).
The visual naked-eye color change was observed under natural light for DPPPH 
(10), m-NO2-DPPPH (12), p-NO2-DPPPH (13), and o, p-NO2-DPPPH (14) in the 
presence of F−. Among these designed chemoreceptors, p-NO2-DPPPH demon-
strated selectivity for F− in UV-vis and fluorescence evaluations in DMSO solution. 
Additionally, experimental results of 1H NMR and 19F NMR revealed that the spectral 
changes occur due to deprotonation of the hydrazone N▬H moiety by fluoride ion [31].
2.3 Hydrazone derivatives as chemosensor for AcO−
Acetate (AcO−) and dicarboxylate are essential components in several metabolic 
processes in living organisms. Without them, many enzymes and antibodies are 
unable to function properly. In this sense, the synthesis of chemosensors that can 
recognize AcO−, mainly via hydrogen bond interaction, is of great importance for 
biological systems [32].
An interesting naked-eye selective colorimetric sensor for AcO− based on 
1,10-phenanthroline-2,9-dicarboxyaldehyde-di-(p-nitrophenylhydrazone) (15) 
was described by Lin’s group. The UV-vis absorption in DMSO showed a dramatic 
color change from yellow to green in the presence of AcO− with no changes for other 
anions. The presence of electron withdrawing groups increasing the hydrogen bond 
donor ability of N▬H framework was favorable for AcO− sensing. In addition, 1H 
NMR studies showed that after interaction, AcO− lead to deprotonation of 15 [33].
Similarly a fluorescent and naked-eye colorimetric chemosensor (16) for AcO− 
based on thiosemicarbazone was evaluated by UV–vis spectroscopic titrations 
in dry DMSO solution, presenting high selectivity and affinity for AcO−. After 
addition of this anion, the absorption band at 373 nm decreased gradually, whereas 
a new band appeared at 457 nm, followed by color change in the solution from light 
yellow to orange. The complex formed between AcO− and 16, through hydrogen 
bond interactions, caused intramolecular charge transfer between the electron-rich 
urea unit and the electron-deficient benzene moiety (Figure 6). In addition, the 
fluorescence spectroscopic titrations were carried out, and the 16 also displayed 
a switch-on reaction toward AcO−, which was attributed to the binding-induced 
Figure 5. 




rigidity of the host molecule. The free receptor (16) had a flexible configuration 
and could rotate freely; however, after complexation with AcO−, the host molecule 
was rigidified, and the fluorescence emission has increased [32].
2.4 Hydrazone derivatives as chemosensors for multiple anions
In contrast to previously described, where receptors had a certain degree of 
selectivity toward single anion, several hydrazone-based chemosensors have been 
published exhibiting a response to more than one anion species, and some interest-
ing examples will be described below [34–36].
A tripodal benzaldehyde-phenylhydrazone (17) was developed as a colorimetric 
naked-eye chemosensor for AcO−, F−, and H2PO4− by Lin and colleagues, and 
UV-vis spectroscopic studies in DMSO were used to determine the binding mode of 
17. After addition of these anions, a naked-eye color change from yellow to purple 
and a significant bathochromic shift of 124 nm were observed. However, both the 
color and spectral changes were reverted by the addition of protic solvent such as 
H2O into the mentioned host-guest system, indicating that protic solvents could 
compete with anion binding sites. Considering these results, the authors proposed 
that a strong hydrogen bonding interaction was taking place between receptor 
17 and AcO− as well as F−, OH−, and H2PO4−. The complete interaction mode 
described in Figure 7 was only attributed after assays indicating that stoichiometry 
of the host and specific guests was different depending on the anion. The receptor 
formed 1:1 complex with F− ion and 1:3 complexes with AcO−, OH−, and H2PO4−. 
This was attributed to the smaller ionic radius of F− than that of other larger ones. A 
further 1H NMR investigation showed that resonance peak at 11.77 ppm, attributed 
to NH protons, exhibited a downfield to 12.27 ppm upon addition of 2 equivalents 
of F− ion confirming the formation of NH…F− hydrogen bonding [34].
A Schiff-base thiophene-based hydrazone (18) was described as visual anion 
chemosensor in aqueous media exhibiting sensing properties for F−, AcO−, and 
H2PO4−, among several anions tested with colorimetric response changes from 
Figure 7. 
Molecular structures of multianalyte chemosensor 17 and their proposed sensing mechanism.
Figure 6. 
Molecular structures of acetate chemosensors 15–16 and the proposed sensing mechanism.
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orange to violet at a micromolar level. The UV-vis analysis confirmed the naked-
eye colorimetric changes and showed a decrease in band centered at 420 nm and 
increase in intensity of the band at 590 nm with the clear isosbestic point at 520 nm 
after addition of F−, AcO−, and H2PO4− to 18 solution. The chemosensor 18 works 
by means of a N▬H deprotonation mechanism. 1H NMR analysis confirmed this 
mechanism, showing that 18 presented signals at δ 11.79 and 8.91 corresponding 
to N▬H and imine protons, respectively. After addition of AcO− and F− ion, N▬H 
signal disappeared (deprotonation), while the signal corresponding to the imine 
and phenyl rings shifted to the upfield at the region of δ 8.59 and 8.54 (Figure 8). 
Additionally, a real sample qualitative estimation analysis of F− and AcO− in com-
mercially available toothpaste and vinegar was successfully achieved by this simple 
and easy colorimetric method [35].
Four furan/thiophene-based fluorescent hydrazones 19–22 were described 
as CN− and F− sensors (Figure 8) and could detect these ions with naked-eye 
color changes from yellow to blue, while their fluorescence emission intensi-
ties were completely quenched. The presence of electron donating/withdrawing 
groups attached to furan ring as in 21 (▬NO2) and 22 (▬CH3) curiously resulted in 
increased selectivity for CN− ions compared to F− ones. 1H NMR confirmed that the 
sensing mechanism goes through hydrogen bonding interaction between sensors 
and F−/CN−, followed by deprotonation, leading to elicited ICT. Job’s plot afforded a 
stoichiometry of 2:1 binding ratio between 19 and 20 and F− ions. However, curi-
ously 21 and 22 exhibited a 1:1 ratio with F− and CN− due to steric constraint. The 
limit of detection (LOD) analysis revealed that the four sensors displayed the LOD 
below 0.3 ppm for CN− and F− and a good selectivity. Competitive experiments 
revealed a negligible perturbation in the optical response which confirms a higher 
selectivity for F− and CN− than other competitor anions [36].
3. Fluorescent chemosensors for metal ions
Metal ions such as Cu2+, Zn2+, Fe3+, Al3+, Hg2+, Mg2+, etc. play an important 
role in many biological and environmental processes, and excessive or insufficient 
amounts may lead to diseases [37]. As an example, copper (Cu2+) is the third most 
abundant transition metal in the human body and plays essential roles in several 
environmental, chemical, and physiological systems. In living organisms, Cu2+ acts 
as a key catalytic center in many enzymes and as cofactor in a variety of metallopro-
teins [38]. Its insufficient concentration may affect the development of bone and 
brain tissues as well as the nervous and immune system, whereas excessive intake 
may lead to serious problems including cirrhosis and neurological diseases such as 
Alzheimer’s and Wilson’s diseases and prion disorders [39]. The extreme toxicity of 
heavy metal ions such as Pb2+ and Hg2+, even in small amounts, remains a danger to 
Figure 8. 





human health and the environment, but they have been widely used in industrial 
processes [40]. Therefore, the development of sensitive sensors for the accurate 
detection and quantification of these ions is of great importance.
3.1 Hydrazone derivatives as chemosensors for Cu2+
Fluorescent and colorimetric hydrazone-based chemosensors for Cu2+ attract 
interest and are mainly based on coordination mechanism, often quenching the 
fluorescence emission due to PET mechanism [41].
Coumarins are widely associated with hydrazones for sensing Cu2+ and the 
on–off fluorescent chemosensor (23) was described for Cu2+ detection in aqueous 
media. This chemosensor showed very strong luminescence in H2O/DMSO (9:1, 
v/v) with quantum yield of 0.289, which was almost completely quenched after 
addition of copper (1 equivalent), decreasing the quantum yield to 0.024. This pro-
cess was associated with the complexation of Cu2+ to the tautomeric enol-like form 
of 23 leading to 23-Cu2+ and the PET mechanism (Figure 9). Compound 20 showed 
detection limit of 0.1 μM for Cu2+, which is useful to sense Cu2+ in blood system, 
a 1:1 binding mode supported by a Job’s plot, an association constant estimated to 
be 6.4 × 105 M−1, and a response time of 2 min upon addition of 1 equivalent of this 
cation. Only Cu2+ causes a significant fluorescence decrease, while other metals 
such as K+, Ag+, Ca2+, Cd2+, Co2+, Cr3+, Fe2+, Fe3+, Hg2+, Mg2+, Mn2+, Ni2+ and Zn2+ 
did not cause any significant change. In addition, living cell experiments were 
successfully applied, and confocal image changes were observed, demonstrating its 
value in practical applications and biological systems [42].
Differently from turn-off PET mechanism, off-on (turn-on) chemosen-
sors for detecting Cu2+ often present a FRET mechanism (described by energy 
transfer between two light-sensitive molecules or chromophores, where a donor 
chromophore in its electronic excited state may transfer energy to an acceptor 
chromophore through nonradiative dipole-dipole coupling). An example is the 
hybrid coumarin-rhodamine hydrazone chemosensor 24 based on metal ion-
induced FRET. In this mechanism, coumarin nucleus acts as donor and rhoda-
mine acts as acceptor of energy. Free ligand coumarin-rhodamine hydrazone 
(24) absorbs around 460 nm, which is attributed to coumarin chromophore. 
The absorbance remained unchanged upon addition of various metal ions except 
Cu2+. Upon addition of Cu2+, the solution color changes from yellow to bright 
red indicating metal complexation. It was confirmed analyzing the decrease in 
absorption band centered at 460 nm with a slowly redshifts to 475 nm, while a 
new peak at 556 nm arise from the rhodamine chromophore in the visible region. 
Figure 9. 
Molecular structures of Cu2+ chemosensors 23 (A) and 24 (B) and their proposed sensing mechanism.
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Free coumarin-rhodamine hydrazone (24) emits in the green fluorescence region 
with a fluorescence band centered at 524 nm which is attributed to N,N-diethyl-
coumarin moiety upon excitation at 480 nm. Upon sequential addition of Cu2+, 
coumarin emission band was observed at 524 nm, while an emission signal 
corresponding to ring-opened rhodamine appeared at 582 nm (Figure 9). This 
chromo-fluorogenic probe can detect concentrations below 20 μM of Cu2+ in 
aqueous buffer medium. The FRET mechanism is possible due to integral overlap 
between emission band of N,N-diethyl coumarin moiety and absorption band of 
ring-opened zwitterionic rhodamine unit in buffer medium. Additionally, probe 
24 undergoes a 1:1 stoichiometric complexation with Cu2+ with the calculated 
association constants of 8.81 M−1 and was successfully employed as ratiometric 
biosensor for living cell imaging of Cu2+ [43].
A highly selective and sensitive naked-eye colorimetric chemosensor for Cu2+ in 
aqueous solution was designed and developed based on hydrazone framework. In 
the UV-vis spectroscopic studies, compound 25 exhibited a broad band at 336 nm, 
and after addition of copper, a new absorption band at 502 nm appeared, whereas 
the absorption band at 336 nm was gradually reduced. This gradually increasing 
absorption peak at 502 nm (after sequential addition of Cu2+) was attributed to the 
coordination of 25 with Cu2+.
Trying to understand its sensing mechanism, the stoichiometry of the 25-Cu2+ 
complexation was determined by the Job’s plot analysis which indicates a 2:1 stoi-
chiometric between 25 and Cu2+ and after confirmed by ESI/MS analysis. With 
stoichiometry on hands, complementary infrared (IR) and 1H NMR spectroscopy 
were employed, and even Cu2+ which is a paramagnetic ion helped to describe the 
coordination mode. The 1H NMR revealed that N▬H (a) proton almost completely 
disappeared upon addition of Cu2+ and proton b became broader after binding, 
indicating that Cu2+ binds with nitrogen of pyridine after an initial tautomerization 
with a deprotonation of O▬H.
The selectivity of 25 over other metals was investigated by adding several metal 
cations to the solution of 25 in THF/H2O (9:1, v/v), and there was no obvious 
change with any other metal. The colorless solution of the compound 25 became 
pink after addition of Cu2+ with the detection limit by the naked eye around 2 μM 
which is lower than the limit of copper in drinking water (~20 μM). Additionally, to 
evaluate the practical application of chemosensor 25, competition experiments of 
Cu2+ mixed with other metal ions were carried out from UV-vis absorption spectra. 
The treatment of 25 solution with Cu2+ in the presence of the same concentration of 
other metal cations did not show any significant changes [44].
Using a strategy of intraligand charge transfer transition (ILCT) turn-on mecha-
nism, a small chromo-fluorogenic chemosensor (26) for Cu2+, based on hydrazones, 
was described. This chemosensor exhibited a weak fluorescence in DMSO with a 
44-fold increase in fluorescence emission intensity upon addition of Cu2+, being 
attributed to ILCT. This receptor showed a prominent colorimetric change from yel-
low to brown in the presence of Cu2+ with a detection limit in the order of 10−8 M. In 
the presence of other environmentally significant metal cations such as Hg2+, 
Pb2+, Cd2+, Ni2+, Co2+, Fe2+, Fe3+, Mn2+, Zn2+, Al3+, and Cr3+, no significant spectral 
changes were observed. Interesting, this chemosensor was capable of extracting 
Cu2+ selectively from aqueous mixture of metal ions using dichloromethane as 
solvent with an efficiency of 94% at 6.5–11 pH range.
The binding sense mechanism was explained by 1H NMR titration in DMSO, 
in which the peak attributed to acid O▬H proton of 26 gradually decreased upon 
addition of Cu2+, also indicating a 2:1 (26-Cu2+) stoichiometric binding (Figure 10). 
During the extraction process, the stoichiometry of ligand and Cu2+ was confirmed 




monitored by a readily usable smartphone as an analysis tool. Interesting, this 
receptor showed a good recyclability and reusability in Cu2+ extraction, being very 
useful for the detection and selective extraction of Cu2+ from aqueous media in 
chemical and biological systems [45].
3.2 Hydrazone derivatives as chemosensors for Zn2+
Zinc (Zn2+) is the second most abundant transition metal (after Fe3+) in the 
human body and is considered essential for living organisms. Zn2+ exerts influence 
on many cellular processes, including proliferation, differentiation, apoptosis, tran-
scription, neural signal transmission, and microtubule polymerization. Therefore, 
significant changes in Zn2+ concentration may be related to many diseases, includ-
ing Alzheimer’s and Parkinson’s diseases, diabetes, and prostate cancer [46, 47]. 
Chemosensors for Zn2+ are mainly based on the coordination mechanism; however, 
these probes often still lack specificity.
Aroylhydrazone derivatives (27–28) were described as fluorescent chemosen-
sors for Zn2+ recognition. These ligands and their metal complexes (27 (Zn2+, Cu2+), 
28 (Zn2+, Co2+, Fe3+)) have been synthesized and characterized in terms of their 
crystal structures, elemental analysis, and spectroscopic properties. First, chemo-
sensor 27 displayed high selectivity for Zn2+ over other transition metals compared 
to 28 in aqueous ethanol solution, which indicate that hydroxyl group exerts effect 
on the selectivity of the fluorescent chemosensor. The possible reason is that the 
presence of hydroxyl group gives the carbonyl a better binding ability for Zn2+ to 
form a 1:1 complex. The fluorescence response of 27 in solution increased approxi-
mately 25-fold upon addition of 10 equivalents of Zn2+ probably due to rigidity 
imposed by the complex formed, inhibiting isomerization (Figure 11). Otherwise, 
28 exhibited only small increase in fluorescence (5-fold) when Zn2+ was introduced 
to the solution, indicating also the importance of ortho-hydroxyl group for fluores-
cence [48].
Figure 10. 
Molecular structures of Cu2+ chemosensor 25 and its coordination mode (A) and structure of chemosensor 26 
and its sensing mechanism (B).
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monitored by a readily usable smartphone as an analysis tool. Interesting, this 
receptor showed a good recyclability and reusability in Cu2+ extraction, being very 
useful for the detection and selective extraction of Cu2+ from aqueous media in 
chemical and biological systems [45].
3.2 Hydrazone derivatives as chemosensors for Zn2+
Zinc (Zn2+) is the second most abundant transition metal (after Fe3+) in the 
human body and is considered essential for living organisms. Zn2+ exerts influence 
on many cellular processes, including proliferation, differentiation, apoptosis, tran-
scription, neural signal transmission, and microtubule polymerization. Therefore, 
significant changes in Zn2+ concentration may be related to many diseases, includ-
ing Alzheimer’s and Parkinson’s diseases, diabetes, and prostate cancer [46, 47]. 
Chemosensors for Zn2+ are mainly based on the coordination mechanism; however, 
these probes often still lack specificity.
Aroylhydrazone derivatives (27–28) were described as fluorescent chemosen-
sors for Zn2+ recognition. These ligands and their metal complexes (27 (Zn2+, Cu2+), 
28 (Zn2+, Co2+, Fe3+)) have been synthesized and characterized in terms of their 
crystal structures, elemental analysis, and spectroscopic properties. First, chemo-
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to 28 in aqueous ethanol solution, which indicate that hydroxyl group exerts effect 
on the selectivity of the fluorescent chemosensor. The possible reason is that the 
presence of hydroxyl group gives the carbonyl a better binding ability for Zn2+ to 
form a 1:1 complex. The fluorescence response of 27 in solution increased approxi-
mately 25-fold upon addition of 10 equivalents of Zn2+ probably due to rigidity 
imposed by the complex formed, inhibiting isomerization (Figure 11). Otherwise, 
28 exhibited only small increase in fluorescence (5-fold) when Zn2+ was introduced 
to the solution, indicating also the importance of ortho-hydroxyl group for fluores-
cence [48].
Figure 10. 
Molecular structures of Cu2+ chemosensor 25 and its coordination mode (A) and structure of chemosensor 26 
and its sensing mechanism (B).
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A fluorescein-coumarin conjugate (29) was reported as turn-on fluorescent 
sensor for Zn2+ in aqueous medium. The mechanism involved in this chemosensor 
is related to spirolactam ring opening mediated selectively by Zn2+ over other earth 
and transition metal ions. The free chemosensor 29 showed almost no absorption 
characteristic of the fluorescein moiety which indicate the existence of the spiro-
lactam form. However, upon Zn2+ addition in the sensing system, a new absorption 
band corresponding to fluorescein moiety increased indicating the generation of a 
ring-opening amide form (29-Zn2+). The absorbance ascended linearly as a func-
tion of Zn2+ concentration with a saturation at the ratio of 1:1 (Figure 12). The 
fluorescence emission intensity was increased 33-fold at 501 nm upon zinc addition, 
which is characteristic of fluorescein, confirming the spirocycle opening of 29 after 
coordination. In addition, this chemosensor was highly selective toward several 
metals such as Na+, K+, Ca2+, Mg2+, Cu2+, Fe3+, Co2+, Ni2+, Hg2+, Cd2+, and Cr3+ that 
showed none or little fluorescence intensity changes. The ability of chemosensor 
29 works in aqueous medium and shows potential applications in environmental, 
biological, and medicinal areas [49].
The hydrazone-based fluorescent chemosensor 30 was reported as an interesting 
and selective sensor for Zn2+ over other biologically important metal ions (Na+, K+, 
Mg2+, Ca2+, Co2+, Ni2+, Cu2+, Cd2+, Ag+, Pb2+, Hg2+, Al3+, Cr3+, Fe3+, and Zn2+) under 
completely physiological conditions (HEPES buffer medium (1 mM, pH = 7.4) 
containing 0.33% of DMSO), also demonstrating detection of zinc in live Hela cells 
by fluorescence imaging. The recognition of Zn2+ was investigated by absorption 
and emission spectroscopy, DFT calculations, ESI-MS experiment, and 1H NMR 
titration.
The free ligand (30) exhibited two absorption peaks at 305 nm and 367 nm 
attributed to the π-π* transitions, in which zinc addition (10 equivalents) promoted 
a prominent change where the absorption band at 305 nm decreased, whereas a 
new peak at 450 nm emerged. This absorption spectra change became minimum 
upon the addition of two equivalents of metal ions, which suggested a 1:2 ratio 
between 30 and Zn2+. Free receptor (30) has weak fluorescence with visible light 
excitability; however zinc caused drastic enhancement in the fluorescence emission 
with a prominent peak at 555 nm. The Zn2+ sensing mechanism was attributed to 
Figure 12. 
Molecular structures of Zn2+ chemosensors 29 (A) and 30 (B) and their sensing mechanism.
Figure 11. 




the chelation-enhanced fluorescence (CHEF) and ICT processes. The low fluores-
cence state of 30 (Φ = 0.009) is may be due to free rotation of imine (▬C═N) bond 
(Figure 12). Upon Zn2+ addition, the coordination of this metal with imine nitrogen 
and the hydroxyl group inhibited the free rotation around the imine bond, leaving 
the system more rigid. Thus, the chelation of Zn2+ leads to the formation of binu-
clear zinc complex with drastic increase in conjugation, resulting in a CHEF effect. 
Furthermore, due to the binding of Zn2+, the ICT is facilitated over the π-system. 
These conjugated effects caused the improvement in the fluorescence emission 
(Φ = 0.16, 18-fold) of 30 (Figure 12) [50].
3.3 Hydrazone derivatives as chemosensors for Hg2+
Mercuric ion (Hg2+) is considered highly dangerous, because it is known as 
one of the most toxic metal ions and is generated by many sources such as mer-
cury lamps, gold production, electronic equipment, paints, and batteries [51]. 
Mercuric ion can cause serious detrimental effects to living organisms, resulting 
in hepatitis, uremia, digestive diseases, and fatal damage to the central nervous 
system, and its accumulation can lead to various cognitive and motor disorders, 
such as Minamata disease [52]. Due to its high toxicity, considerable attention has 
been devoted to the development of new sensors for Hg2+ detection. Hydrazone-
based fluorescence chemosensors for Hg2+ are mainly based on coordination 
mechanism.
One example is the 3,4-ethylenedioxythiophene (EDOT) rhodamine-hydrazine-
based compound 31 which acts as colorimetric and turn-on fluorescent chemosen-
sor for Hg2+ detection. Between several metals, only Hg2+ coordination promoted 
the turn-on effect. The sensing mechanism is quite similar to that observed to 
compound 29, in which free receptor has a spirolactam moiety, which inhibits the 
intramolecular charge transfer between electron-acceptor moiety of xanthene and 
the electron donor of EDOT. Once Hg2+ complexation occurs, a ring opening takes 
place delivering the rhodamine B moiety, which is a well-known fluorophore. The 
spirolactam moiety of the rhodamine acts as a signal switcher, which is envisioned 
to turn on upon complexation with the cation. The spectroscopic parameters of 
Hg2+ in mixed ethanol and HEPES (10 mM, 1:1, v/v, pH = 7.2) solution demon-
strated that only Hg2+ was capable to change the color of the sensing solution from 
colorless to red (570 nm) and to increase fluorescence emission (593 nm), also 
indicating a 2:1 complex formation (Figure 13) [53].
The previous exposed FRET mechanism has been used in the design of selective 
turn-on fluorescent chemosensor for Hg2+ based on bis-hydrazone derivative from 
2,5-furancarboxaldehyde. In this case, furan ring is the donor, and rhodamine B is 
the acceptor chromophore. Free ligand has the spirolactam moiety which in turn 
inhibits the charge transfer between these chromophores. When Hg2+ binds to 32, a 
rapid naked-eye visual color change occurs from colorless to sharp pink, as well as 
a bright red fluorescent emission under UV lamp irradiation, which is attributed to 
the spirolactam ring opening (Figure 13). The FRET mechanism was confirmed by 
overlap of the emission band of 2,5-furan-dicarboxaldehyde (donor) and absorp-
tion spectra of rhodamine B (acceptor). After the binding of 32 to Hg2+, leading to 
32-Hg2+, furan moiety makes an energy transfer to induce the spirolactam opening 
which allowed the FRET process with increasing in the conjugation of the system 
(Figure 13). Additionally, the high increase in quantum yield of 32-Hg2+ (0.23) 
when they compared 32 (0.015) and its limit of the detection at very low ppb level 
concentration (3.6 × 10−9 M) allowed applications for detecting Hg2+ in drinking 
water (LOD = 10 nM) [54].
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3.4 Hydrazone derivatives as chemosensors for Al3+
Aluminum (Al3+) is the most abundant (8.3% by weight) metallic element and, 
after oxygen and silicon, is the third most abundant of all elements in the earth. 
Aluminum is widely used in the environment around us in modern society, such 
as in water treatment, food packing, medicines, etc. However, the excess of this 
metal can result in health problems such as Alzheimer’s and Parkinson’s diseases 
[55]. Moreover, it is believed that around 40% of the world’s acid solid are caused 
by aluminum toxicity, which is harmful to plants’ performance [56]. Thus, the 
detection of aluminum is essential in controlling its effects on environment and 
on human health. Hydrazone-based chemosensors for aluminum ion (Al3+) are 
mainly based on coordination with fluorescence turn-on response as a result of 
restricted molecular motion through inhibiting ESIPT or PET effects.
A Schiff-base 7-methoxychromone-3-carbaldehyde-(pyridylformyl) hydrazone 
was reported as turn-on fluorescent and colorimetric chemosensor for Al3+. This 
chemosensor (33) is colorless and nonfluorescent either in aqueous medium or 
organic solvents; however, in the presence of aluminum ions (Al3+), the develop-
ment of a yellow-green color and yellow-green fluorescence occurred. The emission 
intensity of 33 is very low with low fluorescence quantum yield of 0.051 in ethanol, 
being attributed to a PET mechanism from the Schiff-base nitrogen free pair 
electrons. As exposed, PET process involves the deactivation of excited state of a 
fluorophore by the addition of an electron to one of its excited state frontier orbitals 
which leaves the fluorophore in a non-emissive state.
Metal complexation to Schiff base produces a less efficient electron donor 
character, interrupting the PET process and, in some cases, improving the fluores-
cence emission, which is known as CHEF effect [57]. The selective coordination 
between 33 and Al3+ on the carbonyl of chromone, nitrogen of imine (▬C═N), 
Figure 13. 




and carbonyl of pyridylformyl hydrazone moiety suppressed the PET effect, 
restoring the fluorescence of the system with an increase of more than 800-fold 
(Figure 14) [58].
The simple and selective fluorescent naphthalene-hydrazone chemosensor (34) 
for Al3+ is a good example of chemosensor based on the excited state intramolecular 
proton transfer mechanism, that is a process in which photoexcited molecules relax 
their energy through tautomerization by transfer of protons. Compound 34 has a 
characteristic UV-vis bands 325 nm and 366 nm which should be assigned to π-π* 
transitions of the naphthalene. Only in the presence of Al3+ the spectra of 34 exhib-
ited a peak at 432 nm, which remained constant even after more than 1 equivalent 
of aluminum addition, which indicates 1:1 binding stoichiometry between 34 and 
Al3+. The free receptor (34) exhibited no fluorescence emission with low fluores-
cence quantum yield (0.5%), justified by the electron transfer from nitrogen atom 
of imine to the naphthalene ring (PET) and also transfer of the hydroxyl proton to 
a neighboring imine nitrogen along with the formation of intramolecular hydrogen 
bond (OH⋯N) (ESIPT). Upon addition of several metal ions, only Al3+ could cause 
a significant enhancement in the fluorescence emission at 475 nm with a high 
fluorescence quantum yield (0.26%), due to PET and ESIPT process inhibition 
(Figure 14). Chemosensor 34 showed an interesting fluorogenic response to Al3+ in 
fully aqueous medium which allows its application in biological assays and environ-
mental systems [55].
3.5 Hydrazone derivatives as chemosensors for multiple metals
Although several chemosensors have relatively high degree of selectivity as 
previously exposed, some chemosensors have been reported to recognize more than 
one metal ion.
Following a previous described strategy, probes based on the opening of spiro-
lactam ring upon metal coordination were designed as single molecule multianalyte 
(Cu2+ and Hg2+) chemosensors. Compound 35 was reported as colorless and non-
fluorescent in aqueous or organic medium (Figure 15). The UV-vis spectroscopy 
indicated that this chemosensor is a good chromogenic probe for Cu2+ in ethanol-
water (1:99, v/v), whereas other competitive cations failed. Upon the addition of 
Cu2+ to the solution of 35, a strong absorption band centered at 530 nm appeared, 
with changes from colorless to pink, because of spirolactam opening (35-Cu2+). A 
significant increase in the fluorescence emission in ethanol was also observed in the 
presence of Hg2+ (ϕ = 0.335) and Cr3+ (ϕ = 0.445). However, small addition of water 
to the ethanol quenched the fluorescence produced by Cr3+, whereas the fluores-
cence intensity of 35-Hg2+ declined just a little. The rapid quenching of the 35-Cr3+ 
is justified due to strong coordination between Cr3+ and water which may lead to 
Figure 14. 
Molecular structures of Al3+ chemosensors 33 (A) and 34 (B) and their sensing mechanism.
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Molecular structures of Al3+ chemosensors 33 (A) and 34 (B) and their sensing mechanism.
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hydrolysis of 35-Cr3+, resulting in Cr(OH)3. In addition, the open ring form of 35 
after binding with Cu2+ has no fluorescence, which is attributed to the quenching of 
the fluorescence by Cu2+, due to paramagnetic properties of the d9 Cu2+ system [59].
With a similar structure to compound 30, a hydrazone-based chemosensor 
(36) with off-on fluorescence response to Cu2+ and Zn2+ ion in aqueous media 
was reported. The reaction of 36 with Cu2+ and Zn2+ formed their correspond-
ing dimeric complexes, which were characterized by single X-ray analysis 
(Figure 15).
The UV-vis absorption and fluorescence spectroscopy (CH3CN/0.02 M 
HEPES buffer at pH 7.3) indicated the binding behavior of chemosensor 36 
toward Zn2+ and Cu2+. The electronic spectra of 36 exhibit two sharp bands at 
300 and 363 nm, and upon gradual addition of Cu2+ and Zn2+, new absorption 
bands appeared at 423 and 415 nm, attributed to charge transfer in complexes 
36-Cu2+ and 36-Zn2+. The occurrence of three well-defined isosbestic points 
demonstrated an equilibrium between 36 and 36-M2+. The little fluorescence 
presented by 36 (at 493 nm) was almost quenched upon sequential addition of 
Cu2+, being ascribed to the reverse PET from the 4-methylphenyl moiety to the 
phenolic hydroxyl, and carbohydrazide nitrogen and oxygen atoms, arising from 
the decrease in electron density after copper ion binding (Figure 15). In con-
trast, Zn2+ ion caused the enhancement in the fluorescence emission (~4.1-fold) 
of 36 due to the filled d10 electronic configuration of the Zn2+ ion, which does 
not usually involve energy or electron transfer mechanisms for the deactivation 
of the excited state (Figure 15).
Finally, the sensing mechanism of 36-Cu2+ and 36-Zn2+ has been shown to be 
reversible in the presence of EDTA, in which the fluorescence of 36 was almost 
recovered immediately from both complexes, which suggests the high reversibility 
of the chemosensor and the potential application in real-time monitoring [60].
Figure 15. 
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4. Conclusion
As exposed in this chapter, hydrazone derivatives have been extensively 
employed as fluorescent and colorimetric chemosensors targeting important 
biological analytes such as inorganic anions and metal cations. Thus, it is clear that 
hydrazone scaffold is of great importance in the design of optical sensors. Here 
we have demonstrated just some representative examples of hydrazone and their 
ability as chemosensor for CN−, F−, AcO−, multiple anions, Cu2+, Zn2+, Hg2+, Al3+, 
and multiple metals. Furthermore, we hope that this book chapter with discussions 
about the sensing mechanisms (PET, FRET, ESIPT, etc.) could be an important tool 
and contribute to the development of new rational research projects with the hydra-
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hydrolysis of 35-Cr3+, resulting in Cr(OH)3. In addition, the open ring form of 35 
after binding with Cu2+ has no fluorescence, which is attributed to the quenching of 
the fluorescence by Cu2+, due to paramagnetic properties of the d9 Cu2+ system [59].
With a similar structure to compound 30, a hydrazone-based chemosensor 
(36) with off-on fluorescence response to Cu2+ and Zn2+ ion in aqueous media 
was reported. The reaction of 36 with Cu2+ and Zn2+ formed their correspond-
ing dimeric complexes, which were characterized by single X-ray analysis 
(Figure 15).
The UV-vis absorption and fluorescence spectroscopy (CH3CN/0.02 M 
HEPES buffer at pH 7.3) indicated the binding behavior of chemosensor 36 
toward Zn2+ and Cu2+. The electronic spectra of 36 exhibit two sharp bands at 
300 and 363 nm, and upon gradual addition of Cu2+ and Zn2+, new absorption 
bands appeared at 423 and 415 nm, attributed to charge transfer in complexes 
36-Cu2+ and 36-Zn2+. The occurrence of three well-defined isosbestic points 
demonstrated an equilibrium between 36 and 36-M2+. The little fluorescence 
presented by 36 (at 493 nm) was almost quenched upon sequential addition of 
Cu2+, being ascribed to the reverse PET from the 4-methylphenyl moiety to the 
phenolic hydroxyl, and carbohydrazide nitrogen and oxygen atoms, arising from 
the decrease in electron density after copper ion binding (Figure 15). In con-
trast, Zn2+ ion caused the enhancement in the fluorescence emission (~4.1-fold) 
of 36 due to the filled d10 electronic configuration of the Zn2+ ion, which does 
not usually involve energy or electron transfer mechanisms for the deactivation 
of the excited state (Figure 15).
Finally, the sensing mechanism of 36-Cu2+ and 36-Zn2+ has been shown to be 
reversible in the presence of EDTA, in which the fluorescence of 36 was almost 
recovered immediately from both complexes, which suggests the high reversibility 
of the chemosensor and the potential application in real-time monitoring [60].
Figure 15. 
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4. Conclusion
As exposed in this chapter, hydrazone derivatives have been extensively 
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hydrazone scaffold is of great importance in the design of optical sensors. Here 
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ability as chemosensor for CN−, F−, AcO−, multiple anions, Cu2+, Zn2+, Hg2+, Al3+, 
and multiple metals. Furthermore, we hope that this book chapter with discussions 
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Glycobiology is a glycan-based field of study that focuses on the structure,
function, and biology of carbohydrates, and glycomics is a sub-study of the field of
glycobiology that aims to define structure/function of glycans in living organisms.
With the popularity of the glycobiology and glycomics, application of computa-
tional modeling expanded in the scientific area of glycobiology over the last
decades. The recent availability of progressive Wet-Lab methods in the field of
glycobiology and glycomics is promising for the impact of systems biology on the
research area of the glycome, an emerging field that is termed “systems
glycobiology.” This chapter will summarize the up-to-date leading edge in the use
of bioinformatics tools in the field of glycobiology. The chapter provides basic
knowledge both for glycobiologists interested in the application of bioinformatics
tools and scientists of computational biology interested in studying the glycome.
Keywords: glycan, glycobiology, glycome, systems biology, systems glycobiology
1. Introduction
Glycans are long chains of carbohydrate-based polymers composed of repeating
units of monosaccharide monomers bound together by glycosidic linkages. Com-
plex and diverse glycans appear to be ever-present macromolecules in all cells in
nature, and essential to all biological systems. Glycans play physical, structural, and
metabolic roles in living organisms [1]. In the last century, knowledge on the
biochemistry and biology of nucleic acids and proteins rapidly increased. Never-
theless, it has been much more difficult to understand the biology of glycans, which
are main component of the cell surface [2]. The biosynthesis mechanism of glycans
is totally different from those of nucleic acids and proteins. Biological mechanism of
glycans is complex, which makes analysis of them extremely difficult and limits our
understanding of mechanisms responsible for biological functions of glycans [3].
After the genomics revolution and development of high-throughput technologies,
scientific interests increased to understand the characterization, function, and
interaction of other significant biomolecules (e.g., DNA transcripts, proteins, lipids,
and glycans) for the cell. These interests resulted in emergence of other omic types
such as transcriptomics, proteomics, metabolomics, lipidomics and glycomics [4].
From the perspective of evolutionary conservation, conservation decreased in the
order genomics, transcriptomics, proteomics, metabolomics, lipidomics, and
glycomics. On the other hand, reverse order is present for informational diversity of
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these fields of omics (Figure 1) [5].
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With the progress in high-throughput technologies, studies on glycobiology
increased to screen cells quickly and generate huge glycomics data sets. Moreover,
advanced analytical techniques and tools for data analysis provide possibility to
improve high-throughput techniques for screening glycans as a marker of diseases
and to classify structure of glycans in therapeutic proteins [6].
2. Glycans
Glycans are linear or branched sugar macromolecules composed of repeating
monosaccharides linked glycosidically. Beside nucleic acids and protein, glycans are
known as the third dimension in molecular biology [7, 8]. These macromolecules
can be found in the form of heteropolysaccharides or homopolysaccharides. Fur-
thermore, glycoconjugates (glycolipid, glycoprotein and proteoglycan), can be also
considered as glycan despite the fact that the carbohydrate part of glycoconjugates
are only oligosaccharides [9]. In glycoproteins, oligosaccharides and proteins can be
linked in different forms, namely N-linked glycans and O-linked glycans. N-
acetylglucosamine is linked to the amide side chain of asparagine in N-linked
glycans. C-1 of N-acetylgalactosamine is linked to the hydroxyl function of serine or
threonine in O-linked glycans [10].
With the increasing researches in glycoscience, many different roles of glycans
in biological systems have been revealed in the last decades. Significant functions of
glycans have been determined in numerous research areas such as immunity,
development and differentiation, biopharmaceuticals, cancer, fertilization, blood
types, infectious diseases, etc. Glycans are called as “cloths of cells” since they are
present on the surface of the cell and responsible for the signaling and communica-
tions between cells. Glycans can be classified in several ways. Varki divided the
biological roles of glycans into four main categories: (1) structural and modulatory
roles, (2) extrinsic (interspecies) recognition of glycans, (3) intrinsic (intraspecies)
recognition of glycans, and (4) molecular mimicry of host glycans. A total of 50
distinct roles are defined under these main categories [1].
Glycans perform huge range of biological function due to the diversity of them,
and they have significant roles in several physiological and pathological events, such
Figure 1.
The degree of evolutionary conservation and informational diversity for the omics fields.
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as cell growth, cell signaling, cell-cell interactions, differentiation, and tumor
growth [11–13]. In biological systems, information is carried by glycans, which are
significant biomarker candidates for many diseases such as cardiovascular diseases,
deficiencies of immune system, genetically inherited disorders, several cancer
types, and neurodegenerative diseases [14–16]. Alteration of glycan expression is
observed during the development and progression of these diseases, which is caused
by misregulated enzymes such as glycosyltransferases and glycosidases. As a result,
altered glycan structures have potential use for the identification of these diseases at
an early stage. Besides significant role of glycans in diagnosis and management of
disease, they can be used as therapeutics, markers for identification and isolation of
special cell types, and targets in discovery of drugs [17–19]. Moreover, glycans can
be considered as an ideal target for vaccines due to the presence of them on the
surface of several different pathogens and malignant cells. High affinity and exqui-
site specificity of other molecules to recognize glycans are a vital point of develop-
ments in the research of glycans and related diagnostics and therapeutic
applications.
3. Glycomics
Glycosylation plays significant roles in many biological processes including
growth and development of cell, tumor growth and metastasis, immune recognition
and response, intercommunication of cells, and microbial pathogenesis. As a result,
glycosylation of proteins is the one of the most common and significant posttrans-
lational modifications of proteins [20, 21]. Furthermore, more than half of proteins
undergo glycosylation [6]. Many issues such as genetic factors, nucleotide levels of
monosaccharides, cytokines, metabolites, hormones, and ecological factors can
affect and change glycosylation process [20–24]. Thus, integration of omics
approaches (e.g., proteomics, genomics, transcriptomics, and metabolomics) to the
field of glycobiology is essential to view the big picture of the whole biological
system [20, 21, 25]. Furthermore, for the analysis of glycans and glycosylation
pathways, many glycoinformatics tools and databases are now accessible [6].
Glycomics is one of the most recent types of omics area which is responsible for
the structure and function evaluations of glycans in bio-systems [26]. Integrating
glycomics to other fields of omics provides new system-scale insights in integrative
biology [27].
Moreover, glycomics informs other crucial scholarships such as systems
glycobiology and personalized glycomedicine that collectively aim to explain the
role of glycans in person-to-person and between population variations in disease
susceptibility and response to health interventions such as drugs, nutrition, and
vaccines. Glycosylation is present in both normal and diseased individuals [1].
Abnormal glycosylation is observed in a variety of diseases. Difference between
glycosylation patterns of healthy and diseased individuals can be used as
glycobiomarkers in personalized medicine [28]. As a result, many new medical
implications will be enabled by glycobiology and glycopathology [29]. Development
of glycomedicine can be contributed by holistic approach of functional and struc-
tural glycomics, which have applications in therapy development, fine-tuning
immunological responses and the performance of therapeutic antibodies and
boosting immune responses [28, 30]. Many applications of glycan arrays are present
in many fields, from basic biochemical research to biomedical applications [31]. In
addition to shotgun glycan microarrays [32], cell-based array resource has been
developed [33]. These developments enable deeper understanding of the many
biological roles of the glycome. Nevertheless, multiplatform and multiomics
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technologies are expected to further extend the knowledge of molecular mecha-
nisms of glycans.
3.1 Major glycomics techniques
Monosaccharides represent four free hydroxyl groups for the linkage of
another monosaccharide. As a result of this, glycans have more complex structure
compared to structure of peptides and nucleic acids. It is known that glycans are more
than the sequential monosaccharides; monomer types, modifications, the position of
modifications around the ring of sugar, glycopolymer branching, and linkages chiral-
ity are the factors that are responsible for the complexity. As a result, sequencing
techniques used for peptides or DNA (Sanger or Edman sequencing) are not appro-
priate for glycans. Moreover, most of the glycans are present as a part of a
glycoconjugate. Therefore, glycan part should be released from lipid or protein part,
by the use of enzymatic or chemical methods and isolated for analysis.
In the last decades, a number of techniques developed and applied to determine
structure of the glycans with different degrees of detail [34]. A traditional method is
to label the glycoconjugates radioactively and then apply anionic exchange, gel
filtration, or paper chromatographic analyses prior and subsequent to enzymatic or
chemical treatments. Still, it is difficult to figure out the definition of the actual
structure; in consequence, in earlier studies, if adequate amounts were present, gas
chromatography together with mass spectrometry (GC-MS) and/or nuclear mag-
netic resonance (NMR) studies were performed. However, these analyses involve
special expertise to perform the research and interpret the results, particularly if
standards were unavailable to compare with results.
HPLC and UPLC have superseded simple chromatography systems in recent
years, and radioactive labeling has been replaced by fluorescent labeling. Nowa-
days, variable columns such as graphitized carbon, reversed-phase (RP), anion
exchange, normal phase, or hydrophilic interaction resins can be used along with
suitable enzymatic/chemical treatments. A less used alternative is to analyze gly-
cans at elevated pH. As a result of this, the hydroxyl side chain deprotonation
occurs, that enables the usage of anion exchange together with amperometric
detection (HPAEC-PAD). On the other hand, glycan structure cannot be defined
only by HPLC retention times, and for the unknown structure, analyses in the
absence of standards should be interpreted with attention [35].
With the improvements in the types and the sensitivity, contribution of mass
spectrometer to studies of glycans and glycoconjugates has increased in the last
decades [36, 37]. At first, for the analysis of variable types of glycopolymers from
different sources, researchers used fast atom bombardment mass spectrometers
(FAB-MS). For the analyses with FAB-MS, chemical modifications such as methyl-
ation and acetylation were required. As an alternative method, matrix-assisted
laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
was developed and analysis of both permethylated and native glycans can be
performed with MALDI-TOF MS. Furthermore, current numerous electrospray
techniques with many detector types have significance in glycomics. Mainly, a
significant point in MS-based analysis is the capability to obtain glycan fragments.
Besides, the preparation and separation techniques are of great importance to
obtain the best results. As a consequence, liquid chromatography-mass spectrome-
try (LC-MS) in a number of forms is in general necessary since glycans with low
abundancy or poor ionization capacity can be suppressed in the case of whole
glycome examination. Moreover, reanalysis after the treatment of a chemical and an
enzyme results in maximization of the ability to obtain clear results from the
existing data.
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Glycan is generally a part of the glycoconjugate; thus, glycoproteomics and
glycolipidomics that consider both peptide/lipid and glycan parts are significant
fields. At this point, mass spectrometry technique comes into prominence [38].
Both glycan and polypeptide/lipid parts can be studied with this technique. On the
other hand, glycan parts of glycoproteins and glycolipids can be in various forms
even if the polypeptide/lipid part is same, defined as microheterogeneity. The
nature of glycan modifications is non-template driven and that leads to mentioned
microheterogeneity [39].
Blotting technique can be used for simple screens. Reagents such as lectins and
anti-carbohydrate antibodies with low specificity are often used for this technique;
as a result, misleading results are often obtained [40]. Still, lectins, and antiserums
have significance for immune responses in animals. New array-based systems can
provide essential clues on proteins bounded to glycans [41].
4. Systems glycobiology and integration of omics data sets
Developments in integrative informatics and systems biology of glycans based
on a holistic approach can make available a more comprehensive analysis. It eluci-
dates annotation of glycans, enzyme levels, abundances of glycans biosynthesis
pathways, and other omics data sets which are complementary. Though, several
tools are developed for proteomics and genomics data sets and standard bioinfor-
matics approaches are used in these tools, the complex relationships between
diverse components (such as glycans, enzymes, transporters, and sugar nucleo-
tides) of the glycosylation process are not considered by most of the existing
bioinformatics tools. Consequently, the use of these tools for glycomics data sets has
some limitations. The genome does not encode glycans directly and unlike proteins,
interconnected action of many enzymes provides assembly of glycans. Due to
mentioned limitations, developments in glycan analysis tools and methods have
been delayed and most of the present glycoinformatics tools are special for single
type data analysis [42–45]. For instance, database matching between obtained MS
results and specific glycans in a glycan library is used as a mutual method for MS-
based glycoprofiling for the purpose of individual peak annotation [46, 47]. If the
complexity of glycosylation is wanted to be considered, enzymes of the organism
which synthesize the studied glycans should generate glycan structures used for the
annotation of the spectrum [48]. Due to this alignment, activities of enzyme and
those structures assigned to each peak in the same spectrum will be consistent.
Although many omics approaches have significant progress in the last decades,
existing techniques of bioinformatics are still unsatisfactory for the integration of
varied data sets [49–51]. For instance, relations between expression levels of gene
and specific glycan linkages abundance are investigated by statistical database-
driven approaches, and these approaches could not predict quantity of detailed
glycan distributions [50, 51]. This indicates the necessity of glycoinformatics and
systems biology tools integration for the identification of glycan structure and these
should be also linked to the information of gene expression responsible for glyco-
sylation enzymes which synthesize these glycans. In order to understand levels of
mRNA which is related with the distribution and quantity of glycans present within
healthy and diseased cells, mathematical modeling of glycosylation is considered as
a promising method [48, 49, 52].
Variability in the platform of analytical high-throughput experiments can be
reduced by data integration approach. Increased confidence of biomarker predic-
tions and recommendations can be obtained if different data from experiments
such as glycogenes expression information or mass spectra profile confirm the
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technologies are expected to further extend the knowledge of molecular mecha-
nisms of glycans.
3.1 Major glycomics techniques
Monosaccharides represent four free hydroxyl groups for the linkage of
another monosaccharide. As a result of this, glycans have more complex structure
compared to structure of peptides and nucleic acids. It is known that glycans are more
than the sequential monosaccharides; monomer types, modifications, the position of
modifications around the ring of sugar, glycopolymer branching, and linkages chiral-
ity are the factors that are responsible for the complexity. As a result, sequencing
techniques used for peptides or DNA (Sanger or Edman sequencing) are not appro-
priate for glycans. Moreover, most of the glycans are present as a part of a
glycoconjugate. Therefore, glycan part should be released from lipid or protein part,
by the use of enzymatic or chemical methods and isolated for analysis.
In the last decades, a number of techniques developed and applied to determine
structure of the glycans with different degrees of detail [34]. A traditional method is
to label the glycoconjugates radioactively and then apply anionic exchange, gel
filtration, or paper chromatographic analyses prior and subsequent to enzymatic or
chemical treatments. Still, it is difficult to figure out the definition of the actual
structure; in consequence, in earlier studies, if adequate amounts were present, gas
chromatography together with mass spectrometry (GC-MS) and/or nuclear mag-
netic resonance (NMR) studies were performed. However, these analyses involve
special expertise to perform the research and interpret the results, particularly if
standards were unavailable to compare with results.
HPLC and UPLC have superseded simple chromatography systems in recent
years, and radioactive labeling has been replaced by fluorescent labeling. Nowa-
days, variable columns such as graphitized carbon, reversed-phase (RP), anion
exchange, normal phase, or hydrophilic interaction resins can be used along with
suitable enzymatic/chemical treatments. A less used alternative is to analyze gly-
cans at elevated pH. As a result of this, the hydroxyl side chain deprotonation
occurs, that enables the usage of anion exchange together with amperometric
detection (HPAEC-PAD). On the other hand, glycan structure cannot be defined
only by HPLC retention times, and for the unknown structure, analyses in the
absence of standards should be interpreted with attention [35].
With the improvements in the types and the sensitivity, contribution of mass
spectrometer to studies of glycans and glycoconjugates has increased in the last
decades [36, 37]. At first, for the analysis of variable types of glycopolymers from
different sources, researchers used fast atom bombardment mass spectrometers
(FAB-MS). For the analyses with FAB-MS, chemical modifications such as methyl-
ation and acetylation were required. As an alternative method, matrix-assisted
laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
was developed and analysis of both permethylated and native glycans can be
performed with MALDI-TOF MS. Furthermore, current numerous electrospray
techniques with many detector types have significance in glycomics. Mainly, a
significant point in MS-based analysis is the capability to obtain glycan fragments.
Besides, the preparation and separation techniques are of great importance to
obtain the best results. As a consequence, liquid chromatography-mass spectrome-
try (LC-MS) in a number of forms is in general necessary since glycans with low
abundancy or poor ionization capacity can be suppressed in the case of whole
glycome examination. Moreover, reanalysis after the treatment of a chemical and an
enzyme results in maximization of the ability to obtain clear results from the
existing data.
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Glycan is generally a part of the glycoconjugate; thus, glycoproteomics and
glycolipidomics that consider both peptide/lipid and glycan parts are significant
fields. At this point, mass spectrometry technique comes into prominence [38].
Both glycan and polypeptide/lipid parts can be studied with this technique. On the
other hand, glycan parts of glycoproteins and glycolipids can be in various forms
even if the polypeptide/lipid part is same, defined as microheterogeneity. The
nature of glycan modifications is non-template driven and that leads to mentioned
microheterogeneity [39].
Blotting technique can be used for simple screens. Reagents such as lectins and
anti-carbohydrate antibodies with low specificity are often used for this technique;
as a result, misleading results are often obtained [40]. Still, lectins, and antiserums
have significance for immune responses in animals. New array-based systems can
provide essential clues on proteins bounded to glycans [41].
4. Systems glycobiology and integration of omics data sets
Developments in integrative informatics and systems biology of glycans based
on a holistic approach can make available a more comprehensive analysis. It eluci-
dates annotation of glycans, enzyme levels, abundances of glycans biosynthesis
pathways, and other omics data sets which are complementary. Though, several
tools are developed for proteomics and genomics data sets and standard bioinfor-
matics approaches are used in these tools, the complex relationships between
diverse components (such as glycans, enzymes, transporters, and sugar nucleo-
tides) of the glycosylation process are not considered by most of the existing
bioinformatics tools. Consequently, the use of these tools for glycomics data sets has
some limitations. The genome does not encode glycans directly and unlike proteins,
interconnected action of many enzymes provides assembly of glycans. Due to
mentioned limitations, developments in glycan analysis tools and methods have
been delayed and most of the present glycoinformatics tools are special for single
type data analysis [42–45]. For instance, database matching between obtained MS
results and specific glycans in a glycan library is used as a mutual method for MS-
based glycoprofiling for the purpose of individual peak annotation [46, 47]. If the
complexity of glycosylation is wanted to be considered, enzymes of the organism
which synthesize the studied glycans should generate glycan structures used for the
annotation of the spectrum [48]. Due to this alignment, activities of enzyme and
those structures assigned to each peak in the same spectrum will be consistent.
Although many omics approaches have significant progress in the last decades,
existing techniques of bioinformatics are still unsatisfactory for the integration of
varied data sets [49–51]. For instance, relations between expression levels of gene
and specific glycan linkages abundance are investigated by statistical database-
driven approaches, and these approaches could not predict quantity of detailed
glycan distributions [50, 51]. This indicates the necessity of glycoinformatics and
systems biology tools integration for the identification of glycan structure and these
should be also linked to the information of gene expression responsible for glyco-
sylation enzymes which synthesize these glycans. In order to understand levels of
mRNA which is related with the distribution and quantity of glycans present within
healthy and diseased cells, mathematical modeling of glycosylation is considered as
a promising method [48, 49, 52].
Variability in the platform of analytical high-throughput experiments can be
reduced by data integration approach. Increased confidence of biomarker predic-
tions and recommendations can be obtained if different data from experiments
such as glycogenes expression information or mass spectra profile confirm the
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results from integrative glycoinformatics and systems glycobiology tools.
Although integrated glycoinformatics tools have limitations in analytical
sensitivities, analysis and comparison of various results with various platforms are
enabled by these tools [6].
The integration of glycomics with other various omics data is promising for
further innovation in diagnosis and treatment of diseases [30]. The start point of
multiomics data integration is to sort the data based on the omics level. In the
following part, association between glycomics and other omics levels will be
represented.
4.1 Genomics
Integration of glycomics with genetic sequence can be occur in a number of
ways. For instance, glycosylation site can be gained or lost with the variation of
sequence. A single-nucleotide polymorphism (SNP) affects glycosylation of
prostate-specific antigen (PSA) and an altered function of it increases the risk of
prostate cancer. Functional analysis indicated that the stability and structural con-
formation of PSA are affected by missense variant rs61752561, which causes an
additional extra glycosylation site [53]. Furthermore, computational studies
revealed that variations in cancer somatic cells have potential to cause gain or loss of
glycosylation. In addition to SNP, variations in structure and abnormalities in cyto-
genetics could be integrated with glycomics. Cytogenetic abnormalities have been
associated with glycome expression [54]. A particular glycosyltransferase can gly-
cosylate numerous proteins, so genetic variants of it have extraordinary significance
because function of many glycoproteins can be affected by a single difference in
activity of enzyme. Several downstream pathways and cell metabolism can be
affected by a genetic or epigenetic variant that is called pleiotropic effect of genetic
or epigenetic variant on glycosylation [55].
4.2 Transcriptomics
Most of the glycomics research have been done at the level of transcriptome,
which can be performed either at a particular locus or with a technology of micro-
array. In colorectal cancer (CRC), glycosyltransferase ST6GAL1 is associated with
cancer, and altered ST6GAL1 expression was found by The Cancer Genome Atlas
(TCGA) mining [56]. Moreover, in order to identify differential expression of
glycosylation-related genes Saravanan et al. [57] used GLYCOv2 glycogene micro-
array technology. In the further studies, myeloma was compared with normal
plasma cell samples and 60 upregulated and 20 downregulated genes were found
among 243 genes in glycan-biosynthesis pathway [54]. A novel molecular signature
that is enriched for enzymes of glycosylation was revealed by meta-analysis
performed for gene expression of prostate cancer [58]. Additionally, hepatocellular
carcinoma was investigated by reviewing gene expressions that are related with
core fucosylation of the disease [59]. More systematic reviews and meta-analyses
are required to develop reliable biomarkers.
4.3 Glycoproteomics
Studies on glycoproteomics include peptide structures, glycan structures, and
sites of glycosylation [30]. Single site on the peptide chain can be glycosylated by
different glycans, and by this way, glycans can modulate function of the protein
[60]. In the literature, diverse techniques were associated with different pheno-
types, for instance, breast cancer, colon cancer, liver cancer, skin cancer, ovary
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cancer, bladder cancer, and neurodegenerative diseases, and additionally, a number
of structural variations including sialylation, fucosylation, degree of branching, and
specific glycosyltransferases expression [61–63]. For instance, cerebrospinal fluid
N-glycoproteomics is of significant importance in early diagnosis of Alzheimer’s
disease. Glycosylation patterns were assessed in patients and therapeutics targets
such as glycoenzymes were suggested [63]. For the diagnosis of pancreatic cancer,
specific glycoforms together with protein levels should be measured to improve
potential for diagnosis [64]. Glycoproteins constitute the majority of protein tumor
markers approved by Food and Drug Administration (FDA), and they are also used
currently in clinical practice. Many of these glycoproteins have alterations of glyco-
sylation in cancer [60]. MUC-1 (CA15-3/CA27.29) [65] and plasminogen activator
inhibitor (PAI-1) [66] are biomarkers of breast cancer; beta-human chorionic
gonadotropin (Beta-hCG) [67] is biomarker of colorectal cancer; alpha-fetoprotein
(AFP) [68] is a biomarker of liver cancer and germ cell tumors; chromogranin A
(CgA) [69] is a biomarker of neuroendocrine tumors; MUC16 (CA-125) [70] and
HE4 [71] are biomarkers of ovarian cancer; and many other biomarkers are present
for a variety type of cancer. Most of the results in the existing publications are
heterogeneous; thus, systematic integrative reviews of the literature are required
for further development of glycoproteomics.
4.4 Metabolomics
Metabolomics is the large-scale study of the small molecule substrates that
investigates variations in the metabolites within cells, biofluids, tissues, or organ-
ism. Metabolomics and glycomics were investigated in the research of post-
traumatic stress [72]. According to the researchers of this study, these biomarkers
together with omics markers should be integrated to understand the biological
differences responsible for this stress. For discovery of liver cancer biomarker,
proteomics, glycomics, and metabolomics were integrated and this integration
enhanced performance when compared to separate omics data [73]. Physiological
and pathological conditions are reflected by metabolomic and glycomic data in
individuals. Similar to metabolites, small glycans can be quantified easily [74].
Human Metabolome Database (HMDB) is the most inclusive metabolite source that
offers significant resource for the discovery of biomarkers in glycomics [75].
4.5 Glycolipidomics
Glycolipidomics is a scientific field that identifies and quantifies glycolipids. For
the determination of physiological and pathological conditions of individual, glyco-
lipids can be used as a specific biomarker. They take role in development of neuro-
logical and neurodegenerative diseases, such as Lewy body dementia, Alzheimer’s
disease, Parkinson’s disease, and frontotemporal dementia [30]. Furthermore,
glycosphingolipids are associated with cancer and they are promising molecules for
diagnosis as biomarkers and for malignant tumor immunotherapy as target [76].
More recently, Dehelean et al. [77] reviewed trends in the discovery of glycolipid
biomarker by MS.
4.6 Interactomics
Interactomics is the research field that investigates whole set of interactions
between molecules including glycans. Interaction of glycans with glycan-binding pro-
teins (GBPs) is of significant importance in immune response, signaling, cell recogni-
tion, infections, neurodegenerative diseases, and cancer. High-throughput
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results from integrative glycoinformatics and systems glycobiology tools.
Although integrated glycoinformatics tools have limitations in analytical
sensitivities, analysis and comparison of various results with various platforms are
enabled by these tools [6].
The integration of glycomics with other various omics data is promising for
further innovation in diagnosis and treatment of diseases [30]. The start point of
multiomics data integration is to sort the data based on the omics level. In the
following part, association between glycomics and other omics levels will be
represented.
4.1 Genomics
Integration of glycomics with genetic sequence can be occur in a number of
ways. For instance, glycosylation site can be gained or lost with the variation of
sequence. A single-nucleotide polymorphism (SNP) affects glycosylation of
prostate-specific antigen (PSA) and an altered function of it increases the risk of
prostate cancer. Functional analysis indicated that the stability and structural con-
formation of PSA are affected by missense variant rs61752561, which causes an
additional extra glycosylation site [53]. Furthermore, computational studies
revealed that variations in cancer somatic cells have potential to cause gain or loss of
glycosylation. In addition to SNP, variations in structure and abnormalities in cyto-
genetics could be integrated with glycomics. Cytogenetic abnormalities have been
associated with glycome expression [54]. A particular glycosyltransferase can gly-
cosylate numerous proteins, so genetic variants of it have extraordinary significance
because function of many glycoproteins can be affected by a single difference in
activity of enzyme. Several downstream pathways and cell metabolism can be
affected by a genetic or epigenetic variant that is called pleiotropic effect of genetic
or epigenetic variant on glycosylation [55].
4.2 Transcriptomics
Most of the glycomics research have been done at the level of transcriptome,
which can be performed either at a particular locus or with a technology of micro-
array. In colorectal cancer (CRC), glycosyltransferase ST6GAL1 is associated with
cancer, and altered ST6GAL1 expression was found by The Cancer Genome Atlas
(TCGA) mining [56]. Moreover, in order to identify differential expression of
glycosylation-related genes Saravanan et al. [57] used GLYCOv2 glycogene micro-
array technology. In the further studies, myeloma was compared with normal
plasma cell samples and 60 upregulated and 20 downregulated genes were found
among 243 genes in glycan-biosynthesis pathway [54]. A novel molecular signature
that is enriched for enzymes of glycosylation was revealed by meta-analysis
performed for gene expression of prostate cancer [58]. Additionally, hepatocellular
carcinoma was investigated by reviewing gene expressions that are related with
core fucosylation of the disease [59]. More systematic reviews and meta-analyses
are required to develop reliable biomarkers.
4.3 Glycoproteomics
Studies on glycoproteomics include peptide structures, glycan structures, and
sites of glycosylation [30]. Single site on the peptide chain can be glycosylated by
different glycans, and by this way, glycans can modulate function of the protein
[60]. In the literature, diverse techniques were associated with different pheno-
types, for instance, breast cancer, colon cancer, liver cancer, skin cancer, ovary
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cancer, bladder cancer, and neurodegenerative diseases, and additionally, a number
of structural variations including sialylation, fucosylation, degree of branching, and
specific glycosyltransferases expression [61–63]. For instance, cerebrospinal fluid
N-glycoproteomics is of significant importance in early diagnosis of Alzheimer’s
disease. Glycosylation patterns were assessed in patients and therapeutics targets
such as glycoenzymes were suggested [63]. For the diagnosis of pancreatic cancer,
specific glycoforms together with protein levels should be measured to improve
potential for diagnosis [64]. Glycoproteins constitute the majority of protein tumor
markers approved by Food and Drug Administration (FDA), and they are also used
currently in clinical practice. Many of these glycoproteins have alterations of glyco-
sylation in cancer [60]. MUC-1 (CA15-3/CA27.29) [65] and plasminogen activator
inhibitor (PAI-1) [66] are biomarkers of breast cancer; beta-human chorionic
gonadotropin (Beta-hCG) [67] is biomarker of colorectal cancer; alpha-fetoprotein
(AFP) [68] is a biomarker of liver cancer and germ cell tumors; chromogranin A
(CgA) [69] is a biomarker of neuroendocrine tumors; MUC16 (CA-125) [70] and
HE4 [71] are biomarkers of ovarian cancer; and many other biomarkers are present
for a variety type of cancer. Most of the results in the existing publications are
heterogeneous; thus, systematic integrative reviews of the literature are required
for further development of glycoproteomics.
4.4 Metabolomics
Metabolomics is the large-scale study of the small molecule substrates that
investigates variations in the metabolites within cells, biofluids, tissues, or organ-
ism. Metabolomics and glycomics were investigated in the research of post-
traumatic stress [72]. According to the researchers of this study, these biomarkers
together with omics markers should be integrated to understand the biological
differences responsible for this stress. For discovery of liver cancer biomarker,
proteomics, glycomics, and metabolomics were integrated and this integration
enhanced performance when compared to separate omics data [73]. Physiological
and pathological conditions are reflected by metabolomic and glycomic data in
individuals. Similar to metabolites, small glycans can be quantified easily [74].
Human Metabolome Database (HMDB) is the most inclusive metabolite source that
offers significant resource for the discovery of biomarkers in glycomics [75].
4.5 Glycolipidomics
Glycolipidomics is a scientific field that identifies and quantifies glycolipids. For
the determination of physiological and pathological conditions of individual, glyco-
lipids can be used as a specific biomarker. They take role in development of neuro-
logical and neurodegenerative diseases, such as Lewy body dementia, Alzheimer’s
disease, Parkinson’s disease, and frontotemporal dementia [30]. Furthermore,
glycosphingolipids are associated with cancer and they are promising molecules for
diagnosis as biomarkers and for malignant tumor immunotherapy as target [76].
More recently, Dehelean et al. [77] reviewed trends in the discovery of glycolipid
biomarker by MS.
4.6 Interactomics
Interactomics is the research field that investigates whole set of interactions
between molecules including glycans. Interaction of glycans with glycan-binding pro-
teins (GBPs) is of significant importance in immune response, signaling, cell recogni-
tion, infections, neurodegenerative diseases, and cancer. High-throughput
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technologies ease studies also on interactomics [78]. UniLectin3D is a database that
catalog lectins that aremost studiedGBPs. Database consists of curated information on
3D structures and interacting ligands [79]. Lectin-glycan interaction on surface of the
cell is a significant factor for the regulation in corneal biology (i.e., corneal infection)
and pathophysiology (i.e., inflammation) [80]. The whole protein-glycan interactome
information has not been obtained yet [41]. For future studies, estimated number of
interactions is of importance. GenProBiS is a bioinformatics tool that analyzes binding
sites between peptide-peptide, peptide-nucleic acid, and peptide-compound and also
sites of glycosylation and other posttranslational modifications. Furthermore, it pro-
vides maps between sequence variations and structure of protein. More developments
of bioinformatics tools analyzing huge data will prioritize the objections for experi-
mental verification and provide contribution to interactomics development.
4.7 Other omics fields
In future studies, many other omics fields should be associated with glycomics
such as comparative genomics, epigenomics, regulomics, NcRNomics, MiRNomics,
LncRNomics, etc. Although glycomics is the significant field related with molecular
interactions, information about how these complex processes controlled by
regulatory network is still inadequate. In addition to classic omics fields, omics
applications such as iatromics, environmental omics, pharmacogenomics, and
nutrigenomics should also be reviewed.
5. Bioinformatics tools and databases
Glycoinformatics combines bioinformatics tools with glycome. Glycomics data
is collected by the tools and databases to investigate, reveal, and associate with
other repository of related data of proteomics, genomics, and interactomics.
Commonly used tools and databases are summarized in Table 1.
6. Current bottlenecks for systems glycobiology
System-based analyses applied smoothly to network of signaling, metabolic
processes, and physiological modeling; however, applications in systems
glycobiology still have problems in computational and analytical studies and this
situation arises from prominent bottlenecks [81]: (i) there is no accepted standard
for model building; (ii) glycoinformatics databases are underdeveloped; (iii) and
insufficient quantitative data are from glycoproteomics experiments.
In recent years, many systems based models have been developed to simulate
biosynthesis of glycans. Nevertheless, difficulty in the incorporation of glycan
structure and specificity data of enzymes related with glycosylation into mathe-
matical models. As a result of this difficulty, systematic model building is still not
present in this field. Moreover, limited number of the current models is available in
Systems Biology Markup Language (SBML) format [82], which is the obstacle to
develop, share, and validate computational models.
In the last decades, many databases related to glycoscience have emerged. Nev-
ertheless, functional information is limited when compared to glycan structure and
taxonomy data. In the future, relation of glycan structure to specific enzymes that
synthesize them, the rates of their synthesis, and also their function are required in
order to build model.
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Name Description Link
Databases CAZY Describes the families of structurally
related catalytic and carbohydrate
binding modules (or functional
domains) of enzymes that degrade,
modify, or create glycosidic bonds
http://www.cazy.
org/
KEGG GLYCAN The KEGG GLYCAN structure
database is a collection of
experimentally determined glycan
structures. It contains all unique
structures taken from CarbBank,
structures entered from recent





Glycan Library A list of approximately 830 lipid-
linked sequence-defined glycan
probes derived from diverse natural




GlycoMob An ion mobility-mass spectrometry




GlycoBase 3.2 A database of over 650 N- and O-
linked glycan structures of HPLC,
UPLC, exoglycosidase sequencing,
and mass spectrometry (MALDI-





Glyco3D A portal of 3D structures of mono-,








GlyMAP An online resource mapping of the
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UniProtKB The universal protein sequence




UniCarbKB UniCarbKB is a curated and
annotated glycan database which
curates information from the
scientific literature on glycoprotein-
derived glycan structures. It




UniCarbDB UniCarbDB is a platform for
presenting glycan structures and
fragment data characterized by LC-
MS/MS strategies. The database is
annotated with high-quality datasets
and is designed to extend and
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technologies ease studies also on interactomics [78]. UniLectin3D is a database that
catalog lectins that aremost studiedGBPs. Database consists of curated information on
3D structures and interacting ligands [79]. Lectin-glycan interaction on surface of the
cell is a significant factor for the regulation in corneal biology (i.e., corneal infection)
and pathophysiology (i.e., inflammation) [80]. The whole protein-glycan interactome
information has not been obtained yet [41]. For future studies, estimated number of
interactions is of importance. GenProBiS is a bioinformatics tool that analyzes binding
sites between peptide-peptide, peptide-nucleic acid, and peptide-compound and also
sites of glycosylation and other posttranslational modifications. Furthermore, it pro-
vides maps between sequence variations and structure of protein. More developments
of bioinformatics tools analyzing huge data will prioritize the objections for experi-
mental verification and provide contribution to interactomics development.
4.7 Other omics fields
In future studies, many other omics fields should be associated with glycomics
such as comparative genomics, epigenomics, regulomics, NcRNomics, MiRNomics,
LncRNomics, etc. Although glycomics is the significant field related with molecular
interactions, information about how these complex processes controlled by
regulatory network is still inadequate. In addition to classic omics fields, omics
applications such as iatromics, environmental omics, pharmacogenomics, and
nutrigenomics should also be reviewed.
5. Bioinformatics tools and databases
Glycoinformatics combines bioinformatics tools with glycome. Glycomics data
is collected by the tools and databases to investigate, reveal, and associate with
other repository of related data of proteomics, genomics, and interactomics.
Commonly used tools and databases are summarized in Table 1.
6. Current bottlenecks for systems glycobiology
System-based analyses applied smoothly to network of signaling, metabolic
processes, and physiological modeling; however, applications in systems
glycobiology still have problems in computational and analytical studies and this
situation arises from prominent bottlenecks [81]: (i) there is no accepted standard
for model building; (ii) glycoinformatics databases are underdeveloped; (iii) and
insufficient quantitative data are from glycoproteomics experiments.
In recent years, many systems based models have been developed to simulate
biosynthesis of glycans. Nevertheless, difficulty in the incorporation of glycan
structure and specificity data of enzymes related with glycosylation into mathe-
matical models. As a result of this difficulty, systematic model building is still not
present in this field. Moreover, limited number of the current models is available in
Systems Biology Markup Language (SBML) format [82], which is the obstacle to
develop, share, and validate computational models.
In the last decades, many databases related to glycoscience have emerged. Nev-
ertheless, functional information is limited when compared to glycan structure and
taxonomy data. In the future, relation of glycan structure to specific enzymes that
synthesize them, the rates of their synthesis, and also their function are required in
order to build model.
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Name Description Link
ontologies developed by existing
glycomics databases
UniPep A database for human N-linked
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of known carbohydrate sequences to
which pathogenic organisms
specifically adhere via lectins or
adhesins. The data were compiled
through an exhaustive search of
literature published over the past







The CFG serves to combine the
expertise and glycomics resources to
reveal functions of glycans and
glycan-binding proteins (GBPs) that
impact human health and disease.
The CFG offers resources to the
community, including glycan
array screening services, a
reagent bank, and access to a
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the “Route Searching System for
Glycan Synthesis,” and “GlycoNAVI
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carbohydrates published in the
literature and mostly resolved by
nuclear magnetic resonance (NMR).
CSDB is composed of two parts:
Bacterial and Archeal (BCSDB) and





EXPASy This section of the ExPASy server
gathers a toolbox for processing data
as well as simulating, predicting, or
visualizing information, relative to
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Name Description Link
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shifts of oligo- and polysaccharides
http://www.casper.
organ.su.se/casper/
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allow the rapid drawing of glycan
structures with support for all of the
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interactive comparison of glycan
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proteomics analyses for the
characterization of glycopeptides.
GlycoSpectrumScan is a MS
platform which is independent,
freely accessible, and profiles
glycopeptide MS data using
beforehand separately acquired
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For the measurement of glycome, two main approaches are common. In the first
approach, enzymes or mild hydrolysis is used to separate the glycans from the
peptide backbone. Next, to obtain information about the composition and relative
abundance of the carbohydrate structures, permethylation of glycans and MS anal-
ysis are used [83]. The bottleneck is the lack of well-developed software. For the
data analysis of glycoproteomics and correspondingly acceleration of system-based
model building and validation, more sophisticated computational tools are required.
7. Mathematical modeling of biochemical reaction networks
Mathematical models of glycosylation are developed in three main stages: (i)
biological information gathering; (ii) model formulation; (iii) and simulation and
postsimulation analysis. First step includes definition of components (enzyme,
substrate, and product) crucial for the model. All of the components present in the
biochemical network and connections between them are cataloged in this step. The
process relies on information of biochemistry and cell biology, and analytical tools.
In the next step, behavior in the steady state of the system is investigated by using
Name Description Link
information. Both N- and O-
glycosylated peptides as well as
multiply glycosylated peptides can
be analyzed
SimGlycan A predictive carbohydrate analysis
tool for MS/MS data
http://www.premie
rbiosoft.com/glycan
SugarQb SugarQb enables genome-wide
insights into protein glycosylation
and glycan modifications in complex
biological systems. This is a
collection of software tools (Nodes)
which enable the automated
identification of intact glycopeptides
from HCD‐MS/MS data sets, using




GlycoDigest GlycoDigest is a tool that simulates
exoglycosidase digestion based on
controlled rules acquired from
expert knowledge and experimental
evidence available in GlycoBase
www.glycodigest.
org/
Virtual Glycome This Website is focused on
presenting selected computational
tools and experimental resources
that can be used to better
understand the processes regulating











Tools and databases used in glycoinformatics.
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simple linear algebra and principles of optimization. If time is a variable, the com-
puter model can incorporate ordinary differential equations (ODEs) or Boolean
networks. Proper kinetic/thermodynamic/stochastic/optimization parameters are
collated depending on the formulation nature of the model and processes which are
specified by enzymatically/nonenzymatically. The last step is performed to simulate
the experimental system in the computer and to define unknown parameters of
model by the help of fitting experimental data [81]. Visualization of
multidimensional results is significant because numerous diverse models may
attempt to fit one data set obtained from time labor and concentration-dependent
experiments. As a result, consolidation of the findings obtained by simulations of
complex reaction network and generation of hypotheses that can be tested experi-
mentally require network analysis strategies.
8. Conclusions
Glycomics is a very comprehensive research area of science and interacts with
several different omics fields. As many other omics types, it consists of a huge
number of genomics components. In the future, techniques in high-throughput
analysis and bioinformatics will be developed and enable the integration of all
available data of glycomics into a particular diagram and by this way, it will be
possible to develop biomarker and identify potential new therapeutic targets.
Moreover, progresses in the field reveal that integrative multiomics approach
should include glycomics in order to develop new biomarkers for robust diseases.
One of the specific fields of systems biology is the systems glycobiology. It is based
on a holistic approach that indicates process of complex glycosylation and associa-
tions between its constituents. A more complete glycome overview is targeted by
using enzyme levels, abundances of glycans, pathways for biosynthesis, glycan
annotation, and related omics data sets.
An approach of systems glycobiology is constructed in combination of various
data sets of glycomics with that of other omics fields by the use of glycoinformatics
tools to clarify understanding on process of glycosylation from various data sets.
With the presented chapter, main aspects of glycobiology, glycomics, and systems
glycobiology are summarized. However, these fields are still developing and further
developments provide more insight to this specific research area.
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